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1 INTRODUCTION 
1.1  PHOSPHORYLATION IN CELL SIGNALING 
Cells need to react quickly to changes in their environment and to this end they developed 
mechanisms to translate extracellular and intracellular stimuli into a biochemical code that 
can be read by the protein machinery. As fundamental requirement this often needs to occur 
fast and thus cannot only rest upon synthesis of new proteins. A large part of this code is 
therefore based on posttranslational modifications (PTMs) that are attached to specific sites 
in proteins. In order to maintain flexibility, many types of PTMs can be removed again. 
Phosphorylation is one of the most prominent reversible PTMs on proteins and typically 
occurs on serine, threonine and tyrosine. In prokaryotes, histidine and aspartate are also 
common amino acids for the attachment of phospho-moieties. Apart from proteins, lipids and 
sugars can also be phosphorylated, with phosphatidylinositol phosphates and 
phosphoinositides constituting important docking sites and second messengers, respectively. 
In agreement with the central and manifold role of phosphorylation, the human genome 
harbors more than 500 protein kinases and more than 150 protein phosphatases1, 2. 
1.1.1 Phosphorylation as regulatory switch in proteins 
Phosphorylation can change the functional state of a protein either by triggering a 
conformational change or by facilitating or preventing intermolecular interactions. Regulated 
protein-protein interactions form the basis of cellular signal transduction, and frequently 
posttranslational modifications such as phosphorylation constitute the molecular switch to 
enable the association or dissociation of proteins. A phosphorylated motif can serve as a 
docking site for a specific binding domain. Prominent domains that recognize phosphoserine 
(pSer) and phosphothreonine (pThr) are the 14-3-3, WW, and FHA domains3, 4. 14-3-3 
domains prefer motifs with a proline in the +2 position (with respect to the pSer/pThr), and a 
serine or aromatic amino acid in the -2 position, preceded by an arginine in the -3 or -4 
position. WW domains typically recognize short proline sequences like PPXY, PPLP or PPR. 
Only a subset of WW domains binds to pSer/pThr followed by a proline. FHA domains are 
dedicated to the recognition of pThr-motifs, and they exploit the +3 position for selectivity. 
Phosphotyrosine (pTyr) engages separate domain families for recruitment, which will be 
highlighted in detail below.  
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1.1.2 Tyrosine phosphorylation 
Phosphorylation is a prominent instrument in the toolbox of signaling, and especially tyrosine 
phosphorylation has attracted much attention in the propagation of signals downstream of 
receptor tyrosine kinases (RTKs) and cytoplasmic protein tyrosine kinases. The human 
genome harbors 90 genes for protein tyrosine kinases and 107 genes for protein tyrosine 
phosphatases5. Phosphorylated tyrosine sites serve particularly often as docking interfaces. 
Intramolecular interactions with a pTyr-binding module such as an SH2 domain can activate 
the protein (as in the case of Fes) or inactivate it (as in the case of Src and Abl)6. In 
intermolecular interactions, the mere binding to a phosphorylated motif can also modulate 
the enzymatic activity of the protein in some cases. However, the primary goal of the 
interaction is usually the effect on the localization of the recruited protein. By increasing its 
local concentration and scaffolding it together with its upstream or downstream effectors, 
signaling pathways can be initiated, streamlined and terminated in a concerted manner. 
1.1.3 Interaction modules in phosphotyrosine signaling 
Domains as independent entities within proteins form one of the pivotal pillars on which the 
interplay of proteins in eukaryotic cells is built. Approximately 70% of all human proteins 
contain at least one domain, and each individual domain appears between 10 and 300 times 
in the proteome. Domains involved in protein-protein interaction typically recognize short, 
unstructured sequence motifs7. From a pharmaceutical point of view, this makes them 
somewhat better suited for intervention using small molecule drugs than protein-protein 
interactions involving extended parts of both molecules8. 
There are two domain families that are well-known for their ability to bind to pTyr-containing 
sequences: the Src-homology 2 (SH2) domain and the Phosphotyrosine-binding (PTB) 
domain. The genomes of humans and mice contain 120 different SH2 domains in 110 
different proteins. Ten of those proteins contain two SH2 domains9. PTB domains are 
represented 56 times in the genome. In addition there is a growing body of evidence for the 
existence of other domains with pTyr-binding capability. 
1.1.3.1 SH2 domains 
SH2 domains are made up of approximately 100 amino acids and mediate protein interaction 
in a plethora of different signaling pathways. Consequently, many mutations in genes of 
SH2 domains are known that contribute to human disorders, including cancers, diabetes, 
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developmental disorders, and immunodeficiencies9, 10. A large portion of the free binding 
energy of a pTyr-motif to an SH2 domain is provided by the phospho-moiety itself, laying the 
groundwork for a strong on/off-switch for binding. Even free phosphotyrosine and 
phenylphosphate bind relatively well. The other portion, and most importantly also the 
binding specificity, is contributed by interactions with the residues C-terminal to the 
phosphotyrosine. As determined largely via degenerate peptide library screening, motifs for 
SH2 domains typically encompass residues +1 to +4 relative to the pTyr11. Some 
SH2 domains also exploit amino acids at the N-terminal side for binding11, 12. In few cases 
even more extended contacts from -6 to +6 are formed13, 14. The SH2 domain of SAP, for 
example, engages so many residues that already the non-phosphorylated form shows 
considerable binding, and phosphorylation only enhances the binding 5-fold15. The structure 
of SH2 domains consists of a central -sheet, flanked by two -helices. In almost all 
SH2 domains a conserved arginine is responsible for binding of the pTyr11. The general 
binding mode of SH2 domains directs the sequence of the partner protein perpendicular to 
the central -sheet of the SH2 domain in an extended conformation. Therefore the interaction 
is largely independent of the structural context in the native protein. This allows to study 
SH2-binding using short synthetic peptides11. Typical structures of SH2 and PTB domains 
and their peptide binding manners are shown in figure 1. 
 
Figure 1: Different modes of peptide recognition by SH2 and PTB domains. 
Ribbons representations are shown on the left for the Src SH2 domain [PDB code 1SPS] and on the 
right for the IRS-1 PTB domain [PDB code 1IRS]. Superimposed in each case are multiple different 
ligands, to show how they bind with respect to the SH2 or PTB domain fold. For SH2 domains, eight 
different SH2/phosphopeptide complex structures were overlaid, and for PTB domains six available 
PTB domain/peptide complex structures were taken. Reproduced from Schlessinger and Lemmon, 
Science, 2003. 
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The binding constants of SH2 domains lie in the range of several hundred nanomolar or 
less16. The half-life of SH2-mediated interactions is short, which fulfills the requirements of 
dynamic signaling17. Some SH2 domains may also bind nonpeptide ligands. The SH2 
domains of phosphatidylinositol-3-kinase (PI3K) can bind phosphatidylinositol-3,4,5-
triphosphate (PI(3,4,5)P3), which interferes with recognition of pTyr-containing peptides and 
may thereby provide a feedback inhibition of SH2-phosphoprotein interactions18.  A few 
proteins contain two SH2 domains in a tandem setup. This not only increases specificity, but 
also enhances the affinity up to 1000-fold compared to engaging just one domain6. The 
dendrogram in figure 2 illustrates the relationship between the 120 human SH2 domains 
based on sequence similarity. 
While the major function of SH2 domains consists of their contribution to signal-dependent 
localization, they sometimes serve additional purposes. Binding of the PI3K regulatory 
subunit to pTyr-motifs, for example, not only relocates the constitutively associated catalytic 
domain to the membrane, but also relieves an autoinhibitory configuration. Similarly, the 
cytoplasmic protein tyrosine kinase Src is maintained in an autoinhibited configuration by 
intramolecular interactions mediated by its SH2 and SH3 domains. Besides 
dephosphorylation of the respective tyrosine and binding of the SH3 domain to a different 
protein, the interaction of the SH2 domain with another protein is a mechanism to activate 
Src6. 
SH2-containing proteins span a broad range in terms of the various downstream effects they 
initiate. Figure 3 displays those diverse functions, and at the same time it highlights the 
frequently observed multidomain architecture. Adaptor proteins like Grb2, Crk and Nck are 
typically composed of SH2 and SH3 domains, which they use for binding to downstream 
effectors with proline-rich motifs. While for example the N-terminal SH3-domain of Grb2 
primarily binds to Sos, the C-terminal SH3-domain recruits Gab1. Gab1 then becomes 
phosphorylated, generating binding sites for PI3K. Thus, Grb2 can simultaneously activate 
the Ras/MAPK-pathway and the PI3K/Akt-pathway. The scaffold protein Shc contains a PTB 
domain in addition to the SH2 domain, which enables it to interact with two tyrosine-
phosphorylated proteins simultaneously. pTyr-sites can also directly influence the 
phosphorylation status in their surrounding by recruiting kinases (e.g. Fyn, Src) or 
phosphatases (e.g. PTN11/SHP2). The N-terminal SH2 domain of the tyrosine phosphatase 
SHP2, for example, contains a loop that binds to the catalytic cleft of the phosphatase and 
prevents access of substrates. Binding of this SH2 domain to pTyr-motifs releases this 
autoinhibition. Signal regulation, for example via negative feedback, is carried out by proteins 
of the SOCS and Cbl families. They attenuate the signals generated at the membrane in 
response to cytokines, growth factors and hormones through competitive binding and 
recruitment of E3 ubiquitin ligases which mark proteins for proteasomal degradation. Also at    
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Figure 2: Dendrogram of the Human Complement of SH2 Domains. 
The sequence similarity between the 120 known human SH2 domains is visually depicted. The initial 
branching pattern was built from a neighbor-joining tree derived from a ClustalW protein sequence 
alignment of the domains. Branches of the tree are colored according to the presumed function of the 
protein in which each SH2 domain is embedded according to the legend provided. The protein name 
is indicated in red if one or more structures exist as PDB files. Reproduced from Liu et al, Molecular 
Cell, 2006. 
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Figure 3: Modular Domain Organization of SH2-containing Proteins. 
Classification and domain composition of the 110 nonredundant human SH2 domain-containing 
proteins identified in human and mouse. Reproduced from Liu et al, Molecular Cell, 2006. 
 
 
the level of gene transcription SH2-containing proteins can play an immediate role. Certain 
cytokine receptors activate JAKs, which in turn phosphorylate STATs on tyrosine. Their 
SH2 domains then mediate mutual intermolecular binding. In this dimerized state they shuttle 
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into the nucleus and participate in the regulation of gene expression. Phospholipid signaling 
at the membrane can be modulated by respective kinases (PI3K) and phosphatases 
(SHIP2), as well as by lipases. Phospholipase Cγ (PLCγ) is recruited via its SH2 domains to 
pTyr- motifs in RTKs, and additionally via its PH domain to PI(3,4,5)P3, so that those two 
anchor points attract it to the membrane. It then gets activated by phosphorylation and 
subsequently cleaves PI(4,5)P2 to diacylglycerol and IP3. Rearrangements in the 
cytoskeleton can be mediated by adaptors (Nck), kinases (Csk) and phosphatases (tensines) 
among SH2-proteins. An example from G-protein signaling, Ras-GAP, displays multidomain 
cooperation in a particularly profound way as shown in figure 4.  
 
Figure 4: Multidomain cooperation in membrane targeting. 
Efficient relocalization of Ras-GAP to the cell membrane is mediated by interactions between its two 
SH2 domains, PH domain, C2 domain, and perhaps also SH3 domain with tyrosine-phosphorylated 
receptors and other membrane components. The cooperation of multiple binding events at the cell 
membrane will position the GAP domain of Ras-GAP in proximity to Ras, which results in stimulation 
of GTPase activity and consequently silencing of Ras signaling. Reproduced from Schlessinger and 
Lemmon, 2003. 
1.1.3.2 PTB domains  
The type of binding of PTB domains can vary considerably and is less conserved than is the 
case for SH2 domains19, 20. The peptide motifs typically adopt a -turn structure, which is 
often initiated by Asn and Pro in the -3 and -2 positions. The sequence then constitutes an 
additional -strand, a mechanism termed “antiparallel -sheet augmentation”21. The 
formation of this antiparallel -strand is the most important characteristic for binding, even 
more important than the phosphotyrosine. Figure 1 shows the binding mode of PTB domains 
as compared to SH2 domains. PTB domains are divided into 3 classes: IRS1/DOK-like, Shc-
like, and Dab-like. Despite the name PTB, only members of the first two classes do actually 
bind in a phosphorylation-dependent manner. Those account for just 25% of all PTB 
domains6, 19. Proteins from the DOK (downstream of kinase) and IRS (insulin receptor 
substrate) families utilize their PTB domains for association with RTKs. Shc-proteins act as 
scaffolds and participate in the assembly of protein complexes around RTKs. 
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1.1.3.3 Other phosphotyrosine-binding domains 
Recently several reports have appeared that describe pTyr-dependent protein interactions 
which do not involve SH2 or PTB domains. While in one case this feature could be attributed 
to a C2 domain22, the responsible modules are still elusive in other examples23. Even though 
it is still unclear whether those cases represent exceptions or rather more general principles, 
they certainly pave the way for a more open and flexible view of pTyr-binding domains. 
 
1.2  INSULIN SIGNALING 
1.2.1 Insulin signaling in health and disease 
A particularly interesting and clinically relevant pathway that involves tyrosine 
phosphorylation is the insulin signaling network. The peptide hormone insulin is produced by 
-cells in the pancreas and secreted into the blood stream to reach its target tissues. It 
controls large parts of metabolism, especially utilization and storage of molecules related to 
energy production. Malfunction of insulin signaling therefore has extensive negative effects, 
and can lead to type I diabetes if insulin is absent and to type II diabetes if insulin resistance 
cannot be compensated by pancreatic -cells any longer. Moreover, a plethora of secondary 
diseases can be triggered once insulin signaling is perturbed in the body. 
1.2.1.1 Systemic aspects 
Functional specialization of individual tissues is reflected, among other factors, in their 
differential response to insulin. The main target tissues of insulin are skeletal muscle, liver 
and adipose tissue, with muscle accounting for more than 70% of glucose disposal24. In fact, 
it is one of the most prominent functions of insulin to promote glucose uptake from the 
circulation. For this reason, the translocation of the glucose transporter GLUT-4 from 
intracellular storage vesicles to the plasma membrane is among the most important 
metabolic effects of this hormone25. While the major consequences of insulin in muscle are 
glucose uptake and glycogen synthesis, the liver additionally reacts with protein and lipid 
synthesis, and inhibition of hepatic glucose release and VLDL secretion26, 27. 
Diabetes mellitus is a complex disorder that arises from various causes, including 
dysregulated glucose sensing or insulin secretion (maturity-onset diabetes of the young, 
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MODY), autoimmune-mediated -cell destruction (type I diabetes), or insufficient 
compensation for peripheral insulin resistance (type II diabetes). Type II diabetes accounts 
for the vast majority of cases. It usually occurs in middle to old age, but is increasingly 
appearing in young people owing to the close association with obesity28. Initially, emerging 
insulin resistance can usually be counterbalanced by increased insulin secretion from -cells. 
If this state is maintained for a long period, however, chronic hyperinsulinemia results in 
increased insulin resistance and in a decline of -cell mass and function. Consequently 
insulin levels drop, which opens out into hyperglycemia and diabetes29. Diabetes is not only a 
problem for glucose homeostasis as such, but often entails a cohort of systemic disorders, 
like dyslipidemia, hypertension, cardiovascular disease, stroke, blindness, kidney disease, 
female infertility, and neurodegeneration28. 
While some monogenic forms of diabetes do exist such as maturity onset diabetes in the 
young (MODY), the common type II diabetes has metabolic causes rather than being 
primarily a genetic disease, apart from very few exceptions30. Along these lines, obesity is 
closely associated with the development of diabetes. The amount of evidence for a strong 
link between excess lipids in blood plasma, muscle and liver (so-called “lipotoxicity”) on the 
one hand and reduced insulin sensitivity on the other hand is compelling24. The negative 
effect of obesity has two different reasons: First of all, excess lipids can unintentionally reach 
other tissues than adipose tissue, where their metabolites trigger insulin resistance. While 
lipids can serve as competitive substrates for oxidation and therefore reduce glucose 
utilization, their major negative effect is based on inactivating proteins involved in insulin 
signaling. Secondly, inflammatory cytokines like TNF  secreted by fat cells or macrophages 
among them disturb insulin signaling. In both cases the sphingolipid ceramide plays a key 
role in mediating the inhibitory effects at the molecular level. Ceramide is also involved in 
many accompanying diseases of diabetes, such as hypertension, arteriosclerosis or cardiac 
failure31. However, the key role of lipids in the development of diabetes is not limited to obese 
individuals, but also extends to adult onset type II diabetes as well as inherited type II 
diabetes. This correlation is thought to be based on the reduced numbers and activity of 
mitochondria in muscle tissue. As a consequence, lipid metabolites accumulate faster and 
can cause insulin resistance32. Furthermore, reactive oxygen species (ROS) can be 
generated by various stimuli as well as by metabolic imbalance (e.g. high ceramide levels), 
and subsequently activate certain signaling proteins which are known to downregulate insulin 
signaling33. 
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1.2.1.2 The intracellular signaling network 
Binding of insulin to the receptor triggers the spread of the signal inside of target cells. 
Figure 5 illustrates some of the proteins and pathways involved. IRS (insulin receptor 
substrate) proteins organize the distribution of the signal to a large extent. Among the most 
prominent pathways that are initiated is the mitogenic channel leading to activation of 
mitogen-activated protein kinase (MAPK). The adaptor protein Grb2 recruits Sos to the           
. 
 
Figure 5: The insulin receptor pathway. 
This schematic representation of the pathway contains many of the proteins involved in insulin 
signaling. Various components in the cytoplasm, the plasma membrane, vesicles and the nucleus are 
engaged to carry out the different effects of insulin. Obtained from proteinlounge.com 
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membrane, where it acts as guanine nucleotide exchange factor for the small G-protein 
Ras. .Activated Ras in turn triggers the activation of the canonical cascade from Raf via MEK 
to ERK, which then initiates several mitogenic actions. In parallel, the insulin stimulus affects 
various metabolic routes, with glucose disposal being the most central effect. The rate-
limiting step for glycogen synthesis is glucose uptake into cells. After entering the cell, 
glucose is phosphorylated by hexokinase and either stored as glycogen or oxidized to 
generate ATP24. While the transmembrane protein GLUT-1 carries out basal glucose import, 
GLUT-4 is responsible for insulin-induced glucose uptake. Insulin-stimulated activation of 
PI3K is closely linked to the translocation of GLUT-4 from intracellular vesicles to the plasma 
membrane. However, there is evidence for an alternative pathway besides the one triggered 
by insulin leading to the translocation of GLUT-4 to the cell surface. Muscle contraction by 
exercise has been shown to activate glucose transport and compensate for insulin resistance 
by triggering a PI3K-independent mechanism of GLUT-4 translocation. This has been 
proposed to function via 5´-AMP-activated kinase or increased cytoplasmic Ca2+-
concentrations. In addition to this, exercise has been demonstrated to result in increased 
expression of proteins involved in glucose metabolism as well as in enhanced insulin 
sensitivity34. Interestingly, different stimuli mobilize different pools of GLUT-4. This glucose 
transporter circulates in a complex fashion between trans-golgi-network (TGN), endosomes, 
GLUT-4 storage vesicles (GSVs), and the cell membrane. Under basal conditions, 30-40% of 
GLUT-4 resides in endosomes where it is not responsive to insulin. While insulin triggers the 
release from GSVs, physical exercise targets GLUT-4 in endosomes independently of PI3K. 
GSVs contain the v-snare VAMP2, and the cell membrane of muscle and fat cells harbors 
particularly high amounts of the t-snares syntaxin-4 and SNAP23. The complex of those 
three proteins mediates the exocytosis of GSVs25. 
Besides GLUT-4 translocation, PI3K promotes glycogen synthesis, antilipolysis, fatty acid 
synthesis, acetyl-CoA-carboxylase activity, synthesis of protein and DNA, growth and 
differentiation. This all relates to the PI3K-catalyzed generation of PI(3,4,5)P3 in the 
membrane, which recruits proteins with PH domains and allows for their targeted activation. 
Those include AGC family protein kinases (like Akt/PKB), PKCs and SGK35. One of the best 
known examples is PDK1, which is responsible for the activation of Akt and atypical PKCs. 
Binding of Akt to PI(3,4,5)P3 makes two sites accessible for phosphorylation through PDK1 
and the mTOR/Rictor-complex, respectively. Phosphorylation of both sites is required for full 
activation of the enzyme. Akt then serves as a central signal distributor: It enhances the 
import of glucose and amino acids, it promotes the incorporation of incoming nutrients into 
glycogen, proteins and triacylglycerol, it inhibits apoptosis and stimulates translation of 
mRNA, and it regulates the transcription factors FOXO1 and FOXA231. Phosphorylation of 
FOXO1 by Akt prevents its entry into the nucleus and thereby reduces the transcription of 
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genes involved in gluconeogenesis. FOXA2 is also inactivated by phosphorylation, which 
reduces the transcription of genes involved in fatty acid oxidation. Akt-mediated 
phosphorylation of the nutrient sensor mTOR promotes protein synthesis and growth36. While 
insulin stimulates protein synthesis in general, it especially promotes synthesis of growth-
related proteins. This mechanism is carried out downstream of PI3K by phosphorylation of 
translation initiation factors like eIF4E and PHAS-I37. Specifically, mTOR/S6K mediates the 
enhancement of mRNA-translation of growth-regulated proteins, while PKCδ takes part in 
promoting protein synthesis in general38. However, several kinases including mTOR also 
exert negative feedback upstream of PI3K, which is important to restrain the cancerogenic 
potential of PI3K-signaling39. Negative regulation of insulin signaling is largely carried out 
through inhibitory phosphorylation on serine and threonine residues. However, these amino 
acids can also become modified by O-linked N-acetylglucosamine (O-GlcNAc). The donor 
molecule UDP-GlcNAc originates from hexosamine biosynthesis and correlates with the level 
of glucose. It therefore reflects the metabolic status, and the PTM O-GlcNAc is used as 
nutrient sensor. O-GlcNAc transferase binds via a phosphoinositide-binding domain to 
PI(3,4,5)P3. Subsequently O-GlcNAc gets attached to the insulin receptor, IRS-1 and Akt. 
While this does not reduce the level of tyrosine phosphorylation on these proteins directly, it 
promotes phosphorylation on inhibitory serine sites in IRS-1 and thereby downregulates 
insulin signaling40, 41. 
Recent studies have shed light on the molecular details behind the negative effect of obesity-
related factors on insulin sensitivity. Many of the triggers of insulin resistance like excess 
lipids24, 31, 32, inflammatory cytokines31 or reactive oxygen species33, exert their undesired 
effect through activation of multiple kinases that phosphorylate insulin receptor substrate 
proteins (IRSs) on serine residues24. The fact that many different serine phosphorylation 
sites contribute to the inactivation of IRS proteins permits fine-tuning of the inhibition 
depending on the extent of the activation of the respective upstream kinases. Mitochondrial 
dysfunction is commonly observed along with the insulin resistant state, but it is still a matter 
of debate whether it is a cause or rather a consequence of insulin resistance. It is obvious, 
however, that defective mitochondria are highly detrimental for lipid and carbohydrate 
metabolism, and consequently enhance insulin resistance42, 43. Pancreatic β-cells have a 
special way to react to elevated lipid levels in the circulation. They express a receptor for free 
fatty acids (FFAs) called GPR40, which is responsible for both the acute stimulatory as well 
as the chronic inhibitory effect of FFAs on insulin secretion. The inhibitory effect is carried out 
via inhibition of transcription and translation of the insulin gene, expression changes of 
enzymes involved in glucose and fatty acid metabolism, opening of K+-channels, uncoupling 
of the respiratory chain and thus decreasing ATP levels, and ultimately by promoting 
apoptosis31. 
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1.2.2 The insulin receptor family 
Insulin receptor (InsR), insulin-like growth factor 1 receptor (IGF1R) and insulin receptor-
related receptor (IRR) are highly homologous cell surface receptors with distinct but partially 
overlapping functions. Although InsR and IGF1R share high similarity in sequence and 
structure, and as a result of this activate a comparable spectrum of signaling pathways, the 
IGF1R preferentially controls developmental and growth-related processes whereas the 
insulin receptor is a major player in maintenance of metabolic homeostasis44. Nevertheless, 
they contribute to each other‟s duties to some extent45. Experiments with chimeric receptors 
have shown that it is mainly the intracellular part that determines specificity, not the 
extracellular ligand binding domains46-48. Despite a similar degree of homology, the IRR is 
still an orphan receptor with obscure function, and its expression is limited to few tissues49, 50. 
It harbors the greatest differences compared to the other receptors in the C-terminal part, 
where it also lacks the last 50 amino acids. 
The receptors are receptor tyrosine kinases (RTKs) and form dimers consisting of two 
α-chains and two β-chains. The extracellular α-chains bind their ligand, which triggers a 
conformational change in the intracellular part of the β-chains and activates the kinase 
domains. Full activation of the kinase is accomplished after mutual phosphorylation of the 
kinase domains on three tyrosines. Subsequently, additional tyrosines in the receptors 
become phosphorylated, and recruit various proteins that bind via their SH2 and PTB 
domains. Those can then become phosphorylated as well and propagate the signal within 
the cell. The possible formation of heterodimers generates hybrid receptors and can 
modulate the signal output. Alternative splicing of one exon in the -chain of the InsR yields 
two different versions, InsR-α and InsR-β. InsR-α lacks exon 11 and is expressed mainly 
during development and later in a few specialized tissues, whereas InsR-β is the 
predominant version in the body. Figure 6 shows the ligand binding preferences of the 
different receptors. InsR-α binds insulin with moderate affinity, InsR-β with high affinity. 
Under normal circumstances insulin does not bind to the IGF1R, but during insulin resistance 
circulating insulin concentrations can rise high enough to activate it51. 
INTRODUCTION 
14 
 
Figure 6: The insulin/IGF family and their receptors. 
The insulin and IGF1 receptors can form hybrid receptors with individual binding properties. There are 
no reports so far on the ability of the IRR to integrate into hybrid receptors. The ligand(s) of the IRR 
are still not known. The IGF2 receptor is in fact the mannose-6-phosphate receptor (M6PR) 
responsible for transport of lysosomal enzymes from the Golgi complex and the cell surface to 
lysosomes. It can also bind IGF2, but it targets the hormone for degradation instead of signaling. 
 
1.2.3 The insulin receptor substrate (IRS) family 
A complex and still incompletely understood network of signaling proteins connects the 
insulin receptor family with its downstream effectors. In this context, IRSs play an 
indispensable role as interaction platforms that become phosphorylated on multiple tyrosines 
by the receptors and subsequently attract various signaling proteins to spread the stimulus 
within the cell. All of the 6 members of the IRS-family contain a PH domain and a PTB 
domain at the N-terminus, which they employ for binding to membranes and to NPXpY-
motifs in receptors, respectively. However, they vary in the length of their C-terminal part. 
IRS-1 and IRS-2 are large proteins with many tyrosine phosphorylation sites and are 
expressed in many different tissues. IRS-3 is short and only present in rodents. IRS-4 has 
similar dimensions like IRS-1 and IRS-2, but is only expressed in very few and specialized 
tissues. IRS-5 and IRS-6 (also termed DOK-4 and DOK-5) possess a very short C-terminal 
part and consequently very few potential phosphotyrosine motifs52, 53. Figure 7 highlights the 
role of IRSs as interaction platforms and signal distributors. 
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Figure 7: IRS proteins as interaction platforms connecting receptors to downstream signaling 
proteins. The PH and PTB domains anchor IRSs to their receptors. Subsequent phosphorylation on 
tyrosines generates docking sites for proteins with pTyr-recognizing domains. Adapted from Virkamäki 
et al, Journal of clinical investigation, 1999. 
1.2.4 The pivotal role of IRS-1 and IRS-2 in insulin signaling 
IRS-1 and IRS-2 gained their fame due to their unique role in mediating signals from 
members of the insulin receptor family, but also other receptors engage them for their 
purposes. Those include the prolactin54, androgen55, growth hormone54, 56 and vascular 
endothelial growth factor (VEGF) receptors57, as well as members of the integrin receptor 
family58, 59 and several cytokine receptors60. These IRS-proteins are roughly 135 kDa in size, 
and represent major players in conducting the distribution of the insulin signal within the cell. 
They contain 34 and 36 tyrosines, respectively, and many of these can potentially become 
phosphorylated and subsequently serve as docking sites for a large variety of signaling 
proteins. Their ability to serve as scaffolds for the concerted assembly of many different 
kinases, phosphatases, adaptor proteins, and other kinds of signaling proteins is substantial. 
By being interaction platforms at the top of the signaling network, they can be seen as 
organizers at whose level the decision is taken which of the various possible downstream 
pathways will be activated to which extent. Apart from their role in metabolic signaling, they 
propagate proliferative and anti-apoptotic signals and are consequently overexpressed or 
activated more strongly in most cancers61. In their activated form they tend to associate with 
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cytoskeletal structures62, 63, and IRS-1 has even been reported to enter the nucleus following 
stimulation via the IGF1R64 or the androgen receptor55. They share 75% amino acid 
sequence identity in their N-terminal domains and 35% in their C-terminal part. Despite their 
high degree of homology and many similar tyrosine-phosphorylation motifs, studies in 
knockout mice and knockout cell lines indicate that these two IRS proteins serve 
complementary, rather than redundant, roles in insulin and IGF-1 signaling65. In general, 
IRS-1 plays a prominent role in growth, while IRS-2 is the main contributor for glucose 
homeostasis and is decisive for proper function of pancreatic -cells66. Knockout of either of 
them results in insulin resistance, but only IRS-2-knockout leads to diabetes. The picture 
gets complicated by many tissue-specific differences between IRS-1 and IRS-267. In muscle, 
IRS-1 is more closely associated with glucose uptake, whereas IRS-2 feeds the MAP-kinase 
pathway68, 69. In liver, both of them are involved in metabolic regulation, but IRS-2 has a more 
pronounced role in lipid metabolism and in confining hepatic glucose release into the 
circulation70-72. Adipose tissue engages IRS-1 mainly for differentiation while IRS-2 serves 
insulin-stimulated glucose uptake27. In metastatic breast cancer, IRS-1 is frequently 
inactivated, and compensatory overactivation of IRS-2 has been shown to enhance signaling 
via Akt and mTOR. This triggers increased translation of oncogenes, growth and survival 
signals, elevated cell motility and invasiveness, and angiogenesis73. 
In agreement with the unequal roles of IRS-1 and IRS-2, their phosphorylation kinetics are 
markedly different from each other. As investigated in skeletal muscle cells and adipocytes, 
IRS-2 is dephosphorylated more rapidly on tyrosines than IRS-163, 74. 
Due to their central role, large parts of the regulation and fine-tuning of insulin signaling take 
place at the level of IRS proteins. Phosphorylation of IRS proteins on serine and threonine 
residues is the main „molecular handle‟ to exert negative feedback and set a limit to the 
activation of downstream pathways. In the basal state their phosphorylation level is already 
rather high, and insulin stimulation augments it even further. Those phosphorylation events 
can induce the dissociation of IRS proteins from the receptor, hinder tyrosine 
phosphorylation of IRS proteins, release IRS proteins from intracellular complexes that 
maintain them in close proximity of the receptor, or induce their degradation24. 
Kinases that carry out those inhibitory phosphorylations include mTOR (mammalian target of 
rapamycin), IKK-  (inhibitor kB kinase), JNK (c-Jun NH2-terminal kinase), ERK (extracellular 
signal-regulated kinase), S6K (ribosomal S6 kinase), PKCδ (protein kinase Cδ), PKCθ, PKC , 
GSK3 (glycogen synthase kinase 3), SIK2 (salt-inducible protein kinase 2) and casein 
kinase II24, 39. JNK even has a dedicated binding site in IRS-1 which is independent of 
tyrosine phosphorylation75. Nevertheless, some serine phosphorylations on IRS proteins can 
have a positive effect on insulin signaling, for example because they protect them from the 
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action of tyrosine phosphatases76. When talking about negative regulation, feedback 
inhibition through activation of those kinases following an insulin stimulus is just one aspect. 
Many of them can just as well be activated in a more constitutive way by common inducers of 
insulin resistance. In this respect, free fatty acids, diacylglycerol, acyl-CoA, glucose and 
TNF  contribute to their mobilization52. It appears that a large part of this effect is mediated 
through the generation of ceramide77. Similar to the activation of IRS proteins, their 
desensitization can also occur in a tissue- and IRS-specific way. In muscle, PKCθ exerts this 
function and primarily targets IRS-1, whereas in liver PKCε is a key effector and primarily 
phosphorylates IRS-232. Figure 8 depicts the regulation of IRS activity via phosphorylation on 
serine and threonine residues. 
 
 
Figure 8: Phosphorylation of IRS proteins on serine and threonine residues regulates their functions. 
Phosphorylation of IRS proteins on serines and threonines usually occurs in the context of negative 
feedback inhibition. Several factors like free fatty acids, inflammatory cytokines and other stress 
factors exploit this mechanism to induce insulin resistance via activation of Ser/Thr-kinases. In a few 
cases serine phosphorylation can have a positive effect, for example through Akt/PKB. Reproduced 
from Gual et al, Biochimie, 2005. 
INTRODUCTION 
18 
1.3  MASS SPECTROMETRY-BASED QUANTITATIVE PROTEOMICS 
1.3.1 Modern mass spectrometry applied to protein research 
When studying the molecular components of life, a researcher can choose among a plethora 
of different techniques to pursue his or her endeavor. Typically, several methods are applied 
in combination to exploit synergies. Mass spectrometry (MS) is in a special position as 
compared to many other approaches due to several reasons. First, MS is an unbiased 
technique and therefore able to efficiently investigate mixtures of unknown compounds. In 
contrast to antibody-based approaches, for example, it is not constrained by hypotheses, 
which makes it particularly well-suited for novel discoveries78. Second, MS has a high 
throughput and can provide data for thousands of proteins per day. Accordingly, mass 
spectrometry has become the basis of proteomics as a new discipline that approaches 
biological questions with a global view. And third, proper application of MS results in 
excellent sensitivity, accuracy and reliability of data. It can measure proteins at very low 
levels that are otherwise only detectable by targeted immunoassays. The application of 
tandem mass spectrometry (MS/MS) yields sequence information on top of the accurate 
mass of the intact molecule, which supports unambiguous identification79. 
The typical workflow in MS-based proteomics is visualized in figure 9. Protein samples are 
digested with a protease before analysis to generate peptides that are amenable to 
straightforward mass spectrometric measurement. Information obtained at the peptide level 
can later be mapped back to their parent proteins during data analysis. 
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Figure 9: Workflow in MS-based proteomics. 
Starting out with the initial biological experiment, proteins are extracted and fractionated as desired. 
Enzymatic digestion yields peptides that can be fractionated further and analyzed by MS. In most 
modern setups, samples are introduced into the mass spectrometer through online nanoscale 
reversed phase liquid chromatography. 
1.3.2 Instrumentation 
Mass spectrometers measure the mass-to-charge ratio of analytes. In order to equip each 
molecule with charges, samples are typically introduced into the machine in an acidic 
environment. An ion source is required to transfer the ions into the gas phase before they 
can enter the mass spectrometer. To this end, either MALDI (matrix-assisted laser 
desorption/ionization) or ESI (electrospray ionization) is employed as means to vaporize 
peptides in a mild way without destroying them. In MALDI, analytes are co-crystallized in a 
matrix, from where they are volatized by a laser beam80. ESI, on the contrary, generates 
gaseous ions through a strong difference in the electric potential between spray tip and 
orifice of the mass spectrometer. Tiny liquid droplets evaporate quickly after leaving the tip, 
increasing charge repulsion of the retained ions, which leads to further dispersion and 
ultimately to single ions free of solvent81. In the study described here, an HPLC-system was 
directly coupled to the mass spectrometer (“online” LC-MS), supplying peptide ions via 
reversed phase chromatography and nanoelectrospray. A picture of the ion source is given in 
figure 10. 
 
Figure 10: Nanoelectrospray ion source in an online LC-MS configuration. 
The analytes are separated by reversed phase chromatography on a thin column (inner diameter 
75 µm), and are directly transferred into the orifice of a mass spectrometer via nanoelectrospray 
throughout the whole LC-gradient. 
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The types of mass spectrometers used in this study are briefly described in the following 
section. 
1.3.2.1 Linear ion trap 
As its name already implies, an ion trap mass spectrometer is able to accumulate and 
confine ions. In addition, mass spectra can be acquired by linearly increasing the potential of 
electrodes, which leads to the ejection of ions from the potential well depending on their 
mass-to-charge ratio (m/z)82. Ion traps are known for their high sensitivity and speed. Linear 
ion traps are superior to 3D ion traps because they offer higher ion storage capacity and 
trapping efficiency. Drawbacks of ion traps are relatively low resolution and mass accuracy. 
These characteristics make them ideally suited as part of hybrid instruments. When fusing an 
ion trap together with a mass spectrometer that features high resolution and mass accuracy, 
the advantages of each machine can be intelligently exploited. In this study, hybrid 
instruments were employed that contain either an FT-ICR or an Orbitrap mass spectrometer 
following a linear ion trap. 
The division of labor between the two consecutive mass spectrometers is as follows: The ion 
trap accumulates defined amounts of ions and passes them on to the FT-ICR or Orbitrap for 
high accuracy mass measurement. Based on the acquired mass spectrum, data dependent 
decisions are taken, typically about which ions shall be fragmented to gain sequence 
information. For fragment ion spectra, high mass accuracy is less critical. However, speed 
and sensitivity are very important to keep scan cycle times short. The ion trap fulfills these 
criteria, and parallel operation of ion trap MS/MS during full scan acquisition in the FT-ICR or 
Orbitrap further improves the performance with respect to the time invested. Fragment ion 
spectra are generated by collisionally induced dissociation (CID). The selected precursor ion 
is isolated and excited via an electric field, which increases its internal energy. Collision with 
inert gas molecules can then break the ion at one of the peptide bonds. Since the cleavage 
occurs semi-randomly, a fragment spectrum usually contains many different ions. Figure 11 
shows the structure of a peptide with cleavage sites for CID. Calculation of the distance 
between two consecutive fragment ions in the mass spectrum yields the corresponding 
amino acid mass and therefore allows sequence assignments83. 
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Figure 11: Peptide structure with sites for fragmentation by CID. 
b-ions originate if the charge is retained by the C-terminal fragment, and y-ions if the charge is 
retained by the N-terminal fragment. 
1.3.2.2 FT-ICR 
The cyclotron detection mode of Fourier transform ion cyclotron (FT-ICR)84, 85 mass 
spectrometers enables unmatched resolution and mass accuracy. Whereas in other mass 
spectrometers ions are filtered in a magnetic or electric field or selected by flight time, 
FT-ICR instruments detect them by their resonance frequency. ICR spectrometry is based on 
the principle of cyclotron motion in a uniform electric field. Ions are detected in a cyclotron 
cell, which is located inside a super-conducting magnet with a fixed field strength. 
Figure 12 contains a scheme of a hybrid linear ion trap-FTICR mass spectrometer and of an 
ICR cell. Ions arriving inside the cyclotron cell are forced into an orbit by the uniform 
magnetic field. The front and end plates work as trapping plates to trap the ions inside the 
cyclotron cell. The two excitation plates are connected with a radiofrequency (RF) transmitter 
to excite the ions, and the detection plates register the induced current of the ions for 
detection. The transient signal from all ions is digitized and processed with a fast FT 
algorithm, resulting in a mass spectrum with ion abundance versus mass-to-charge ratio 
(m/z). 
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Figure 12: The principle of FT-ICR mass spectrometry. 
a) A hybrid instrument comprised of a linear ion trap and an FT-ICR mass spectrometer is depicted. 
Their analytical strengths result in a synergy of speed, sensitivity, resolution and mass accuracy. 
b) The cyclotron motion of ions in the ICR cell generates a frequency spectrum that is transformed into 
a conventional mass spectrum by fast Fourier transformation. Adapted from Schrader and Klein, 2004. 
1.3.2.3 Orbitrap 
Similar to ICR mass spectrometers, also Orbitraps86, 87 detect ions in a non-destructive 
fashion. Instead of employing a strong magnetic field, however, they use electrodes to guide 
the motion of ions in the cell. The electrostatic attraction towards the central electrode is 
compensated by a centrifugal force that arises from the initial tangential velocity of ions. 
Instead of the rotational frequency like in the case of ICR, an Orbitrap measures axial 
oscillations along the central electrode to obtain a mass spectrum. The outer electrodes 
register the axial oscillations, and Fourier transformation results in the determination of their 
a) 
b) 
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frequencies and subsequently the calculation of a mass spectrum. For a controlled injection 
of ions into the Orbitrap, they are first accumulated in a so-called C-trap. This is a curved 
(C-shaped) quadrupole that traps and cools ions, squeezes them into a small cloud, and 
finally injects them into the Orbitrap analyzer. The minimized distance between C-trap and 
Orbitrap reduces time-of-flight effects and enhances sensitivity. In addition, the C-trap allows 
for the co-injection of defined background ions for use as a so-called lock mass88. This 
internal mass calibration further improves mass accuracy, which serves higher identification 
confidence and lower false positive rates89. Figure 13 shows a scheme of a hybrid linear ion 
trap-Orbitrap mass spectrometer, and a close-up view of an Orbitrap cell. 
 
 
 
Figure 13: The principle of Orbitrap mass spectrometry. 
a) A hybrid instrument comprised of a linear ion trap and an Orbitrap mass spectrometer is depicted. 
Particularly for complex mixtures, improved performance can be achieved as compared to linear ion 
trap FT-ICR. 
b) Ion packages spin around the central electrode in the Orbitrap cell and generate a frequency 
spectrum that is transformed into a conventional mass spectrum by fast Fourier transformation. 
Adapted from Scigelova and Makarov, 2006. 
a) 
b) 
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1.3.3 Stable isotope labeling for quantitative readout 
Mass spectrometry is largely applied as a qualitative method to identify components in a 
sample. In addition, it also possesses the ability to generate quantitative information. The 
signals of consecutive analyses can be compared, and differences in abundance of 
individual proteins between two samples can be extracted. The number of identified 
peptides90, sequence coverage91, spectral counting92, identified peptides in relation to 
theoretically observable peptides93, 94, and intensity or peak area of peptide signals95, 96 have 
been used for this purpose. However, these methods often suffer from low accuracy and 
poor reliability. Truly accurate quantitative comparison between proteins of different samples 
can best be achieved if their peptides appear in the same spectra of one single analysis. This 
is possible if one of the two samples is labeled with heavy isotopes (usually 13C, 15N, 2H), 
inducing a defined increase in mass. This way samples can be mixed prior to MS-analysis, 
since distinct signals are created in mass spectra for every proteolytic peptide present in 
labeled and non-labeled form. As depicted in figure 12, peptides appear as pairs, or even as 
triplets if an additional labeling state is applied. 
 
 
Figure 14: The principle of isotope labeling for quantitation between samples in mass spectrometry. 
Incorporation of heavy labels results in slightly increased mass. a) Peptides appear as pairs in mass 
spectra when labeled and unlabeled samples are mixed. b) If an additional labeling state was chosen, 
peptides are present as triplets. 
 
By comparing peak areas of peptides originating from different samples, one can deduce the 
quantitative difference between the amounts of their parent proteins. Monitoring peptide 
peaks across their elution time results in extracted ion chromatograms (XIC) as illustrated in 
figure 15. 
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Figure 15: Relative quantitation of a peptide between two samples by stable isotope labeling. 
As the peptides elute from the column, the signal is sampled several times, forming XIC-curves as 
depicted in the right panel. Modified from Ong and Mann, 2005. 
 
1.3.3.1 Relative quantitation 
Relative quantitation by isotope labeling between samples subjected to defined different 
experimental conditions is a widely used approach. Several methods have been developed 
for introducing heavy isotopes into a sample. Digestion in heavy water (H218O)97, 98, or 
chemical addition of labeled reagents like in ICAT99, iTRAQ100 or ICPL101 integrate the label 
before, during or after protein digestion. Metabolic labeling techniques such as 15N-labeling102 
and SILAC103-105 even allow the incorporation of the label pre-harvest during culture. In cases 
where metabolic labeling is hard to accomplish, like with tissue samples, a modified SILAC-
approach such as CDIT106 can be applied. 
Figure 16 summarizes different labeling types with respect to the stage at which the label is 
introduced in the experimental workflow. 
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Figure 16: Different strategies for isotope labeling. 
The various techniques differ in the timepoint of labeling in the experimental workflow. Metabolic 
labeling allows combination of samples directly after harvest, while other methods require parallel 
sample handling during the first steps. Reproduced from Bantscheff et al, 2007. 
 
Variations in sample handling are difficult to control from a quantitative point of view. Thus, 
metabolic labeling is superior due to the very early combination of samples to be compared. 
Therefore SILAC was employed in the work presented here. SILAC stands for stable isotope 
labeling by amino acids in cell culture. Cells are cultured in medium that is deficient in one or 
more amino acids. These amino acids are supplemented in stable isotope labeled form, or in 
unlabeled form for the control culture to compare against. It is advisable to use labeled 
arginine and lysine, because trypsin cleaves C-terminal to these amino acids. This results in 
each proteolytic peptide containing a heavy label, and the presence at the C-terminus can 
aid in sequence assignment. Different labeling states of arginine that can be used for SILAC 
are shown in figure 17. 
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Figure 17: SILAC-labeling by different isotope-labeled versions of arginine. 
If all 12C-atoms are replaced by their heavy 13C counterparts, the mass increment is 6 Da. If in addition 
all 14N-atoms are replaced by 15N, the mass increment is close to 10 Da. 
 
During culture, cells incorporate the labeled amino acids into all newly synthesized proteins. 
After more than 5 cell doublings, labeling efficiency is close to 100%. Experiments with 
differential treatment can be conducted, such as comparison of hormone stimulation versus 
no stimulation. Subsequently, samples can be combined following cell lysis and protein 
extraction, because their different origin is encoded in the masses of their proteins. Any 
losses or variations in downstream sample processing have no influence on the 
stoichiometry between the mixed samples (figure 18). 
 
 
Figure 18: General workflow in SILAC-experiments. 
The early combination of differentially labeled samples allows truly equal downstream sample 
processing. 
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1.3.3.2 Absolute quantitation  
In addition to relative quantitation, several methods are available that combine isotope 
labeling and mass spectrometry for absolute quantitation of proteins. In each quantitation 
approach, a known amount of an isotope-labeled standard which resembles the protein to be 
quantified or a peptide thereof is spiked into the biological sample. Historically, digestion in 
heavy water was the first method used for absolute quantitation107, followed by the use of 
synthetic peptide standards containing isotope-labeled amino acids for the quantitation of the 
parent protein108, a concept expanded further and termed AQUA109. A protein-like standard in 
the form of concatenated peptides is employed in the QconCAT110-112 or PCS113 approach. 
Artificial genes comprising peptides from different proteins are expressed in medium 
containing 15NH4Cl or labeled amino acids. These techniques can supply quantitative data, 
however, their accuracy is not very high and suffers from several principal limitations. 
Difficulties of digestion in heavy water include the control of incorporation of one or two 
18O atoms as well as the necessity to add the standard at a very late stage in sample 
preparation. AQUA has the advantage that labeled synthetic peptides are easy to obtain, 
even though it should be noted that they are expensive reagents. However, when the 
absolute quantitation of a protein is based on only one or two peptides as is typically the 
case in AQUA and QconCAT, precision may suffer. Furthermore, not all peptides are 
amenable for use as standards because amino acids that could introduce side products need 
to be avoided. The chief limitation that these methods have in common is the relatively late 
addition of the quantitation standard to the sample. Any fractionation steps or other 
treatments that would result in differential effects on standard and endogenous protein need 
to be carried out before the standard can be added. This means that the absolute amount of 
a protein´s tryptic peptides that are present after sample digestion can be accurately 
determined. The actual purpose of the experiment, however, is to provide an accurate 
measure of the protein´s amount in the original sample. A truly accurate technique for 
absolute quantitation needs to be insensitive to protein losses and chemical modifications 
during sample processing, as well as incomplete digestion and recovery of proteolytic 
peptides. 
One of the goals of this work was therefore the development of an MS-based absolute 
quantitation method which addresses these problems by spiking in the isotope labeled 
standard at the earliest possible stage. To achieve this, the standard needs to be highly 
similar if not identical to the endogenous protein to be quantified. The SILAC-approach that 
has proven to be very powerful for relative quantitation (see above) has therefore been 
adapted for its use in absolute quantitation of individual proteins. 
An overview of several methods for absolute protein quantitation is given in table 1. 
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Table 1: Summary of approaches for absolute quantitation of protein abundance with mass spectro-
metry. Adapted from Kito and Ito, 2008. 
 
 
 
1.4  GOALS OF THE STUDY 
This work was conducted with two major goals in mind. One focus was on the 
characterization of pTyr-based protein interactions, mainly embarking on molecular 
interaction platforms in the insulin signaling pathway. The other objective was the 
development of a novel approach for protein quantitation, particularly for absolute 
quantitation. 
The insulin signaling network contains critical nodes for signal distribution at the start of the 
intracellular pathway. The receptors are able to attract various proteins and integrate them 
into spreading the signal. Importantly, the receptors utilize IRS proteins as mediators for a 
large part of these interactions. A recently established protein interaction technology based 
on bait-fishing from whole cell lysates was therefore destined for the discovery of proteins 
that interact with the receptors (InsR, IGF1R and IRR) or IRS proteins (IRS-1 and IRS-2). 
Through a systematic and exhaustive profiling of all potential pTyr-dependent interaction 
sites in these key players of the pathway, a comprehensive and comparative picture of their 
interaction capabilities was envisioned. The design of the experimental setup was chosen in 
a way that allows obtaining site-specific information for known interaction partners as well as 
the discovery of novel interactions. 
In a separate project, the same approach was to be employed to experimentally assess and 
validate pTyr-based interaction motifs originated from a new bioinformatic algorithm that 
clusters known phosphorylation sites according to their surrounding sequence. 
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Representative synthetic phosphopeptides were to be probed for their potential to mediate 
protein interactions. Particular emphasis was placed on previously undefined motifs that 
might constitute novel binding motifs for certain pTyr-binding domains. 
The suboptimal accuracy of absolute quantitation of protein abundance in conventional MS-
based techniques provided the motivation to develop a method to solve this problem. Based 
on its excellent properties in relative quantitation, the SILAC-technique was the fundament 
on which a novel technique was to be developed that offers high accuracy in absolute 
quantitation. In addition to the establishment of quantitation standard generation at the 
protein level, thorough characterization of the method and devising guidelines for optimal 
application formed an integral part of the project. This included the design of targeted data 
acquisition methods on the mass spectrometer that enhance identification rate, detection 
sensitivity, and quantitation quality. 
The production of recombinant proteins in a SILAC-labeled fashion was primarily aimed at its 
use for absolute quantitation of proteins in regular bottom-up proteomics. With SILAC-labeled 
protein standards at hand, it was interesting to investigate their application in top-down 
proteomics as well. MS-analysis of intact protein pairs in labeled and unlabeled state was 
envisioned, aiming at a profound characterization of their behavior with respect to the effects 
of isotope labeling. Based on the results, conclusions for potential applications in 
quantitation, identification and assessment of posttranslational modifications were expected.
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2 PROFILING OF PHOSPHOTYROSINE-INTERACTION 
PLATFORMS IN THE INSULIN SIGNALING PATHWAY 
2.1 PUBLICATION: THE PHOSPHOTYROSINE INTERACTOME OF 
THE INSULIN RECEPTOR FAMILY AND ITS SUBSTRATES IRS-1 
AND IRS-2 
 
This manuscript presents the results from the pTyr-interactome project in the insulin 
signaling pathway. At the time of writing this thesis, it had been submitted for publication 
in the journal Molecular and Cellular Proteomics. 
The following pages contain the submitted version of the manuscript. 
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SUMMARY 
The insulin signaling pathway is critical in regulating glucose levels and is associated with 
diabetes, obesity and longevity. A tyrosine phosphorylation cascade creates docking sites 
for protein interactions, initiating subsequent propagation of the signal throughout the cell. 
The phosphotyrosine interactome of this medically important pathway has not yet been 
studied comprehensively. We therefore applied quantitative interaction proteomics to 
exhaustively profile all potential phosphotyrosine (pTyr)-dependent interaction sites in its 
key players. We targeted and compared insulin receptor substrates 1 and 2 (IRS-1 and 
IRS-2) as central distributors of the insulin signal, the insulin receptor (InsR), the insulin-
like growth factor 1 receptor (IGF1R), and the insulin receptor related receptor (IRR). 
Using the SILAC approach with phosphorylated vs. non-phosphorylated bait peptides, we 
found phosphorylation-specific interaction partners for 52 out of 109 investigated sites. In 
addition, doubly and triply phosphorylated motifs provided insight into the combinatorial 
effects of phosphorylation events in close proximity to each other. Our results retrieve 
known interactions and substantially broaden the spectrum of potential interaction 
partners of IRS-1 and IRS-2. A large number of common interactors rationalize their 
extensive functional redundancy. However, several proteins involved in signaling and 
metabolism interact differentially with IRS-1 and IRS-2 and thus provide leads into their 
different physiological roles. Differences at the receptor level are reflected in multisite 
recruitment of SHP2 by the IGF1R and limited but exclusive interactions with the IRR. In 
common with other recent reports, our data furthermore hint at non-SH2 or PTB domain 
mediated pTyr-binding. 
 
INTRODUCTION 
Regulated protein-protein interactions form the basis of cellular signal transduction, and 
frequently posttranslational modifications constitute the molecular switch to facilitate the 
association or dissociation of proteins. Phosphorylation is a prominent instrument in the 
toolbox of signaling, and tyrosine phosphorylation in particular is important in the 
upstream events following ligand binding to receptor tyrosine kinases (RTKs). The mere 
binding to a phosphorylated motif can modulate enzymatic activity in some cases. 
However, the primary effect of the interaction is usually to increase the local concentration 
of the recruited protein and scaffold it together with its upstream or downstream effectors. 
Common recognition modules for tyrosine phosphorylated sequences are the Src 
homology 2 (SH2) domain and the phosphotyrosine binding (PTB) domain (1, 2). A large 
part of the free binding energy to an SH2 domain is provided by the phospho-moiety itself. 
Another part, and most importantly the binding specificity, is contributed by interactions 
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with the residues C-terminal to the phosphotyrosine (pTyr). As determined by degenerate 
peptide library screening, motifs for SH2 domains typically encompass residues +1 to +4 
relative to the pTyr (3). Some SH2-domains also exploit amino acids at the N-terminal 
side for binding (3, 4). In few cases even more extended contacts from -6 to +6 are 
formed (5, 6). The SH2-domain of SAP, for example, engages so many residues that 
already the non-phosphorylated form shows considerable binding, and phosphorylation 
only enhances this binding 5-fold (7). The general interaction mode of SH2 domains 
directs the sequence of the partner protein perpendicular to the central -sheet of the SH2 
domain in an extended conformation. Therefore the interaction is largely independent of 
the structural context in the native protein. This allows studying SH2-binding using short 
synthetic peptides (3). The genomes of humans and mice contain 120 different SH2 
domains in 110 different proteins. 
The other canonical interaction domain for pTyr, the PTB domain, occurs 56 times in the 
genome; its binding mode can vary considerably and is less conserved than is the case 
for SH2 domains (8, 9). PTB domains are divided into three classes: IRS1/DOK-like, Shc-
like, and Dab-like. Only members of the first two classes, which account for just 25% of all 
PTB domains, actually bind in a phosphorylation-dependent manner (1, 8). Recently 
several reports have described pTyr-dependent protein interactions that do not involve 
SH2 or PTB domains. In one case binding was attributed to a C2 domain (10), but in other 
cases the responsible modules are still elusive (11). Even though it is still unclear whether 
those cases represent exceptions or instead more general principles, they demonstrate 
that pTyr mediated binding is not limited to the classical interaction domains.  
A particularly important and clinically relevant pathway that involves tyrosine 
phosphorylation is the insulin signaling network. Malfunction of insulin signaling can lead 
to type II diabetes if insulin resistance cannot be compensated by pancreatic -cells any 
longer. Initially, insulin resistance is counterbalanced by increased insulin secretion by 
-cells, but chronic hyperinsulinemia results in increased insulin resistance and finally 
leads to a decline of -cell mass and function, facilitating hyperglycemia and diabetes 
(12). The main target tissues of insulin are skeletal muscle, liver and adipose tissue, with 
muscle accounting for more than 70% of glucose disposal (13). One of the most important 
metabolic effects of insulin is the translocation of the glucose transporter GLUT-4 from 
intracellular storage vesicles to the plasma membrane (14).  
A complex and still incompletely understood network of signaling proteins connects the 
insulin receptor (InsR) with its downstream effectors. Insulin receptor substrate proteins 
(IRSs) play a pivotal role as interaction platforms that become phosphorylated on multiple 
tyrosines by the InsR and subsequently attract various signaling proteins to spread the 
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stimulus within the cell. All six members of the IRS-family contain a PH domain and a PTB 
domain at the N-terminus, but they vary in the length of their C-terminal part. IRS-1 and 
IRS-2 are large proteins with many tyrosine phosphorylation sites and are ubiquitously 
expressed. IRS-3 is short and only present in rodents. IRS-4 has similar dimensions as 
IRS-1 and IRS-2, but is only expressed in very few and specialized tissues. IRS-5 and 
IRS-6 (also termed DOK-4 and DOK-5) possess very short C-terminal parts and 
consequently very few potential phosphotyrosine motifs (15, 16).  
By far the most important players in insulin signaling are IRS-1 and IRS-2. Apart from their 
role in metabolic signaling, they propagate proliferative and anti-apoptotic signals and are 
consequently overexpressed or activated more strongly in most cancers (17). Furthermore 
many of the triggers of insulin resistance like excess lipids (13, 18, 19), inflammatory 
cytokines (18) or reactive oxygen species (20), exert their undesired effect through 
activation of multiple kinases that phosphorylate IRSs on serine residues (13). IRS-1 and 
IRS-2 share 75% amino acid sequence identity in their N-terminal domains and 35% in 
their C-terminal part. Despite their high degree of homology and many similar tyrosine-
phosphorylation motifs, studies in knockout mice and knockout cell lines indicate that 
these two IRS proteins also serve complementary, rather than completely redundant, 
roles in insulin and IGF-1 signaling (21). In general, IRS-1 plays a prominent role in 
growth, while the main functions of IRS-2 are in glucose homeostasis and proper function 
of pancreatic -cells (22). Knockout of either of them results in insulin resistance, but only 
IRS-2-knockout leads to diabetes. Tissue-specific differences between IRS-1 and IRS-2 
add a further level of complexity (23). In muscle, IRS-1 is more closely associated with 
glucose uptake, whereas IRS-2 stimulates the MAP-kinase pathway (24, 25). In liver, both 
are involved in metabolic regulation, but IRS-2 has a more pronounced role in lipid 
metabolism (26, 27). Adipose tissue engages IRS-1 mainly for differentiation while IRS-2 
serves insulin-stimulated glucose uptake (28). 
Similarly, among the three different receptors – insulin receptor (InsR), insulin-like growth 
factor-1 receptor (IGF1R) and insulin receptor related receptor (IRR), relatively small 
differences in the C-terminal, cytosolic sequence lead to considerable diversity in the 
signaling output. The insulin receptor and its ligand maintain metabolic homeostasis, 
whereas IGF-1 and its receptor preferentially control developmental and growth processes 
(29). Despite a similar degree of homology, the IRR is still an orphan receptor with 
obscure function and is expressed in few tissues (30, 31). Its greatest differences 
compared to the other receptors are in the C-terminal part, where it lacks the last 50 
amino acids compared to InsR and IGF1R.  
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Here we undertook a systematic and exhaustive profiling of all potential phosphotyrosine-
dependent interaction sites in IRS-1, IRS-2, InsR, IGF1R and IRR. Since this kind of 
interaction is mediated by short, unstructured sequence motifs (2, 32, 33), and based on 
our previous results with ErbB-receptors (34), bacterial proteins and the histone code (35), 
we employed peptide bait fishing from cell lysates combined with state-of-the-art mass 
spectrometry as readout. Our peptide pulldown approach, combined with the SILAC 
technique (36), allows straightforward discrimination between specific interaction partners 
and background binders (37). In contrast to in vitro experiments using purified 
components (38), the interactions take place within the competitive environment of a 
whole cell lysate. In addition to the site-specific information obtained, the unbiased nature 
of the approach facilitates the discovery of unexpected interactions. This makes it 
possible, in principle, to uncover novel kinds of interactions mediated by modules other 
than the currently known SH2 and PTB domains in pTyr-dependent signaling.  
Our large-scale experiment resulted in a global overview of specificity, redundancy and 
distribution of protein interaction sites in the insulin signaling platform. It furthermore 
allows comparing the principle signaling capabilities between IRS-1 and IRS-2 as well as 
between InsR, IGF1R and IRR. The pTyr-interactomes of the IRS-proteins were relatively 
similar, accounting for the large functional redundancy. However, we did observe specific 
differences in the binding of SH2/PTB domain containing proteins and intriguingly in some 
proteins with other functions such as fatty acid degrading enzymes.  
A main difference between InsR and IGF1R turned out to be the recruitment of the 
tyrosine phosphatase SHP2 to more sites in the IGF1R. The cryptic function of the IRR 
could be attributed to lack of interactions in its C-terminal part, perhaps combined with the 
unique recruitment of a membrane-associated guanylate kinase discovered here. Finally, 
in some instances combinatorial tyrosine phosphorylation either abolished or enabled 
certain protein interactions. 
 
EXPERIMENTAL PROCEDURES 
SILAC cell culture and lysis – Murine C2C12 muscle cells were cultured in Dulbecco´s 
modified Eagle´s medium (DMEM) containing 4.5% glucose and deficient in arginine (Arg) 
and lysine (Lys), supplemented with 10% dialyzed fetal calf serum and antibiotics. One 
cell population was supplied with normal Arg and Lys, and the other one with the stable 
isotope labeled heavy analogues 13C615N4-Arg (or 13C6-Arg) and 13C615N2-Lys from Sigma 
Isotec. For triple labeling experiments 13C6-Arg and D4-Lys as well as 13C615N4-Arg and 
13C615N2-Lys were employed. Cells were expanded as myoblasts for at least five doublings 
and differentiation into myotubes was initiated by lowering serum content to 2% in 
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confluent dishes. After 8 days myotube cultures typically contained less than 15% 
mononucleated cells. Harvesting was carried out by washing dishes with PBS and adding 
ice-cold lysis buffer to the dishes for 15 minutes. Lysis buffer consisted of 1% Igepal 
(NP-40; v/v), 150 mM NaCl, 50 mM Tris-HCl, pH 7.5, 1 mM DTT, protease inhibitor 
cocktail (Roche complete tablets) and 1 mM sodium orthovanadate as tyrosine 
phosphatase inhibitor. Cells were scraped off the dishes and vortexed vigorously. 
Following centrifugation at 16,000 g for 15 minutes the supernatant was used for peptide 
affinity pulldown experiments.  
Peptide synthesis – Peptides were synthesized as pairs in phosphorylated and non-
phosphorylated form on a solid-phase peptide synthesizer using amide resin (Intavis, 
Germany). Peptides were designed as 15-mers with 8 amino acids N-terminal and six C-
terminal of the (phospho)tyrosine. In addition, the dipeptide linker SG and a desthiobiotin 
were attached to the N-terminus. Identity and purity of the synthetic peptides were 
confirmed by mass spectrometric analysis. 
Peptide pulldown procedure – Peptides were bound to streptavidin-coated magnetic 
beads (Dynal MyOne, Invitrogen), and cell lysate typically corresponding to 1.5 mg of 
protein (~5 mg/ml protein) was added to 75 µl of beads containing an estimated amount of 
2 nmol peptide. Heavy SILAC-labeled lysate was incubated with the phosphorylated 
version of the peptide, while light SILAC-labeled lysate was added to the non-
phosphorylated counterpart. In parallel a crossover experiment was conducted, where the 
incubation was inverted, that is heavy lysate was incubated with non-phosphorylated 
peptide and light lysate with phosphorylated version. After rotation at 4°C for six hours or 
overnight, the beads were washed for at least 3 times by vortexing with lysis buffer. Beads 
from each peptide pair were combined and bound proteins were eluted using 20 mM 
biotin. Eluted proteins were then precipitated by adding 5 volumes of ethanol together with 
sodium acetate and 20 µg glycoblue (Ambion, USA). 
In-solution digestion of proteins – Proteins were resuspended in 20 µl 6M urea, 2M 
thiourea, 20 mM TrisHCl pH8,0 and reduced by adding 1 µg DTT for 30min, followed by 
alkylation of cysteines by incubating with 5 µg iodoacetamide for 20 min. Digestion was 
started by adding endoproteinase LysC (Wako). After three hours samples were diluted 
with four volumes of 50 mM NH4HCO3, and trypsin (Promega) was added for overnight 
incubation. Proteases were applied in a ratio of 1:50 to protein material and all steps were 
carried out at room temperature. Digestion was stopped by acidifying with TFA and the 
samples were loaded onto StageTips (39, 40) packed with RP-C18 Empore disks, 3M for 
desalting and concentration prior to LC-MS-analysis. 
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NanoLC-MS/MS – Digested peptide mixtures were separated by online reversed-phase 
(RP) nanoscale capillary liquid chromatography (nanoLC) and analyzed by electrospray 
tandem mass spectrometry (ES-MS/MS). Experiments were performed with an Agilent 
1100 nanoflow system connected to an LTQ-Orbitrap or LTQ-FT mass spectrometer 
(Thermo Fisher Scientific, Bremen, Germany) equipped with a nanoelectrospray ion 
source (Proxeon Biosystems, Odense, Denmark). Binding and chromatographic 
separation of the peptides took place in a 15 cm fused silica emitter (75 μm inner 
diameter) in-house packed (41) with reversed-phase ReproSil-Pur C18-AQ 3 µm resin (Dr. 
Maisch GmbH, Ammerbuch-Entringen, Germany). 
Peptide mixtures were injected onto the column with a flow of 500 nL/min and 
subsequently eluted with a flow of 250 nL/min from 2% to 40% MeCN in 0.5% acetic acid, 
in a 100 min gradient. The mass spectrometer was operated in data dependent mode to 
automatically switch between MS and MS/MS (MS2) acquisition. Survey full scan MS 
spectra with m/z 300-1600 were acquired in the Orbitrap with a resolution of 60,000 at m/z 
400 after accumulation to a target value of 1 million charges in the linear ion trap using the 
lock mass option for internal calibration of each spectrum (42). The five most intense ions 
were sequentially isolated for fragmentation in the linear ion trap using collisionally 
induced dissociation with normalized collision energy of 30% at a target value of 5000. 
The resulting fragment ions were recorded in the linear ion trap with unit resolution. Ions 
already selected for MS/MS were dynamically excluded for 60 seconds. For LTQ-FT 
measurement resolution was set to 25,000 for full scan, 5 million ions were accumulated 
and the top three ions were selected for sequencing. In FT-ICR, selected ion monitoring 
(SIM) scans  were acquired before fragmentation for enhanced mass accuracy and signal-
to-noise of the parent ion (resolution 50,000 at m/z 400, target value 50,000). MS3 was 
performed on the most abundant fragment ion for increased certainty of identification. 
Peptide identification and quantitation – Peak lists for database searching were 
generated from the raw data using in-house developed software called Raw2msm. From 
each fragment spectrum the six most intense peaks per 100 Th were extracted. Proteins 
were identified by automated database searching (Mascot version 2.1, Matrix Science) 
against an in-house curated version of the mouse IPI database (versions ranged from 
3.00 to 3.37 and contained between 40,613 and 68,655 entries complemented with 
frequently observed contaminants like porcine trypsin and human keratins. 
Carbamidomethyl-cysteine was used as a fixed modification; variable modifications were 
oxidation of methionine, protein N-acetylation, deamidation of Asn and Gln, N-
pyroglutamate and heavy versions of Arg and Lys. We required full tryptic specificity 
(cleavage at Arg-Pro and Lys-Pro as well as Asp-Pro was included), a maximum of two 
missed cleavages, and maximal mass deviation of 5 ppm for the parent ion and 0.5 Da for 
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fragment ions. As initial identification threshold for peptides we chose a false positive rate 
of max. 5% as judged by searching a concatenated database consisting of normal and 
reverse sequences. However, we required peptides with twice that score for final protein 
identification for phosphorylation-specific interaction partners (for example, MASCOT 
score 50 if score 25 corresponded to 5% false positive rate). Identification confidence of 
interaction partners was further enhanced by requirement of a SILAC ratio different from 
1:1, and the identification of the binder in an independent, crossover experiment with 
inversed ratio. For the relative quantitation of SILAC peptide pairs our in-house developed 
software MSQuant was used (http://msquant.sourceforge.net). All peptides from proteins 
appearing with an elevated SILAC-ratio were verified and re-analyzed manually.  
Determination of significant binding partners – A typical pulldown experiment yielded 
hundreds of identified proteins. The vast majority had a SILAC-ratio close to 1:1, 
indicating that they represent background binders of the beads irrespective of the 
phosphorylation state of the peptide. All protein ratios were normalized against the 
median. Proteins with a ratio more than 2-3 standard deviations above the median were 
considered as phosphorylation-specific binders, given that they had a correspondingly 
inverted ratio in the crossover experiment. It was not appropriate to decide on a fixed cut-
off value, since the number of interactors with ratio different from 1:1 influences the 
standard deviation. In borderline cases (referring to the ratio or the amount of identified 
peptides), or whenever an unexpected binding partner was discovered (e.g. a protein 
without known pTyr-binding domain), the experiment was repeated at least once to verify 
the significance of binding. 
 
RESULTS 
Quantitative proteomics for unbiased identification of interactions – For the 
identification of site-specific, pTyr-dependent interaction partners, we applied our 
previously established peptide pulldown approach, which is based on quantitative 
proteomics (43). Briefly, we separately incubated cell extract with synthetic peptides in 
both the phosphorylated and non-phosphorylated version. These peptides were 
synthesized with an N-terminal desthiobiotin for coupling to streptavidin-coated beads and 
efficient elution via biotin. To enhance accessibility, a short flexible linker of one serine 
and one glycine preceded the actual sequence. In order to further account for steric 
limitations and to build on current knowledge of binding modes of SH2 and PTB domains, 
we chose the sequence stretch as a 15-mer with 8 residues N-terminal of the pTyr and 6 
residues C-terminal.  
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Due to the central role of skeletal muscle in insulin signaling, we employed whole cell 
lysate from the murine muscle cell line C2C12, which we differentiated to myotubes before 
harvest. The SILAC technique was applied by incubating the phosphorylated peptide with 
lysate from cells grown in medium containing stable isotope labeled arginine and lysine, 
whereas unlabeled lysate was added to the control peptides. After washing steps and 
elution of bound proteins, LC-MS/MS of the combined samples yielded mass spectra in 
which unspecific background binders appeared with a signal intensity ratio of 1:1 between 
labeled and unlabeled versions of the peptides originating from protein digestion. 
Phosphorylation-specific binders were uncovered through their high ratios. The 
experimental design is depicted in Fig. 1. Every pulldown experiment was also carried out 
in a crossover fashion where cell lysates were swapped, resulting in inverted ratios for 
genuine, specific binders. 
 
Fig. 1. Proteomic screening for interaction partners of tyrosine phosphorylated sequences. 
Peptides corresponding to potential tyrosine phosphorylation sites are synthesized in 
phosphorylated and non-phosphorylated form. Cell populations are metabolically labeled using the 
SILAC technique to allow discrimination based on different peptide masses. Cell lysate from the 
population labeled with heavy Arg and Lys is incubated with the phosphorylated version of the 
peptide, while the control cell lysate is incubated with the non-phosphorylated peptide. Eluted 
proteins from those parallel pulldown experiments are combined and digested with trypsin. 
Peptides from unspecific background binders appear as pairs with abundance ratios close to 1:1 in 
the mass spectra. Phosphorylation-specific binders are identified as such through their high 
abundance ratio between heavy and light labeling states. In a crossover experiment, the incubation 
scheme is swapped, resulting in inverted ratios. 
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Fig. 2 contrasts unbiased, quantitative proteomics with the classical candidate- and 
western blotting-based approach. When visualizing eluates from a pulldown experiment 
on a gel, it is impossible to distinguish a low abundant, phosphorylation-specific binder 
among abundant background proteins without targeted immunoassays. However, the 
unbiased mass spectrometric readout is ideally suited for discovering novel interactors 
since it does not depend on a priori hypotheses as is the case for western blotting (44). 
This is made possible by quantitative proteomics – in this case though SILAC –, which 
allows straightforward discrimination between phosphorylation-specific interactors and 
background binders. 
 
Fig. 2. Peptide pulldown experiment as visualized by SDS-gel and western blot. Instead of 
combining protein samples from phosphorylated and non-phosphorylated bait peptides followed by 
direct in-solution digestion for LC-MS/MS analysis, one pulldown sample was applied to an SDS-
gel to illustrate sensitivity and importance of SILAC-based MS-readout. The sample contains 
roughly 1-2 µg of protein. An interaction partner of IRS-2 pY0649, PI3K p85 , was detected by 
western blotting after its identification by quantitative proteomics. The intense band at 45 kDa is 
actin. 
 
Figure 3 depicts a typical result from a peptide pulldown experiment. The high abundance 
ratio between labeled and unlabeled state distinguishes phosphorylation-specific binders 
from hundreds of background binders. Note that specificity of binding is evident when a 
ratio is statistically different from the ratios of background binders. The value of the ratio 
itself, however, does not directly reflect the affinity or the stoichiometry of the interaction. 
In fact, repetitions of an experiment can yield fluctuations in the ratios, due to minor 
variations in the stringency of washing steps without, however, changing the significance 
of the interaction. Furthermore, in many cases the differences between binding to the bait 
and the control are so great that the unlabeled peptides (representing binding to the 
PROFILING OF PHOSPHOTYROSINE INTERACTION PLATFORMS IN INSULIN SIGNALING 
42 
control bait) become undetectable and hence unquantifiable (45). Even though this clearly 
indicates phosphorylation-specific interaction, it leads to imprecise ratios. For this reason, 
we recommend to consider the outlier significance (distance from mean) in addition to the 
absolute ratio. 
 
Fig. 3. Typical result of a SILAC peptide pulldown experiment, exemplified by the bait 
peptide IRS-1 Y0891. (A) A peptide derived from the interaction partner Grb2 is about 40 times 
more abundant in the heavy form than in the light form, indicating that Grb2 binds specifically to 
IRS1 phosphorylated on Y0891. (B) In a crossover experiment (swapped SILAC labels) the 
abundance ratio of the same peptide is inverted. (C) Most other proteins have a 1:1 ratio, indicating 
that they are unspecific binders to the peptides or the magnetic beads that are bound irrespective 
of phosphorylation. (D) A plot of the protein abundance ratios shows that Grb2 and SHP2 are 
significant outliers in both the Y0891 pulldown and the crossover experiment. Every dot represents 
one protein. 
 
In total, we performed pulldowns for 109 individual sites in forward and crossover 
experiments. The majority of pulldowns were additionally repeated in separate 
experiments to validate novel interactors. Fourteen sites were furthermore targeted in 
combinatorial binding experiments (see below). The interaction data is provided in Tables 
1-3 and summarized in Figures 4 and 5.  
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The pTyr-interactome of IRS-1 and IRS-2 – IRS-1 and IRS-2 have been recognized as 
interaction platforms soon after their discovery, and literature reviews report approximately 
10 known pTyr-dependent interaction partners, albeit sometimes with little supporting 
evidence (see DISCUSSION). Our study, for the first time, provides a systematic study of 
the pTyr interactome of these proteins. However, the interaction partners depicted in 
Fig. 4 – while specific to the phosphorylated baits – are not validated as biological 
interactions of the full length endogenous proteins in the cell, nor do we know for all pTyr 
sites if they are indeed phosphorylated upon insulin stimulation. Therefore we refer to 
them as potential interaction partners.  
We first checked if our large-scale screen yielded known interaction partners. We indeed 
found these proteins, including the PI3K subunits, Grb2, SHP2, Nck, Csk and Crk. 
Additionally, the majority of interaction partners in Table 1 have SH2 or PTB domains, 
suggesting that these interactions are direct and specific. Thus we conclude that the 
screen performed well both in retrieving interaction partners known from literature as well 
as in expanding the interactome.  
IRS proteins contain multiple interaction motifs for phosphatidylinositol-3-kinase (PI3K). 
For each of these motifs, we found the alpha isoform of the SH2-domain containing 
regulatory subunit, suggesting that each of the nine (IRS-1) or 11 (IRS-2) is indeed 
capable of binding to PI3K. This is not self-evident because some of these motifs are 
imperfect, i.e. they lack methionine in the +3 position. The beta isoform of the regulatory 
PI3K was found less often, perhaps due to its low expression levels. Likewise, the 
catalytic subunits of PI3K were frequently identified due to their tight association with the 
regulatory subunits.  
The protein tyrosine phosphatase SHP2 and the adaptor protein Grb2 are also well-
established IRS interactors. Here we mapped the specific sites on IRS-1 and IRS-2 that 
these effector proteins can dock to (7 and 4 sites for SHP2, respectively and 2 and 3 for 
Grb2; Fig. 4 and Table 1).  In addition, the inositol-5-phosphatase SHIP-2 and the Ras 
GTPase activating protein RasGAP can bind to various sites on IRS-1 and IRS-2. In 
contrast, the adaptor molecules Crk and Crk-like protein were pulled down by only one 
specific tyrosine in each IRS-protein. Interestingly, this tyrosine occurs at a similar position 
(Y0760 in IRS-1 and Y0734 in IRS-2 in the mouse sequence) but the binding sequences 
are very different. Apart from Crk and Crk-like protein, the site in IRS-2, Y0734, attracts 
many different proteins simultaneously. Even though our washing steps were optimized to 
detect direct binders to the phosphorylated bait peptide, it is possible that some of the 
detected interactions occur via indirect binding such as noted above for the catalytic 
subunits of PI3K.  
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Fig. 4. The phosphotyrosine interactome of IRS-1 and IRS-2. pTyr-specific interaction partners 
obtained in peptide pulldown experiments are depicted as symbols along the primary structure of 
IRS-1 and IRS-2. Detailed data for every pulldown experiment is provided in Table 1. 
 
Most interactors were recruited by both IRS-proteins. However, cases of exclusive 
interactions also occurred. Phospholipase C gamma (PLCγ), for example, docks to 
several sites in IRS-2 but none in IRS-1 in our experiment. Similarly, Shc, Cullin-5, 
LRCH3, DOCK-6 and -7 as well as glycylpeptide N-myristoyltransferase 1 were 
PROFILING OF PHOSPHOTYROSINE INTERACTION PLATFORMS IN INSULIN SIGNALING 
49 
exclusively recruited by IRS-2 derived peptides. IRS-1-specific binders include Csk, WD-
repeat domain phosphoinositide-interacting protein 3, and several enzymes involved in 
fatty and amino acid degradation. Detailed results of all pulldown experiments are listed in 
Table 1. 
The ubichinol-cytochrome c reductase complex chaperone CBP3 homolog (Swiss-Prot 
Q9CWU6) was exclusively and repeatedly found in pulldowns with the two homologous 
sites IRS-1 Y0107 and IRS-2 Y0136 with a slightly elevated ratio, but in most cases it was 
not significantly phosphorylation-dependent (and is hence not listed in Table 1). It could 
therefore be an indirect binder recruited via one of the fatty acid metabolizing enzymes. 
The protein tyrosine kinase Fyn has been reported as an IRS-2 interactor previously (46), 
and we similarly found consistent but relatively weak ratios when binding to Y0734 of 
IRS-2. 
The phosphotyrosine interactome of InsR, IGF1R and IRR – As expected, the 
receptors yielded fewer interactors than the IRS proteins (Fig. 5). InsR and IGF1R share a 
very similar pTyr-interaction profile. However, the IGF1R contains multiple sites for 
recruitment of SHP2, and a site that binds RasGAP as well as short chain specific acyl-
CoA dehydrogenase. The physiological importance of the latter site is questionable, 
however, because it is not conserved in the human IGF1R sequence. Strikingly, the IRR 
lacks interactions in its C-terminal part. InsR Y1001 and IGF1R Y0988 can recruit many 
different proteins, and apparently minor differences in the sequence N-terminal of the pTyr 
in the corresponding site IRR Y0967 impede some of these binding events. Interestingly, 
2,4-dienoyl-CoA reductase shows phosphorylation-dependent binding only for the latter 
site but is strongly bound by the other sites irrespective of their phosphorylation state. This 
behavior was observed for a few sites in IRS proteins as well, and is indicated by skew 
stripes in the protein symbols in Figs. 4 and 5. Binding of IRS-1 and Shc to the NPEY-
sites in the receptors was only detectable when the bait sequence was enlarged by six 
amino acids towards the N-terminal side. This observation can be rationalized on 
structural grounds: crystal structures of the IRS-1 PTB domain bound to the InsR reveal 
that a relatively long sequence at the N-terminal side of the pTyr is involved. Residues -8 
to -3 form a beta-strand that establishes hydrogen bonds with a beta-strand of the PTB 
domain. The leucine at position -8 is particularly important and hydrophobic residues from 
-6 to -8 are favored by Shc and IRS-1 (47, 48). These findings suggest the desirability of 
providing longer and freely accessible N-terminal regions for sequences that are involved 
in PTB domain recruitment. However, IRS-1 was still only present with few peptides and 
IRS-2 was not detected. The PTB domains of Shc and IRS-1 are electrostatically 
polarized similar to PH domains, and can therefore associate with phosphoinositides in 
the membrane through their positively charged surface (1). Since these additional and  
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Fig. 5. The phosphotyrosine interactome of InsR, IGF1R and IRR. pTyr-specific interaction 
partners obtained in peptide pulldown experiments are depicted as symbols along the primary 
structure of the intracellular regions of the receptors. The cytoplasmic part starts at position 968 for 
the InsR, 961 for the IGF1R, and 944 for the IRR, according to the Swiss-Prot database. Detailed 
data for every pulldown experiment is provided in Table 1. 
 
stabilizing interactions are not present in our experiment, reduced affinity (but not reduced 
specificity) is to be expected. We conclude that PTB domain interactions are more 
challenging to detect in our assay and that they might need further optimization. In 
contrast to its binding to InsR and IGF1R, IRS-1 was not detected in the experiment with 
the bait sequence of the IRR, likely due to the challenges of detection. However, the 
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membrane-associated guanylate kinase MAGUK p55 subfamily member 6 was identified 
as an interactor with IRR. We did not find interactors for a fourth receptor, IGF2R also 
called mannose-6-phosphate receptor that has two cytosolic tyrosines.  
One of the advantages of conducting a large number of peptide pulldown experiments in 
the same system is facilitated discrimination of biochemical noise. We were initially 
puzzled by the identification of certain unexpected proteins with elevated ratios that 
passed the significance threshold in many pulldown experiments with completely 
unrelated bait sequences. We soon realized that the combination of frequent observation 
across multiple experiments and irreproducibility in repetitions with the same bait 
sequence classifies this kind of candidates as unlikely to be biologically relevant. Indeed, 
7 out of those 8 „uninvited guests‟ are RNA-binding proteins, providing a ready 
explanation for their specific binding to phosphorylated peptides: the negative charges on 
the phosphorylated bait peptides introduce an ion exchange effect with the positively 
charged RNA-binding proteins, somewhat mimicking their binding to RNA. We list those 
proteins here, and advise to take care in categorizing such candidates in similar studies: 
60S ribosomal protein L11, RNA-binding protein SiahBP homolog, Activated RNA 
polymerase II transcriptional coactivator p15 precursor, Eukaryotic translation initiation 
factor 5, Splicing factor U2AF 35 kDa and 65 kDa subunit, Peptidylprolyl isomerase B, 
ATP-dependent RNA helicase DDX3X.  
Doubly and triply phosphorylated motifs – In order to assess the effect of 
phosphorylation events in close proximity to each other, we performed experiments with 
doubly or triply phosphorylated bait peptides for some of the sequence stretches that 
contain neighboring tyrosines (Table 2). We reasoned that combinatorial phosphorylation 
might either prevent binding events compared to the monophosphorylated counterpart, or 
even generate new binding interfaces. We indeed encountered some sites whose 
interaction capability was modified by additional phosphorylations. For example PI3K was 
not displaced by phosphorylations N-terminal of its binding sequences around IRS-2 
Y0538 and InsR Y1351. However, it failed to interact with the IRS-2 Y0628 peptide 
sequence, which matches to a weaker consensus motif, if positions Y0621 and Y0624 
were phosphorylated at the same time. Most strikingly, the triply phosphorylated peptide 
resembling the kinase activation loop of the InsR recruited several interactors (dedicators 
of cytokinesis 6 and 7, RasGAP, LRCH3), whereas a doubly and the singly 
phosphorylated versions did not recruit any proteins (see DISCUSSION). 
For precise mapping of differences between mono- and doubly phosphorylated versions, 
we performed triple SILAC labeling experiments for selected cases (Table 3). In this type 
of pulldown experiments, non-phosphorylated peptide was incubated with unlabeled cell 
lysate (Arg0 + Lys0), monophosphorylated peptide was incubated with a medium labeled  
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state (Arg6 + Lys4) and doubly phosphorylated peptide was incubated with heavily 
labeled lysate (Arg10 + Lys8). Peptides appear as triplets in mass spectra, enabling 
accurate comparison between the three conditions. Using this assay we encountered 
differential effects of a phosphorylation located seven residues upstream of the NPEY 
motif in the receptors. The recruitment of Shc was not affected by this additional 
phosphorylation within the binding motif of the PTB domain in case of IGF1R and IRR. 
However, binding of Shc to the respective sequence in the InsR proved to be sensitive to 
this change, and the interaction was abolished (Fig. 6). In case of IRS-1 Y0546/Y0554, 
the second phosphorylation neither increased nor diminished the binding of interactors. 
On the other hand, for IRS-1 Y0759/Y0760 the double phosphorylation induced novel 
interactions. While SHP2, Csk, Crk and Crk-like protein were equally attracted by mono- 
and doubly phosphorylated version, the binding of RasGAP and SHIP-2 was enhanced by 
the additional phosphorylation. Some proteins were even exclusively recruited by the 
doubly phosphorylated sequence, namely Nck2, PLCγ, Grb2, PI3K and Cbl-B. 
 
Fig. 6. Triple labeling pulldown reveals distinct combinatorial effects of double 
phosphorylation within the NPEY-motifs in the insulin receptor family. (A) When 
phosphorylated at the tyrosine within the NPEY-motif, the InsR recruits Shc, as demonstrated by 
the high ratio between the medium-label state and the unlabeled state. If the tyrosine located seven 
amino acids further N-terminal also carries a phosphorylation, the interaction with Shc is abolished. 
(B) and (C) When IGF1R or IRR exhibit this phosphorylation pattern, the interaction between Shc 
and the receptor is not influenced by the second phosphorylation event (Table 3.) 
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DISCUSSION 
Capabilities and limitations of quantitative proteomics combined with peptide bait 
fishing – In recent years, MS-based quantitative proteomics has become a powerful and 
versatile tool for comparing complex proteomes and their modifications (49-51), and in 
particular, metabolic labeling by the SILAC technique has proven to be a very accurate 
method for this purpose (52). In addition, interaction proteomics using quantitative 
readouts has developed substantially during recent years (37). Our strategy aimed to 
uncover pTyr-dependent binding events on proteins that serve as interaction platforms in 
the insulin signaling pathway. To achieve this, we employed synthetic phosphorylated 
peptides as baits in pulldown experiments from whole cell lysates. An advantage of this 
approach is the application of sequence defined baits yielding site-specific interaction 
information. In comparison to purely in vitro experiments such as chip-based assays, the 
unbiased nature of the mass spectrometric approach enables discovery of novel 
interactors, unconstrained by prior hypotheses. Furthermore, our experiment involves the 
original expression level of the interacting proteins in the competitive environment of the 
whole proteome of the cell type studied. This mimics the true situation within a cell much 
more closely than in vitro assays do. Importantly, using quantitative proteomics enabled 
straightforward discrimination between specific phosphorylation-dependent interactors 
and background binders. However, even though all significant interactors found in our 
experiments are per definition specific for the phosphorylated form of the peptide, they 
can only take place in vivo if the site is accessible, becomes phosphorylated by a kinase, 
and if the binding partner is available for the interaction. Subcellular localization and 
tissue-specific differences will often play a decisive role in this respect. Affinity, relative 
expression levels, effects of the neighboring sequence and the involvement of additional 
interaction domains co-determine the actual occurrence of the pTyr-mediated interaction 
in vivo. For most interacting proteins there is additional information, such as known 
subcellular localization and the presence of known interaction domains that can help in 
determining the likelihood that the interaction is biologically relevant. Taken together our 
results represent a catalogue of interactions that are proven to be biophysically possible 
and – for interactions that fulfill the above criteria – likely to occur in vivo. In this regard, 
the present study is complemented by our recent, systematic investigation of the tyrosine 
phosphoproteome induced by insulin and IGF-1 stimulation (53). Below we first discuss 
the common and distinct interactomes of the IRS proteins and the three receptors that 
involve classical SH2 or PTB domain mediated interactions. We then discuss interactions 
with proteins not containing these binding modules.  
Common interactors of IRS-1 and IRS-2 – Most of the interaction partners identified in 
this work contain an SH2 domain that mediates binding to the pTyr-sequence. 
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Recognition motifs for many SH2 domains have been determined by peptide library 
screening (3, 54). Despite their large number, SH2 domains do not bind to arbitrary 
sequences surrounding the pTyr but instead bind only to a subset of consensus motifs. 
Conversely, the same peptide sequence can bind to different SH2 domains (3), which is 
reflected here by the recruitment of a range of binding partners in many of our peptide 
pulldowns. 
Among the proteins recruited to both IRS proteins, PI3K bound to the largest number of 
different sites. PI3K is a critical node in insulin signaling (28), which activates the Akt 
kinase through generation of phosphatidylinositol-3,4,5-triphosphate at the plasma 
membrane. Akt in turn has several downstream pathway branches important for growth 
and metabolism. Our prevailing observation of the alpha isoform of PI3K agrees with its 
predominant role in insulin signaling (55). The adaptor protein Grb2, which interacts with 
multiple phosphorylated peptides from IRS-1 and IRS-2, triggers signaling via the 
activation of the Ras to MAP-kinase axis. Intriguingly, the suppressor of Ras signaling 
RasGAP binds to multiple sites in IRS proteins. This novel finding suggests that the 
activity of RasGAP is regulated by recruitment to the IRS platform.  
The tyrosine phosphatase SHP2 plays a dynamic role in the activity of the pathway by 
both providing negative feedback for PI3K activation via dephosphorylating pTyr-sites on 
IRS proteins that bind PI3K (56) and stimulating mitogenic signaling via insulin (57-59). 
Here we systematically map binding sites of SHP2 on the IRS signaling platforms. 
The lipid phosphatase SHIP-2 dephosphorylates phosphatidylinositol phosphates at the 
5´-position. Even though SHIP-2 action does not abolish the ability of PIPs to activate Akt, 
it clearly antagonizes insulin signaling (60). Here we mapped five interaction sites of 
SHIP-2 to IRS-1 and two to IRS-2. 
Crk family adaptors mediate protein complex formation in various signaling pathways, and 
have been shown to influence mitogenesis, cytoskeletal rearrangements and insulin-
stimulated glucose uptake (61, 62). While binding to IRS-1 and IRS-2 has been observed 
before (46), our data provides the specific docking sites. 
Differential interactions between IRS-1 and IRS-2 – The physiological effects of insulin 
can vary greatly in different target tissues due to different modes of signal transmission 
and modulation inside cells. For example in liver synthesis of glycogen, proteins and lipids 
is triggered along with inhibition of hepatic glucose production and very low density 
lipoprotein (VLDL) secretion. In muscle, the response mainly involves glucose uptake and 
glycogen synthesis (28, 63). Previously many of these differences were attributed to 
stronger activation of IRS-1 or IRS-2. However, differences in binding partners between 
IRS-1 and IRS-2 are not only determined at the level of their primary sequence motifs, but 
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also by differing time-courses of phosphorylation, dose-response curves towards 
hormones, and intracellular compartmentalization (24). The expression level of IRSs and 
their interactors also play a role, and those factors can even result in opposite functions of 
an IRS protein depending on the cell type investigated (64). Illustrating this complexity, a 
recent study found that IRS-1 and IRS-2 trigger the same downstream signals, but IRS-1 
was more active in the postprandial state, whereas IRS-2 was employed during fasting 
(65). 
Given the extensive and often contradictory investigations into the differential roles of 
IRS-1 and IRS-2, our experiment at the least provides a large-scale data set delineating 
potential common and differential pTyr mediated interactors. In general, our results 
reinforce the notion of a large overlap in the signaling capabilities between IRS-1 and 
IRS-2. Most pTyr-dependent interaction partners involved in growth and metabolic 
signaling were recruited by both proteins. However, we also detected clear differences in 
the interactomes. For example, as noted above SHIP-2 binds to substantially more sites in 
IRS-1. Exclusive binding to IRS-1 was observed for Csk (C-terminal Src-kinase), which 
phosphorylates members of the Src family of kinases at C-terminal tyrosines, inhibiting 
their activity. Csk has been shown to bind to IRS-1 via its SH2-domain (66), whereas 
interaction or lack thereof with IRS-2 has not previously been noted. The Csk-mediated 
inactivation of Src-family kinases leads to an insulin-dependent decrease of pTyr on FAK 
and Paxillin, which reduces actin stress fibers and allows insulin to influence the 
reorganization of the cytoskeleton. Our observation that Csk is recruited only to IRS-1 
derived peptides and not to IRS-2 derived peptides is in line with the observation that 
IRS-1, but not IRS-2, mediates actin remodeling in myotubes (24).  
Shc and PLCγ were only found as interactors of IRS-2. Shc is an adaptor protein best 
known for its ability to bind Grb2 and accordingly promote Ras activation. PLCγ is the only 
PLC that contains SH2 domains. Binding via its N-terminal SH2 domain to a tyrosine 
kinase leads to phosphorylation of PLCγ on several tyrosines, thereby activating it and 
ultimately stimulating PKC activation (67). PLCγ has previously been shown to bind to IRS 
proteins in an insulin-dependent manner (46). Our finding that PLCγ is recruited to three 
sites in IRS-2 and none in IRS-1 suggests one mechanism for specific functions of the two 
signaling platforms.  
The pTyr-interactome of InsR, IGF1R and IRR – The insulin signaling pathway is 
activated by the insulin receptor (InsR) as well as the insulin-like growth factor 1 receptor 
(IGF1R). Signaling through InsR has metabolic functions whereas IGF1R, as its name 
implies, has mainly growth and mitogenic effects. However, there is also a significant level 
of crosstalk between these functions. Experiments with chimeric receptors have shown 
that it is mainly the intracellular part that determines specificity, not the extracellular ligand 
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binding domains (68). The most apparent difference between the interactomes of IGF1R 
and InsR as determined here is the larger number of SHP2 binding sites to IGF1R (four 
vs. one). This observation helps to explain the stimulatory role of this phosphatase in 
growth signaling. Both are able to recruit Cbl, even though the interaction was only weakly 
pTyr-dependent in the case of the IGF1R. Cbl is an E3 ligase and allosterically activates 
an E2-enzyme for ubiquitinylation, which leads to the internalization and subsequent 
degradation of the receptor (69).  
Insulin receptor related receptor (IRR) is thought to have a less prominent role in the 
insulin/IGF pathway and few functions have been described. We found that IRR is less 
prone to participate in pTyr-dependent binding events and detected just three interactors 
with SH2 domains. Only the membrane proximal sites recruit interaction partners. Our 
failure to detect IRS-1 binding to IRR might be due to very weak binding of the IRS PTB 
domain under the conditions of this assay (see RESULTS).  
The NPEY-motif containing phosphopeptide derived from IRR did bind to MAGUK p55 
(membrane-associated guanylate kinase MAGUK p55 subfamily member 6 – also termed 
PALS2), one of the non SH2 domain containing proteins otherwise discussed below. Little 
functional information is known about MAGUK p55 but it appears to be involved in proper 
targeting of receptors in polarized cells, as well as in stabilization of receptors and acting 
as signaling scaffold in non-polarized cells (70). This potential interaction would be unique 
to the IRR as compared to its other family members. 
Doubly and triply phosphorylated motifs – Another interesting difference between the 
receptors became apparent when studying the combinatorial effects of an additional 
phosphorylation at the tyrosine located seven residues N-terminal of the NPEY-motif. In 
the doubly phosphorylated peptide, this site bound to SHIP-2 and SHP2 (to InsR and 
IGFR + IRR, respectively) just as in the case of the monophosphorylated peptide (Table 
3). Likewise the doubly phosphorylated peptide still bound IRS-1. However, binding of Shc 
to the NPEY-motif was abrogated specifically for the InsR-sequence derived peptide. 
Since Shc activates MAP kinase signaling when associated with tyrosine kinases this is a 
possible mechanism of differential control – towards metabolic signaling – between the 
receptors.  
In most other cases of combinatorial phosphorylation, we did not observe any changes. 
The kinase activation loop, interestingly, yielded several binding partners in its triply 
phosphorylated state. This may ensure that the interactions can only take place after full 
activation of the kinase. Selective binding to the triply phosphorylated sequence of the 
activation loop has previously been reported for APS and IRS-2 (71, 72). The sequence in 
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this region is identical between InsR and IGF1R and only has one Ile/Val substitution in 
IRR, therefore this result likely applies to all of the receptors. 
IRS-1 has two tyrosines adjacent to each other (Y0759/Y0760). In pulldowns with singly 
phosphorylated peptides pY0760 interacts with SHP2 as well as five other proteins 
containing SH2 domains, however, pY0759 only interacts with SHP2. The doubly 
phosphorylated peptide still binds to all interactors and strikingly to several additional 
ones. These proteins - Grb2, PLCγ, Nck2 and Cbl – all contain SH2 domains and for two 
of them binding to doubly phosphorylated peptides has previously been described. PLCγ, 
for example, usually binds hydrophobic sequences with its C-terminal SH2-domain, but 
following a conformational change it creates a second pTyr-binding pocket and can then 
also bind doubly phosphorylated motifs, such as pYESPpYAD in the activated Syk 
tyrosine kinase (73). For Grb2, which binds selectively to the pYpY-sequence here, a 
similar observation has been made for a pYpY-motif in Shc (74). This doubly 
phosphorylated peptide is the only one binding Nck2 in our study. Nck has previously 
been observed to bind to IRS-1 in an insulin-dependent manner, and is engaged in 
cytoskeletal rearrangements and mitogenic signaling (75, 76), but the mode of its binding 
has not been described. The doubly phosphorylated version clearly bound the Src-kinase 
Fyn, albeit not in a significantly pTyr-dependent manner. Fyn has been reported to bind to 
IRS-1 and IRS-2 (46) and to tyrosine phosphorylated Cbl after insulin stimulation (77).  
pTyr-binding independent of SH2 and PTB domains – The interactions described 
above are all readily explained by pTyr-SH2 or -PTB domain mediated binding. Most of 
them recapitulate and extend known interactions or can be readily understood in terms of 
the biology of this well studied pathway. A further goal of our experiments was to possibly 
detect novel interaction partners and interaction modes, not mediated by known 
interaction domains or interactions with known members of the insulin signaling pathway. 
Our results indeed contain a number of such interaction partners. Since indirect binding is 
possible in our experimental setup, they might have been recruited as secondary 
interactors. For some of the investigated sites, however, we exclusively found non-SH2 
domain containing proteins. Furthermore, even for those sites where SH2-containing 
proteins might indirectly recruit other proteins, this may be unlikely since it should happen 
at all sites with which they interact. We therefore consider it unlikely that indirect binding is 
the only explanation for these binders.  
As demonstrated by the relatively late discovery of the Cbl SH2 domain, genome 
annotation algorithms can sometimes miss an SH2 domain if it has an atypical sequence 
(78). More importantly, alternative pTyr-binding domains have recently been described. 
The C2 domain of PKCδ has been shown to bind pTyr (79). A very recent report by the 
Cantley group (also using the SILAC technology) showed that a yet uncharacterized 
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region in pyruvate kinase M2 binds specifically to pTyr containing peptides (11). This was 
interpreted to provide a direct link to mitochondria-based metabolic functions. In total we 
found 21 „non-classical‟ interaction partners and based on co-occurrence estimate that at 
least ten of these bind directly to pTyr containing bait peptides. 
Note that some of the interactions might not necessarily occur in insulin or IGF1 signaling, 
because IRS-1 and IRS-2 can also be engaged by other receptors. Those include the 
prolactin (80), androgen (81), growth hormone (80, 82) and vascular endothelial growth 
factor (VEGF) receptors (83), as well as members of the integrin receptor family (84, 85) 
and several cytokine receptors (86). 
Cytosolic interactors of the IRS proteins included two WD repeat proteins. The function of 
WDR92 (WD repeat-containing protein 92) is still elusive, but it has been suggested to act 
as a modulator of apoptosis (87). The function of WD-repeat domain phosphoinositide-
interacting protein 3, which bound to a phosphopeptide derived from IRS-1, is also not yet 
known. It potentially binds to membrane phosphoinositides in addition to the interaction 
with Y0087 in the PH domain of IRS-1, which is membrane-associated, and thus could 
enhance membrane anchoring of IRS-1 after stimulation. Several septins were found as 
interactors of both IRS proteins. Septins behave like filaments or scaffold proteins and 
play a role in cytokinesis and in cytoskeleton and membrane organization (88). 
Among the proteins exclusively interacting with peptides derived from IRS-2, Cullin-5 is a 
scaffold protein and part of an E3 ubiquitin ligase complex. As such it might be involved in 
proteasomal degradation of IRS proteins. Another cullin, cullin-7, triggers proteasomal 
degradation of IRSs (89). LRCH3 (leucine-rich repeat and calponin homology domain-
containing protein 3) is a protein with unknown function, and DOCK-6 and -7 (dedicator of 
cytokinesis) act as GEFs (guanine nucleotide exchange factor) for small G-proteins of the 
Rho-family according to their UniProt annotation. This connects them to regulation of 
cytoskeletal changes, one of the known effects of insulin and IGF1 signaling. 
Glycylpeptide N-myristoyltransferase 1 attaches myristoyl-groups to proteins with a 
glycine at their N-terminus. Myristoylation of proteins equips them with a membrane 
anchor, targeting them to cellular membranes.  
Intriguingly, we detected several effectors of metabolic regulation in insulin signaling, 
which bound to homologous sites in IRS-1 and IRS-2. We encountered a number of 
enzymes associated with fatty acid catabolism in mitochondria. Acyl-CoA dehydrogenases 
catalyze the first step in beta-oxidation, and enoyl-CoA hydratase is responsible for the 
second step. 2,4-dienoyl-CoA reductase participates in beta-oxidation by feeding 
unsaturated fatty acids into the pathway. Hydroxysteroid (17-beta) dehydrogenase 10 is 
crucial in the degradation of branched chain fatty acids and isoleucine as well as in the 
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metabolism of steroid hormones (90). The activity of these enzymes is known to exert an 
effect back on IRS signaling. Long-chain acyl-CoA can be metabolized to diacylglycerol, 
which activates PKCθ (91). PKCθ directly and indirectly (via JNK and IKK) leads to 
phosphorylation of IRS-1 on inhibitory serine-residues (92). A recent bioinformatic 
analysis even reports that two related acyl-CoA dehydrogenases (family members 10 and 
11) contain kinase domains, pointing to a direct link between fatty acid catabolism and cell 
signaling (93).  
Furthermore, several enzymes involved in amino acid catabolism were found to be able to 
interact with IRS-1 derived phosphopeptides. Methylcrotonoyl-CoA-carboxylase degrades 
leucine, isobutyryl-CoA-dehydrogenase degrades valine, and glutaryl-CoA-
dehydrogenase degrades lysine and tryptophane. Branched chain amino acids play an 
important role in the regulation of translation via mTOR-signaling and in insulin signaling 
(94, 95).  
Finally, a complex consisting of prefoldin, RPABC1/RPB5 and „unconventional prefoldin 
RPB5 interactor‟ binds to homologous sites in the IRS-1 and IRS-2 PH and PTB domains. 
This complex shuttles between cytosol and nucleus, where it is believed to mediate 
transcriptional effects of nutrient signaling via mTOR (96).   
Figure 7 summarizes the various pathways that are potentially directly linked to IRS- 1 
and IRS-2 via their pTyr-dependent interaction partners as measured in this study.  
 
 
Fig. 7. Molecular functions potentially influenced by IRS-1 and IRS-2 through direct binding. 
The pTyr-dependent interaction partners of IRS-1 and IRS-2 identified in this study are grouped 
according to their function and subcellular location. Stimulatory and inhibitory effects on the 
pathways are indicated by  and Θ, respectively. 
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CONCLUSIONS 
Here we have used quantitative interaction proteomics based on the SILAC technology in 
a systematic study of phosphotyrosine binding in the insulin signaling pathway. With this 
work we hope to have contributed new knowledge to the insulin signaling pathway, whose 
malfunction underlies diabetes, a disease that will soon afflict 300 million patients world-
wide and that threatens the very functioning of national health systems (97). High 
accuracy mass spectrometry and relative quantitation between phosphopeptide pulldowns 
and control pulldowns from cell extracts ensured that our data represents specific 
phosphopeptide – protein interactions. Further studies are needed to validate these 
interactions in the context of endogenous, full-length proteins. However, for most of our 
interactors, previous knowledge of binding modes and involvement in the pathway make 
this extremely likely. For the potential interaction partners with non-traditional binding 
modes, our data raises interesting hypotheses that can be followed up in a directed way 
by researchers in the field. Recent work from a number of laboratories encourage us to 
believe that at least some of these interactions may point to novel and as yet unstudied 
mechanisms in insulin signaling.   
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3 DEVELOPMENT OF A NOVEL METHOD FOR VERY HIGH 
ACCURACY IN PROTEIN QUANTITATION 
3.1 PUBLICATION: ABSOLUTE SILAC FOR ACCURATE 
QUANTITATION OF PROTEINS IN COMPLEX MIXTURES DOWN 
TO THE ATTOMOLE LEVEL 
 
This article presents the results of the project on absolute protein quantitation and was 
published in 2008, in the March issue of Journal of Proteome Research on pages 1118-
1130. 
The project was a joint effort together with Dr. Hüseyin Besir and Prof. Dr. Dieter 
Oesterhelt from the department of membrane biochemistry at the Max-Planck-Institute for 
biochemistry. 
The following pages contain the published version of the article. 
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Mass spectrometry based proteomics can routinely identify hundreds of proteins in a single LC-MS
run, and methods have been developed for relative quantitation between differentially treated samples
using stable isotopes. However, absolute quantitation has so far required addition of a labeled standard
late in the experimental workflow, introducing variability due to sample preparation. Here we present
a new variant of the stable isotope labeling by amino acids in cell culture (SILAC) technique termed
“Absolute SILAC” that allows accurate quantitation of selected proteins in complex mixtures. SILAC-
labeled recombinant proteins produced in vivo or in vitro are used as internal standards, which are
directly mixed into lysates of cells or tissues. This minimizes differences in sample processing between
the isotope-labeled standard and its endogenous counterpart. We show that it is possible to quantify
over several orders of magnitude, even in the background of a whole cell lysate. We furthermore devise
a strategy to quantify peptides at or below their signal-to-noise level on hybrid ion trap instruments,
shown here for the LTQ-Orbitrap. The data system triggers on peptides of the SILAC-labeled protein,
initiating ion collection in a narrow mass range including the endogenous and labeled peptide. This
strategy extends the regular detection limit of an LTQ-Orbitrap by at least an order of magnitude and
accurately quantifies down to 150 attomole of protein in a cell lysate without any fractionation prior to
LC-MS. We use Absolute SILAC to determine the copy number per cell of growth factor receptor-
bound protein 2 (Grb2) in HeLa, HepG2, and C2C12 cells to 5.5 × 105, 8.8 × 105, and 5.7 × 105,
respectively, in the exponential growth phase.
Keywords: mass spectrometry • quantitation • quantification • isotope labeling • LC-MS • selected ion
monitoring • proteomics • diagnostics • biomarkers • detection limit
Introduction
The literature of molecular biology contains an overwhelm-
ing amount of information on the function of proteins in a cell
or the body, alone and in their interplay with each other.
However, in the majority of cases, the published results are
limited to qualitative information or relative quantitation of
the proteins of interest, while quantitative data on their
absolute amounts are lacking. Ultimately, it would be highly
desirable to obtain exact quantitative values of each protein
in a system, e.g., their copy number per cell or their concentra-
tion in nanogram per milliliter of body fluid. While this kind
of basic information about a protein is already per se valuable
for the biologist, systems biology even requires it as input for
modeling. In a medical context, knowing the exact amounts
of certain proteins in blood or other common sources of
biomarkers can provide diagnostically relevant information for
patient treatment. To this end, most clinically important
markers are measured by quantitative immunoassays. These
approaches can be very accurate and easy to perform once a
suitable antibody has been generated, but assay development
generally lags behind the increasing pace of discovery of new
interesting biomarkers by modern proteomic and microarray
methods. In addition, immunoassays can be affected by
unspecific reactions and nonlinearity of quantitation, and they
can fail if a relevant epitope has been removed by conforma-
tional changes, proteolysis, or posttranslational modifications.
Since the quantitation of each protein normally requires a
separate experiment, the procedure can also be very laborious
and expensive. A generally applicable and robust method,
comparably or even more sensitive and specific as an immu-
noassay but without its disadvantages, would therefore be
highly desirable.
Mass spectrometry has become a widespread technology for
relative quantitation between two or more experimental condi-
tions.1 While peak areas of peptide signals can be compared
between consecutive LC-MS runs,2–4 more sophisticated meth-
ods exploit stable isotope labeling. Differentially treated samples
are labeled with heavy and light isotopes, creating distinct
signals in a mass spectrum for every proteolytic peptide present
in labeled and nonlabeled form. By comparing their peak areas,
one can directly deduce the effect of the differential treatment
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on protein amount. Several methods have been developed for
introducing heavy isotopes into a sample. Digestion in heavy
water (H2
18O)5,6 or chemical addition of labeled reagents in
the case of ICAT,7 iTRAQ,8 ICPL,9 and HysTag10 integrate the
label before, during, or after protein digestion. Metabolic
labeling techniques such as 15N-labeling11 and SILAC12–14 even
allow the incorporation of the label preharvest during culture.
In cases where metabolic labeling is hard to accomplish, like
with tissue samples, a modified SILAC approach such as CDIT15
can be applied.
Recently, several methods have been developed that com-
bine isotope labeling and mass spectrometry for absolute
quantitation of proteins. On the instrumentation side, improve-
ments in sensitivity and sequencing speed have ameliorated
the quantitation of low abundant proteins, and for triple
quadrupole mass spectrometers in particular, the multiple
reaction monitoring (MRM) method16–19 has gained popularity
for quantitation of selected proteins in complex mixtures. In
each quantitation approach, a known amount of an isotope-
labeled standard which resembles the protein to be quantified
or a peptide thereof is spiked into the biological sample.
Desiderio et al. were the first to use this principle for the
absolute quantitation of peptides in 1983, by digestion in heavy
water.20 A report in 1996 describes the first application of
synthetic peptide standards containing 13C- and 2H-labeled
amino acids for the quantitation of the parent protein,21 a
concept expanded further in 2003 and termed AQUA.22 The
absolute quantitation of 15N-labeled peptide hormones by top-
down-MS was demonstrated in 1997.23 In 2005, the QconCAT
principle was introduced,24–26 which is based on the expression
of artificial genes comprising peptides from different proteins
in medium containing 15NH4Cl or
13C-arginine and 13C-lysine.
Inherent problems of 15N-labeling include the wide isotope
distributions of labeled peptides,1 and difficulties of digestion
in heavy water include the control of incorporation of one or
two 18O atoms as well as the necessity to add the standard at
a very late stage in sample preparation. AQUA has the
advantage that labeled synthetic peptides are easy to obtain.
However, when the absolute quantitation of a protein is based
on only one or two peptides as is typically the case in AQUA
and QconCAT, accuracy may suffer. Furthermore, not all
peptides are amenable for use as standards because amino
acids that could introduce side products need to be avoided.
Because the standards do not behave the same as the endog-
enous protein during fractionation steps, these methods require
that they are added at the level of protein digestion introducing
several pitfalls in quantitation. First, each experimental step is
subject to sample losses, and therefore, strictly speaking, one
only determines the absolute amount of protein present at the
stage of mixing in the standard. Second, all variations due to
sample handling influence the result as long as sample and
standard are separated. Third, incomplete digestion and, when
using in-gel digestion, incomplete recovery of proteolytic
peptides can further complicate the picture.27
We therefore set out to develop an MS-based absolute
quantitation method which addresses these problems by
spiking in the isotope-labeled standard at the earliest possible
stage. To achieve this, the standard needs to be highly similar
if not identical to the endogenous protein to be quantified. We
adapt the SILAC approach that has proven to be very powerful
for relative quantitation28 and show that it can also be applied
to absolute quantitation of individual proteins. We express
recombinant proteins both in a cell-free system and in an
Escherichia coli strain auxotrophic for arginine and lysine. This
yields stable isotope-labeled proteins when expressed in mini-
mal medium supplemented with heavy labeled analogues of
these two amino acids. Following purification and quantitation
of the standard proteins, we add defined amounts of those
proteins directly to lysates from cells or tissues. Since they have
the same physicochemical properties as their endogenous
unlabeled counterparts, any losses or modifications during
sample fractionation and processing will not affect the quan-
titation (Figure 1). In addition, since all proteolytic peptides
except for the C-terminal one are labeled, the chance of
detecting several of them is high, improving statistical confi-
dence of quantitation. Once the standard proteins have been
generated, several of them can in principle be added to a
biological sample. This multiplexed format can provide a
quantitative readout for many different proteins in one single
experiment. We show that quantitation via Absolute SILAC is
highly accurate and linear over a wide range by mixing a
protein in its normal and isotope-labeled versions at defined
ratios from 1:300 to 300:1. In addition, we describe a novel
strategy to improve sensitivity in complex mixtures by more
than an order of magnitude by triggering narrow mass range
scans upon detection of the labeled peptides. This is demon-
strated with the accurate quantitation of a protein in a complex
lysate down to 150 attomole, without any fractionation prior
to LC-MS. Finally, as an example of relevance to systems
biology, we determine the copy number per cell of the signaling
adaptor protein Grb2 in HeLa, HepG2, and C2C12 cells.
Materials and Methods
Clones and Vectors. The cDNA for growth factor receptor-
bound protein 2 (Grb2) in a Gateway compatible vector was
purchased from the RZPD German resource center for genome
research (Berlin, Germany) (clone RZPDo834A0934D). It was
transferred into pDEST17 via Gateway cloning for T7-RNA
polymerase dependent expression as the N-terminally His6-
tagged protein. The maltose binding protein (MBP) was
expressed without a tag under control of a lac-promotor from
the plasmid pMAL-C2 (New England Biolabs).
In Vitro Expression and Purification of Proteins. Recom-
binant N-terminally His6-tagged Grb2 was expressed using a
cell-free system prepared as described29 with slight modifica-
tions. E. coli S30 lysate was prepared from BL21(DE3)RIL cells
(Novagen). T7 RNA polymerase was also expressed in BL21(DE3)
RIL containing the vector pAR1219 as described,30 but no
purification of the enzyme was performed. Instead, we pre-
pared another lysate from this IPTG-induced culture and added
60 µL of this lysate with 400 µL of the standard lysate to 1 mL
of reaction volume. The concentration of the reaction compo-
nents was adjusted to 57 mM HEPES-KOH buffer (pH 8.2), 2
mM DTT, 1.2 mM ATP, 0.85 mM each of CTP, GTP, and UTP,
100 mM creatine phosphate, 130 µg/mL of creatine kinase, 2.0%
PEG 8000, 0.64 mM 3′,5′-cyclic AMP, 34 µM L-(-)-5-formyl-
5,6,7,8-tetrahydrofolic acid, 175 µg/mL of E. coli total tRNA,
90 mM potassium glutamate, 80 mM ammonium acetate, 12
mM magnesium acetate, 2.0 mM each of the 20 amino acids,
and 6.7 µg/mL of plasmid DNA. The reaction mixture was
incubated with shaking at 600 rpm at 30 °C for 2 h.
By exchanging normal arginine and lysine with their heavy-
isotope counterparts 13C6
15N4-arginine and
13C6
15N2-lysine in
the reaction, the SILAC-labeled protein was obtained. All amino
acids were applied at a concentration of 2 mM. Labeled Arg
and Lys were purchased from Sigma Isotec (at least 98% atom
Absolute SILAC research articles
Journal of Proteome Research • Vol. 7, No. 3, 2008 1119
72
percent isotope enrichment). The reaction mixture contained
the target protein mostly as insoluble precipitate which was
solubilized with 6 M guanidinium chloride and subsequently
purified employing Ni2+-affinity chromatography according to
the manufacturer’s protocol for purification of denatured
proteins using Ni-NTA sepharose (Qiagen, Germany) and spin
columns (MoBiTec, Germany). The purity of the protein was
checked by SDS-PAGE, and it was dialyzed against distilled
water to remove imidazole and guanidinium. After refolding,
protein aggregates were removed by centrifugation.
In Vivo Expression and Purification of Proteins. For
expression of SILAC-labeled proteins, the E. coli strain AT713
was used (E. coli Genetic Resource Center, New Haven, strain
number 4529), which is auxotrophic for arginine and lysine.
Expression was conducted in M9 minimal medium supple-
mented with 0.2% glucose and 100 µg/mL of each amino acid.
For SILAC-labeled proteins, 13C6
15N4-arginine and
13C6
15N2-
lysine from Sigma Isotec were used. After harvesting, the
bacteria were lysed in 20 mM TrisHCl, pH7.4, 200 mM NaCl, 1
mM EDTA, 1 mM DTT, 1 mM AEBSF-HCl, 2 µg/mL of
Aprotinin, 1 µg/mL of Leupeptin, and 1 µg/mL of Pepstatin.
Debris was removed by centrifugation, and MBP was enriched
from the supernatant by affinity chromatography on an amy-
lose resin, followed by size exclusion chromatography using a
Superdex75 column. The purity of the protein was checked by
SDS-PAGE, and the main fractions containing MBP were pooled
and stored in PBS containing 10% glycerol.
Quantitation of Purified Proteins and Storage. The con-
centration of purified Grb2-protein was measured by amino
acid analysis (Biotronik LC3000). The concentration of purified
MBP protein was measured by UV absorption at 280 nm, using
a double-beam spectrophotometer (Lambda 19, Perkin-Elmer).
We averaged five independent measurements (all within 2%
deviation) to calculate the concentration based on the formula
A ) c × d × ε, where the molar absorption coefficient ε was
calculated from the protein sequence applying the formula ε
) #Trp × 5500 + #Tyr × 1490 + #Cystine × 125, as suggested
by Pace et al.31
The stock solution was aliquoted, and different dilutions
down to 500 fmol/µL were prepared in storage buffer or in 6
M urea, 2 M thiourea, 20 mM Tris, pH 8.0. If required, further
dilutions were carried out directly before use to minimize
losses. For MBP, solutions with fixed ratios from 1:300 to 300:1
between labeled and normal proteins were generated, along
with dilution series down to the attomole range in steps of a
factor of 10.
All protein solutions were prepared in protein LoBind-tubes
from Eppendorf which were presaturated with a solution of 1
mg/mL of BSA in the respective buffer overnight to eliminate
any unwanted adsorption sites. Before use, the solution was
removed, and after a short centrifugation, the remainder was
removed again. The samples were snap-frozen in liquid
nitrogen and stored at -80 °C.
Cell Culture, Counting, and Lysis for Determination of
Grb2 Copy Number. HeLa, HepG2, and C2C12 cells were
cultured in Dulbecco′s modified Eagle′s medium (DMEM)
supplemented with 10% fetal calf serum and antibiotics. Cells
were harvested at 70% confluency by trypsination and resus-
Figure 1. Experimental workflow in MS-based absolute quantitation of proteins. Different methods for introducing an isotope-labeled
standard are shown. Absolute SILAC allows spiking the standard at an early level in the experimental procedure, thereby minimizing
the quantitation error arising from losses and modifications during sample handling.
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pended in an ice-cold growth medium. The concentration of
cells was determined in a Neubauer counting chamber by 24
rounds of counting, and the average value was used for
subsequent calculations. The cell suspension was aliquoted to
microcentrifuge tubes and centrifuged at 400g. The cell pellet
was washed twice with ice-cold PBS and either stored at -80
°C or lysed directly in 1% Igepal (NP-40), 150 mM NaCl, 50
mM Tris, pH 7.5, and protease inhibitor cocktail Roche
complete. After repeated vortexing and incubation on ice for
15 min, several freeze–thaw cycles were conducted until no
intact cells could be observed. Following centrifugation at
10 000g for 15 min at 4 °C, the supernatant was removed and
the pellet washed 3 times with cold PBS. The desired amounts
of SILAC-labeled Grb2 were then spiked into supernatant and
pellet. The supernatant was precipitated with acetone before
the protein pellet was resuspended in SDS-sample buffer for
SDS-PAGE. The centrifugation pellet was partially resuspended
in 2x SDS-sample buffer and treated with Benzonase (Roche)
for degradation of DNA.
1D-SDS-PAGE and In-Gel Digestion of Proteins. The protein
samples were separated by one-dimensional SDS-PAGE using
NuPage Novex 4–12% Bis-Tris gels and NuPage MOPS running
buffer (Invitrogen) according to the manufacturer’s instruc-
tions. The gels were stained with colloidal Coomassie (Initro-
gen). Gel slices were cut into 1 mm3 cubes, washed twice with
50 mM ammonium bicarbonate and 50% ethanol, dehydrated
with 100% ethanol, and incubated with 10 mM DTT in 50 mM
ammonium bicarbonate for 1 h at 56 °C for protein reduction.
The resulting free thiol (-SH) groups were subsequently
alkylated by incubating the samples with 55 mM iodoacetamide
in 50 mM ammonium bicarbonate for 1 h at 25 °C in the dark.
The gel pieces were washed twice with 50 mM ammonium
bicarbonate, dehydrated with 100% ethanol, and dried in a
vacuum concentrator. The gel pieces were rehydrated with 12.5
ng/µL of trypsin (Promega) in 50 mM ammonium bicarbonate
and incubated for 16 h at 37 °C for protein digestion. Super-
natants were transferred to fresh tubes, and the remaining
peptides were extracted by incubating the gel pieces in 30%
acetonitrile (MeCN) with 3% trifluoroacetic acid (TFA), followed
by dehydration with 100% MeCN. The latter two steps were
repeated. The extracts were combined, and organic solvent was
removed in a vacuum concentrator. Desalting and concentra-
tion were carried out on RP-C18 (Empore disks, 3M) StageTip
columns,32,33 and the eluted peptides were subjected to LC-
MS.
In-Solution Digestion of Proteins. Proteins in 20 µL of 6 M
urea, 2 M thiourea, 20 mM TrisHCl, pH 8.0, were reduced by
adding 1 µg of DTT for 30 min, followed by alkylation of
cysteines by incubating with 5 µg of iodoacetamide for 20 min.
Digestion was started by adding endoproteinase LysC (Wako).
After 3 h, the sample was diluted with 4 volumes of 50 mM
NH4HCO3, and trypsin (Promega) was added for overnight
incubation. The proteases were applied in a ratio of 1:50 to
protein material, and all steps were carried out at room
temperature. The digestion was stopped by acidifying with TFA,
and the samples were loaded onto StageTips32,33 for desalting
and concentration prior to LC-MS analysis.
NanoLC-MS/MS. The digested peptide mixtures were sepa-
rated by online reversed-phase (RP) nanoscale capillary liquid
chromatography (nanoLC) and analyzed by electrospray tan-
dem mass spectrometry (ES-MS/MS). The experiments were
performed with an Agilent 1100 nanoflow system connected
to an LTQ-Orbitrap mass spectrometer (Thermo Electron,
Bremen, Germany) equipped with a nanoelectrospray ion
source (Proxeon Biosystems, Odense, Denmark). Binding and
chromatographic separation of the peptides took place in a 15
cm fused silica emitter (75 µm inner diameter) in-house
packed34 with reversed-phase ReproSil-Pur C18-AQ 3 µm resin
(Dr. Maisch GmbH, Ammerbuch-Entringen, Germany).
Peptide mixtures were injected onto the column with a flow
of 500 nL/min and subsequently eluted with a flow of 250 nL/
min from 2% to 40% MeCN in 0.5% acetic acid, in a 100 min
gradient, or 20 min in the case of single protein digests. The
mass spectrometer was operated in data-dependent mode to
automatically switch between MS and MS/MS (MS2) acquisi-
tion. Survey full scan MS spectra (from m/z 300 to 1600) were
acquired in the Orbitrap with a resolution of 60 000 at m/z 400
(after accumulation to a target value of 1 000 000 charges in
the linear ion trap) using the lock mass option for internal
calibration of each spectrum.35 The most intense ions (up to
five, depending on signal intensity) were sequentially isolated
for fragmentation in the linear ion trap using collisionally
induced dissociation with a normalized collision energy of 30%
at a target value of 5000. Target ions already selected for MS/
MS were dynamically excluded for 60 s. The resulting fragment
ions were recorded in the linear ion trap with unit resolution.
For experiments involving SIM scans, we constructed an
inclusion list with the “heavy” masses of previously observed
peptides from Grb2 or MBP. Detection of an ion from the
inclusion list within 5 ppm triggered four narrow mass range
(selected-ion-monitoring, SIM) scans and four MS/MS events
at different collision energies (35, 40, 45, and 50%) at target
values of 100 000 and 10 000, respectively. SIM scans were
granted a maximum fill time of 0.5 s in the ion trap and were
recorded in the Orbitrap at a resolution of 30 000 at m/z 400
and at a width from -6 to +3 m/z units around the selected
mass.
Peptide Identification and Quantitation. Peak lists for
database searching were generated from the raw data using
in-house developed software called Raw2msm. From each
fragment spectrum, the seven most intense peaks per 100
Thomson were extracted. Proteins were identified by auto-
mated database searching (Mascot, Matrix Science) against an
in-house curated version of the human IPI database, version
3.19 (60 428 entries). This database was complemented with
MBP and frequently observed contaminants like porcine trypsin
and human keratins. Carbamidomethyl-cysteine was used as
a fixed modification, and variable modifications were oxidation
of methionine, protein N-acetylation, deamidation of Asn and
Gln, arginine-13C6
15N4, lysine-
13C6
15N2, and N-pyroglutamate.
We required full tryptic specificity (cleavage at Arg-Pro and Lys-
Pro as well as Asp-Pro was included), a maximum of two
miscleavages, and mass accuracies of 5 ppm for the parent ion
and 0.5 Da for fragment ions.
For the relative quantitation of the peptides against their
SILAC-labeled counterparts, our in-house developed software
MSQuant36 was used (http://msquant.sourceforge.net).
Results and Discussion
Generation of Protein Standard in Vitro and in Vivo. The
aim of this work was to develop and characterize Absolute
SILAC as an MS-based method for the absolute quantitation
of individual proteins in complex mixtures. Using metabolically
labeled full length proteins as a quantitation reference has the
major advantage of exposing standard and endogenous pro-
teins to the same conditions beginning at the level of cell or
Absolute SILAC research articles
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tissue lysis (Figure 1). This enables the quantitation of proteins
present in the lysate, as opposed to quantitation of proteins
present after fractionation and digestion as is the case in other
MS-based methods. We decided in favor of arginine (Arg) and
lysine (Lys) as the amino acids to carry the isotope label, since
trypsin cleaves C-terminal to both of them, rendering all
proteolytic peptides except the C-terminal one accessible for
quantitation. In a first step, we established protein expression
methods which allowed us to produce SILAC-labeled proteins.
We worked with a cell-free in vitro expression system as well
as with a bacterial in vivo expression system. In both cases,
we substituted normal arginine and lysine with their heavy
isotope-labeled counterparts. While this is trivial to achieve in
the cell-free approach by adding heavy instead of light amino
acids to a minimal medium, in vivo it required working with
an E. coli mutant that is auxotrophic for arginine and lysine
to avoid contamination by endogenously produced unlabeled
Arg and Lys. Janecki et al.37 tried to produce isotope-labeled
proteins in a regular E. coli BL21-strain, but they reported an
incorporation efficiency of only 70%. This underscores that,
unless the chosen amino acid(s) are essential to the host,
auxotrophic mutants should be employed. We therefore used
the E. coli strain AT713, which is deficient for the ArgA and
the LysA genes. Since LysA catalyzes the last step in the
biosynthesis pathway of lysine, this mutation should prevent
the synthesis of lysine very efficiently. ArgA, however, is located
further upstream in the biosynthesis pathway of arginine. We
therefore challenged bacterial growth in the arginine-deficient
medium to check auxotrophy. Since no growth occurred, we
accepted AT713 as a strain suitable for the recombinant
expression of SILAC-labeled proteins. Metabolic conversion
from unlabeled precursors to Arg or Lys proved to be vanish-
ingly low, with far less than 1% of the proteolytic peptides from
the expressed proteins containing unlabeled Arg or Lys as
determined by quantitative mass spectrometry (see below).
Conversion of labeled arginine to proline can occur in certain
strains or cell types13 but was not observed here. The aux-
otrophic E. coli strain used in these experiments is not a
dedicated expression strain with features like protease defi-
ciency or optimized tRNA-composition. Nevertheless, we ob-
tained good yields with all proteins tested. For the future, the
construction of a SILAC version of an expression strain such
as BL21 is still desirable. This strain would be auxotrophic for
arginine and lysine and would not be limited to lac-promotor-
dependent expression like AT713 but could use T7-RNA-
polymerase-dependent promotors. Absolute SILAC is in prin-
ciple amenable to any expression system, including eukaryotic
hosts, provided that they can be SILAC labeled and that the
amino acids chosen for labeling are not affected by metabolic
conversion.
For this study, we expressed the maltose-binding protein
(MBP) in vivo in E. coli AT713, and growth factor receptor-
bound protein 2 (Grb2) employing the in vitro approach. Figure
2 shows the basic workflow for the production of stable isotope-
labeled protein standards. Several aspects in the procedure
require special consideration. While cell-free production is
rather economic due to the small volume required (mL range),
the in vivo approach will consume several hundreds of dollars
due to the larger culture volumes (L range) and attendant
higher amounts of labeled amino acids. Since only small
amounts of protein are consumed in MS experiments, the cell-
free approach usually provides sufficient material for well-
expressed proteins and is anyway the method of choice for toxic
proteins. For multiple and long-term use as well as for poorly
expressed proteins, the in vivo approach may be preferable.
In any case, one should avoid an expression procedure that
leads to degradation products which still carry the tag for
purification. This would not only cause problems in quantita-
tion of the standard prior to use but also result in different
ratios for peptides derived from the N-terminal versus the
C-terminal part. Purity of the standard protein is an important
requirement because any contaminant proteins would lead to
an overestimation of the concentration of the standard. De-
pending on the experiment, a purification tag on the recom-
binant SILAC protein may induce separation of standard and
endogenous proteins during fractionation. Therefore, it should
be cleavable to avoid differences in the physicochemical
properties between the two proteins. The protease used for
cleavage can either be chosen to likewise contain a tag for
removal after cleavage or be added at a substoichiometric
amount which does not impair the quantitation of the stock
solution afterward.
Quantitation and Handling of the Standard Protein. No
matter how sophisticated the mass spectrometric analysis and
quantitation, total quantitation accuracy (rather than precision)
can never be better than the biophysical or biochemical
Figure 2. Production of SILAC-labeled proteins for absolute quantitation. The protein of interest is recombinantly produced in an
expression host strain which is auxotrophic for the amino acids chosen for labeling. Alternatively, a cell-free approach is employed.
The stable isotope-labeled analogues of those amino acids are added to a minimal medium along with the remaining other amino
acids. High purity of the isolated protein and accurate measurement of its concentration are requirements for Absolute SILAC.
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quantitation of the standard protein. For MBP, we chose to
measure the absorption at 280 nm, which is known to provide
the most accurate values with an error margin of approximately
3% for proteins containing tryptophane.31 Grb2 contained some
contamination by nucleic acids as judged from the UV spec-
trum; therefore, we used amino acid analysis for this protein
instead (error margin of around 10%).
Incorporation levels of labeled amino acids into the proteins
were very close to 100%. Specifically, the in vitro expressed Grb2
incorporated 99.8% heavy isotope label, and the in vivo
expressed MBP incorporated 100% arginine and 99.2% lysine
in labeled form. This renders the error stemming from the
labeled standard protein insignificant.
We found it to be highly important to properly aliquot and
store the standard protein, especially at low concentrations.
Any losses due to precipitation or adsorption to surfaces which
happen after the standard quantitation will distort the quan-
titation values of the sample later on. We addressed this issue
by subjecting labeled MBP to different storage conditions and
by comparing it to unlabeled MBP freshly diluted from the
stock, using quantitative MS as readout. Remarkably, for a
solution of 15 fmol/µL (≈1 µg/mL), the protein loss was more
than 90% when stored at 4 °C for 24 h in a regular plastic tube.
Storage at -20 and -80 °C increased the recovery substantially,
but storage in special low-adsorption plastic tubes was even
better (see Materials and Methods). The highest recovery,
however, was achieved by presaturating the tubes with a
solution of 1 mg/mL of BSA. In this case, it did not matter
which kind of tubes we used. Presaturating with 10 mg/mL of
BSA or storing the protein in 0.1 mg/mL of BSA did not further
improve the yield. Under these conditions, even repeated
freeze–thaw cycles did not show any negative effect. Note that
addition of BSA to our standard would not influence quanti-
tation results, as the amount of labeled protein has already
been determined at this point. If no presaturation was carried
out, it proved to be beneficial to store the protein under
denaturing conditions (6 M urea, 2 M thiourea). Clearly this
environment is not compatible with most subsequent frac-
tionation steps and is only recommended if a direct in-solution
digestion of the sample is envisioned. This observation also
demonstrates that Absolute SILAC is a powerful tool for
choosing between or optimizing different protein protocols.
Characteristics of Quantitation by Absolute SILAC. Figure
3 shows the quantitation of a protein in a whole cell lysate by
Absolute SILAC. The total ions current trace and all mass
spectra are the same as in a nonlabeling experiment. The only
difference is that peptides of the protein to be quantified appear
in SILAC doublets. This also provides an easy way to identify
the protein, in principle even without sequencing or with
sequencing only the peaks that appear as doublets.
One of the main advantages of Absolute SILAC is the fact
that all tryptic peptides in a protein, except for the C-terminal
one, appear in quantifiable peptide pairs when labeling with
Arg and Lys. Compared to methods based on the MS quanti-
tation of only one or two peptides per protein, this permits a
more accurate quantitation and more robust statistical assess-
ment. Since most peptides will usually not be identifiable due
to sample complexity, dynamic range, or ionization issues,
using a fully labeled protein increases the chance of obtaining
a sufficient number of peptides for quantitation.
Post-translational modifications or alternative splicing are
possible confounding factors in protein quantitation. In the
case of Absolute SILAC, stoichiometric post-translational modi-
fications on the endogenous proteins will not lead to a peptide
pair as the recombinant protein will not be modified, and
hence they will not lead to a quantitation error. Substoichio-
metric modifications or splice variants may be recognizable
because of the altered ratio of the nonmodified peptide pair
compared to the ratios of peptides that carry no modification.37
While this is a potential pitfall for methods which rely on only
one or two peptides for quantitation, it can be exploited as an
advantage in the case of Absolute SILAC. For example, if 50%
of the endogenous protein is phosphorylated at a particular
location, the ratio for the nonphosphorylated peptide will be
twice that of the other peptides, indicating that the peptide in
question may be modified.
To characterize the behavior of Absolute SILAC across a large
range of possible ratios between the “heavy” standard and the
“light” endogenous protein, we analyzed defined ratios of heavy
and light labeled MBP, keeping the amount of light MBP
constant at 150 fmol. We created a titration curve ranging from
1:300 to 300:1 (heavy to light protein) in steps of a factor of 3
(Figure 4). Defined ratios of MBP were digested in solution,
either in pure form or spiked into 1 µg of whole cell HeLa-
lysate. Automated quantitation of the mass spectrometric data
was carried out by MSQuant (see Materials and Methods). The
linearity between expected and experimental ratios proved to
be excellent over a broad range from 1:100 to 100:1 with
correlation coefficients of 0.9994 and 0.9964, respectively. Thus,
the dynamic range of Absolute SILAC can span 4 orders of
magnitude, providing a large window for the researcher who
sometimes may only have a vague idea of the amount of
standard protein required to mix into the sample. Table 1
Figure 3. LC-MS-based quantitation of a peptide in a complex
sample. Whole cell HeLa-lysate (1 µg) was spiked with 50 fmol
of labeled and 150 fmol of unlabeled MBP. The upper panel
illustrates the total ion signal across the elution time of the LC-
MS experiment. The middle panel shows a survey scan acquired
at the indicated time point. Zooming into this spectrum, the lower
panel highlights a doubly charged SILAC-peptide pair with a
ratio of 3:1 between light and heavy versions. The mass offset
corresponds to the expected difference of 8.0142 Da for a peptide
containing 13C6
15N2-lysine.
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contains the data displayed in Figure 4. Within a 10-fold
difference between labeled and unlabeled proteins, the devia-
tion from the expected ratio is typically below 5%. In technical
replicates, we generally observe fluctuations of 2–3% (data not
shown), which indicates that around half of the error stems
from the quantitative MS readout, and the other half is due to
upstream sample handling. The standard deviations arising
from fluctuations of the quantitation of individual peptides
amount to approximately 10% of the average value. We were
surprised that even ratios of 300 could still be quantified
relatively well. In the background of a complex mixture,
however, the quantitative accuracy at this ratio is poor (up to
a factor of 2–3 uncertainty). Under these circumstances, the
low abundant peptide partner is barely detectable, and back-
ground ions can sometimes appear even in the narrow quan-
titation window (here set to 0.02 Da) and contribute to the ratio.
In most cases, manual inspection can prevent this, and software
may be able to automatically subtract such noise as well. In
any case, one can employ an iterative strategy by adjusting the
amount of standard protein to be spiked into the sample after
a first rough measurement. We generally recommend to aim
for an excess of 3 to 10 times of the labeled versus unlabeled
protein. While this is still within the range of a highly accurate
quantitative readout, it increases the likelihood that more
peptide pairs can be identified during the LC-MS experiment.
Another important point is the quality of instrumentation.
High-resolution mass spectrometers are capable of separating
coeluting peptides with similar masses, and high sensitivity aids
in increasing the signal of weak peaks. Fast sequencing cycles
allow the identification and subsequent quantitation of a
protein on the basis of several peptides. Since accuracy of
quantitation is mainly influenced by signal-to-noise, larger
peaks can be quantified more accurately than smaller peaks.1
Targeted Narrow Mass Range Scans for Enhanced Sensitiv-
ity, Signal-to-Noise Ratio, and Quantitative Accuracy. A
central challenge for mass spectrometry especially in the
biomarker field is the quantitation of peptides in the presence
of a very complex background. In triple quadrupole-type
instruments, this problem can be alleviated by monitoring a
fragment of the ion of interest rather than the ion itself. This
technique can be multiplexed (Multiple Reaction Monitoring,
MRM) and allows the detection of substances much below their
signal-to-noise ratio in a full scan.16–19 Unfortunately, it cannot
be used on a trapping instrument such as the LTQ-Orbitrap
employed here. We therefore developed a data acquisition
scheme that addresses this challenge and is able to substantially
improve the usual limit of detection and quantitation. In
experiments on the LTQ-Orbitrap, where the full mass range
is trapped, total dynamic range is limited by the fact that the
C-trap can only accommodate a finite number of ions (one
million). However, selected ion monitoring (SIM) scans ac-
cumulate only a very narrow mass range. Consequently, ions
outside of this range do not limit the measurement; the desired
number of ions is devoted to this mass window; and the
dynamic range is solely determined by ions within it. We
reasoned that the mass spectrometer could be programmed
to recognize peptides belonging to the labeled protein standard
based on their precise mass. Upon this trigger, it could start
acquiring a series of narrow mass range windows including the
labeled peptides and the calculated location of the endogenous
peptide, even if it was not visible in the spectrum. In this way,
the effective accumulation time in complex mixtures, which is
usually only a few milliseconds, should increase at least 10-
fold with concomitant increase in sensitivity for the protein to
be quantified. Therefore, using data-dependent acquisition with
an inclusion list containing the masses of the expected peptides
of the SILAC-labeled standard protein, we instructed the mass
spectrometer to record several SIM scans as soon as an ion
from the inclusion list was detected. Resolution, amount of
ions, fill time, and dimensions of the isolation window can be
defined individually according to the type of sample and the
goal of the experiment. We chose a window width for the SIM
scans from -6 to +3 m/z units around the detected mass from
the inclusion list, covering the complete isotope pattern of the
Figure 4. Linearity of quantitation of a protein by Absolute SILAC. The figure shows titration curves of a protein (maltose-binding
protein) in pure form (a) and in the background of 1 µg of total cell lysate (b). The heavy, SILAC-labeled version of the protein was kept
constant at 150 fmol, whereas the amount of unlabeled version varied from 500 amol to 45 000 fmol, resulting in ratios between 1:300
and 300:1. The regression line was calculated based on the values from 1:100 to 100:1. For each ratio, three independent experiments
were performed, and all data points are indicated in the figure and in Table 1.
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SILAC pair for both Arg and Lys and doubly and higher-charged
peptides. This SIM width is sufficiently narrow to exclude the
vast majority of coeluting ions, typically eliminating more than
99% of the total ion current when measuring low concentra-
tions of the protein of interest. We checked if the SIM isolation
had any effect on the measured peptide ratios but did not find
this to be the case.
Figure 5 illustrates the power of SILAC-directed SIM scans
for absolute quantitation close to the detection limit. While the
signal of the endogenous peptide was not detected in full scans,
it was readily recorded in SIM scans, showing the boost in
sensitivity gained by this approach. In addition, the signal-to-
noise ratio is markedly increased, which is of great importance
for accurate quantitation. The fluctuations in peak intensity
and shape of the isotope pattern that are observed for low
signals in consecutive full scans were also largely reduced in
SIM scans. Injection times of electrosprayed ions into the ion
trap to reach the nominal target value of 106 ions for the full
scan were 5 ms on average. To reach the 105 ions in the SIM
scan required an average injection time of 100 ms, in agreement
with the 10- to 20-fold higher signal-to-noise ratio observed
(Figure 5). This example also highlights the benefits of spiking
the SILAC-labeled protein at a higher amount than the level of
endogenous protein. In fact, in the example given in Figure 5,
the peptide would not have been detected if the standard had
been present at the same amount as the unlabeled protein
because the data systems would not have triggered the SIM
window acquisition. Once the more abundant standard peptide
is identified, the quantitation software can easily pinpoint
where in the spectrum the lower abundant endogenous peptide
peak is located. Thus, regardless of the endogenous level of
the protein of interest, the labeled standard should be added
at a level enabling robust detection by the data system. Our
targeted SIM window approach bypasses the normal detection
limit in complex mixtures, which is given by sequencing speed,
ion count, and fragment spectrum quality.38 It therefore enables
the identification and quantitation of proteins even below the
identification threshold in our standard proteomic experiments.
Taking advantage of this strategy, we identified and quanti-
fied as little as 150 attomole of a protein (MBP) in a very
complex matrix (whole cell HeLa lysate) without any fraction-
ation prior to the LC-MS experiment (Figure 5). This corre-
sponds to a detection and quantitation limit of an endogenous
protein of roughly 10 000 molecules per cell. Fractionation such
as one-dimensional gel electrophoresis or peptide fractionation
would be expected to allow the quantitation of even lower
amounts. Even at this very low level in a very complex mixture,
the quantitation error was only 7% (ratio of 9.3 instead of 10.0
as expected). Quantitation precision seems to be limited by the
short elution times, which permit only a few scans, and by the
low number of peptides of the protein (two in this case) rather
than reduced quantitative accuracy in single scans.
So far, only multiple reaction monitoring (MRM) measure-
ments on triple quadrupole mass spectrometers have been
reported to reach such low levels for quantitation.16,17 With the
approach presented here, the identification and accurate
quantitation of proteins in the attomole range in highly
complex samples are now accessible to other types of mass
spectrometers. The SIM scan strategy is a valuable tool for
absolute quantitation, which shifts the detection limit in
complex mixtures by at least a factor of 10 and allows for
unprecedented accuracy of quantitation at these low levels
compared to full scan quantitation on the same instruments.
Determination of Copy Number per Cell of Grb2. It should
be possible to use Absolute SILAC to reveal the copy number
Table 1. Titration Experiments of a Protein (Maltose-Binding
Protein) in Pure Form and in the Background of 1 µg of Total
Cell Lysate (see Figure 4)a
expected ratio exptl ratio
heavy:light
1 µg of cell
lysate added
peptides
quantified heavy:light (avg ( SD)
1:300 - 4 0.0036 ( 0.0013
1:300 - 5 0.0052 ( 0.0021
1:300 - 4 0.0051 ( 0.0021
1:300 × 5 0.0213 ( 0.0182
1:300 × 3 0.0110 ( 0.0068
1:300 × 4 0.0129 ( 0.0113
1:100 - 6 0.0105 ( 0.0045
1:100 - 4 0.0109 ( 0.0057
1:100 - 8 0.0080 ( 0.0021
1:100 × 5 0.0115 ( 0.0045
1:100 × 7 0.0111 ( 0.0030
1:100 × 8 0.0203 ( 0.0138
1:30 - 7 0.0317 ( 0.011
1:30 - 4 0.0355 ( 0.021
1:30 - 6 0.0274 ( 0.014
1:30 × 3 0.0301 ( 0.012
1:30 × 9 0.0372 ( 0.023
1:30 × 11 0.0313 ( 0.011
1:10 - 6 0.0940 ( 0.017
1:10 - 10 0.0998 ( 0.021
1:10 - 10 0.0907 ( 0.011
1:10 × 13 0.0982 ( 0.017
1:10 × 11 0.0946 ( 0.012
1:10 × 10 0.1012 ( 0.013
1:3 - 12 0.314 ( 0.035
1:3 - 15 0.312 ( 0.046
1:3 - 16 0.338 ( 0.031
1:3 × 8 0.324 ( 0.052
1:3 × 13 0.304 ( 0.029
1:3 × 9 0.316 ( 0.051
1:1 - 18 1.024 ( 0.081
1:1 - 15 0.991 ( 0.100
1:1 - 14 1.040 ( 0.043
1:1 × 22 1.026 ( 0.067
1:1 × 19 1.005 ( 0.110
1:1 × 5 1.010 ( 0.121
3:1 - 25 3.078 ( 0.19
3:1 - 26 3.085 ( 0.22
3:1 - 18 3.221 ( 0.38
3:1 × 29 3.137 ( 0.25
3:1 × 29 3.161 ( 0.27
3:1 × 32 3.195 ( 0.30
10:1 - 10 9.965 ( 0.99
10:1 - 12 10.19 ( 2.22
10:1 - 35 10.16 ( 1.33
10:1 × 36 10.67 ( 1.83
10:1 × 28 10,41 ( 1,27
10:1 × 11 10.07 ( 0.79
30:1 - 34 34.83 ( 5.83
30:1 - 38 33.76 ( 6.03
30:1 - 34 34.14 ( 7.91
30:1 × 35 34.56 ( 6.07
30:1 × 34 34.18 ( 5.61
30:1 × 22 31.47 ( 5.22
100:1 - 30 108.1 ( 44.7
100:1 - 34 115.5 ( 54.9
100:1 - 23 94.6 ( 34.7
100:1 × 31 99.6 ( 40.9
100:1 × 11 137.6 ( 53.3
100:1 × 24 98.5 ( 33.9
300:1 - 23 353.6 ( 252.5
300:1 - 29 316.4 ( 204.3
300:1 - 27 213.9 ( 133.9
300:1 × 24 105.9 ( 41.6
300:1 × 23 183.3 ( 107.1
300:1 × 24 247.7 ( 169.2
a The heavy, SILAC-labeled version of the protein was kept constant at
150 fmol, whereas the amount of unlabeled version varied from 500 amol
to 45 000 fmol, resulting in ratios between 1:300 and 300:1. For each
ratio, three independent experiments were performed.
Absolute SILAC research articles
Journal of Proteome Research • Vol. 7, No. 3, 2008 1125
78
per cell of any protein that can be expressed recombinantly.
As an example, we chose the signaling adaptor protein growth
factor receptor bound protein 2 (Grb2). This 25 kDa protein
contains phosphotyrosine and polyproline binding domains
and is a key player in the transduction of growth signals from
receptors to intracellular effectors. We harvested HeLa, HepG2,
and C2C12 cells during the exponential growth phase at 70%
confluency and subjected defined numbers of cells to lysis,
removal of insoluble material by centrifugation, and subsequent
SDS-PAGE. We added defined amounts of labeled standard
Grb2 to supernatant and pellet after the centrifugation step.
Following SDS-PAGE, we excised the region corresponding to
Grb2, performed in-gel digestion with trypsin, and analyzed
the samples by LC-MS (Figure 6). The quantitative results from
five separate aliquots of cells of each cell line are listed in Table
2. We measured the number of molecules of Grb2 per HeLa
cell to be 5.55 ( 0.26 × 105. Of these, 4.4% were retained in
the pellet. The liver cell line HepG2 had 8.80 ( 0.12 × 105 Grb2
molecules (1.2% in pellet), and the murine muscle cell line
C2C12 contained 5.67 ( 0.20 × 105 copies (3.2% in pellet) per
cell. Due to the high identity between the human and murine
sequence of Grb2 (only one amino acid is different), the human
Grb2 standard protein could also be used for C2C12 cells. The
literature reports 1.5 × 104 copies per cell for the yeast
homologue.39 Tissue-derived murine thymocytes, which are
also much smaller than HeLa cells, were shown to contain 2.3
× 104 copies,40 and hepatocytes isolated from rats had 5.1 ×
104 Grb2 molecules.41 The finding that exponentially growing
transformed cell lines contain an order of magnitude more
copies of the growth-related protein Grb2 as compared to
tissue-derived cells or yeast cells is not surprising. Moreover,
copy numbers of growth factor receptors like epidermal growth
factor receptor (EGFR), insulin-like growth factor 1 receptor
(IGF1R), or insulin receptor (INSR) are in the range of 104 to
105 depending on cell type. Thus, it appears that the number
of Grb2 molecules, whose function is to bind to these receptors
and other signaling proteins in the cell, is not a bottleneck in
propagating the signal in the cell lines investigated here.
In a recent large-scale measurement of the HeLa cell
proteome, Grb2 was ranked as protein number 996 out of more
Figure 5. Targeted narrow mass range scans enhance the sensitivity of detection and quantitation. The figure shows analysis of 1.5
fmol of heavy MBP together with 150 amol of light MBP in 1 µg of HeLa-cell lysate, digested in solution and analyzed by reversed
phase LC–MS using a 2 h gradient. In the upper panel, the acquisition software detected an ion from the SILAC-labeled standard
(LIAYPIAVEALSLIYNK, m/z ) 633.7078 in the inclusion list) and automatically triggered a SIM scan. The red arrows indicate the isotope
pattern of the labeled peptide (right) and the calculated position at which the unlabeled peptide to be quantified would be expected.
In the SIM scan (middle panel), the unlabeled peptide is clearly visible (left group of arrows) due to increased accumulation time. (The
coeluting peptide with m/z 632.3359 disappeared during the second between the full scan and SIM scan.) The bottom panel explains
the acquisition strategy. Rectangles in the first row represent target values for ion accumulation and triggering of MS/MS events. The
second row depicts transient accumulation in the orbitrap for full scans and SIM scans.
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than 4000 proteins based on summed peptide intensities.42 This
rough measure of protein abundance therefore suggests that
more than a thousand proteins have copy numbers of several
hundred thousand.
The small fluctuations of the results in samples 1–5 lie within
the expected error range (Table 2). The pipetting error at the
spiking step presumably dominates this error due to the small
volume of 2 µL which was added. In general, the error arising
from mass spectrometric quantitation is low compared to the
crucial steps during sample processing. In particular, the care
which is taken during the following steps will determine the
accuracy of quantitation that one can expect: cell counting,
complete cell lysis, quantitation of the recombinant SILAC-
labeled protein, proper storage and handling of the protein,
and precision in pipetting.
It is important to avoid errors due to differences between
recombinant and endogenous proteins, for example, due to
aggregation of the standard. In our study of Grb2, this turned
out to be important because when we spiked the protein before
cell lysis, 35% of the labeled protein ended up in the pellet, as
opposed to only 4% of the endogenous protein. This is
presumably because Grb2 was mainly present in inclusion
bodies and might not have refolded completely afterward. We
therefore recommend addressing this issue in case spiking
before removal of the pellet is desired or biochemical fraction-
ation of the supernatant is planned. Because we used a non-
native method for fractionation, SDS-PAGE, our analysis was
not affected by this observation. We also did not remove the
His-tag used for purification but instead excised a slightly
broader slice from the gel.
Isotope Distributions in Absolute Quantitation by MS-
Based Proteomics. No matter which approach involving stable
isotope labeling is employed, one should keep in mind that
the labeled amino acids are not provided at complete isotope
content by the manufacturer. Typically, an isotope enrichment
of 98 atom percent or higher is specified. For 13C6
15N2-lysine,
this implies that 0.988 or 85.1% of the molecules are fully
labeled. 12.9% contain one 12C or 14N atom; 1.8% contain two;
and 0.2% contain three or more of them. Those 14.9% which
are not fully labeled will accordingly shift one unit to lower
mass in the isotope pattern of the peptide. This does not mean
that 14.9% of the signal is lost, but instead it implies that this
percentage of each peak moves to the neighboring peak on the
left. Depending on peptide mass, this effect can either increase
or decrease the signal of a peak and create an additional peak
to the low mass side of the monoisotopic peak. For maximum
accuracy, the quantitation algorithm should take this fact into
account. However, there is also the antagonistic effect of the
labeled atoms not participating in the isotopic distribution (they
cannot be 12C or 14N atoms). This renders the monoisotopic
peak slightly higher than it would otherwise be. In our
experience, those two effects largely compensate for each other
at the level of the monoisotopic peak, which is why we based
the quantitation on the peak areas of the monoisotopic peaks.
We are currently developing a program which takes into
account both of the above-mentioned phenomena, eliminating
any bias caused by the quality of the labeled amino acids.
Practical Aspects of Using Absolute SILAC Compared to
Other Methods. Several different methods exist for absolute
quantitation of proteins using stable isotope-labeled amino
acids. Any of them may be the most appropriate depending
on the quantitation task, but there are some general properties
that define their potential for absolute quantitation. Dif-
ferentiating aspects are the time point in the workflow when
the standard can be mixed in, the amount of peptides per
protein amenable to quantitation, completeness of labeling, as
well as practical aspects such as costs and labor associated with
the method. In any of the methods, the heavy isotopes should
preferably introduce a mass difference of at least 4 Da to avoid
overlapping isotope clusters, and it should ensure chromato-
graphic coelution. Furthermore, each method needs suitable
bioinformatic software that can deal with the data and provide
a quantitative output.
The AQUA method, among the methods using stable isotope-
labeled amino acids, is the most straightforward to apply but
also the least accurate for absolute quantitation of protein in
Figure 6. Copy number of Grb2 in HeLa cells. The pellet and supernatant of a cell lysate were spiked with defined amounts of SILAC-
labeled Grb2 and separated by SDS-PAGE (a). The gel region around Grb2 was in-gel digested and analyzed. Representative spectra
with SILAC pairs of the doubly charged peptide YFLWVVK from the supernatant (b) and pellet (c) are depicted. The entire experiment
was repeated five times.
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the original sample. The loss of protein to be quantified during
sample processing can be substantial, and the recovery of
different peptides of a protein can vary tremendously43 leading
to different quantitative results depending on the AQUA
peptide chosen. Especially in the case of gel-based procedures,
much material can be lost due to incomplete digestion and
also due to incomplete extraction, since different peptides are
extracted with different efficiencies from the gel.27 Therefore,
even though this method can be very valuable to obtain a rough
estimate of protein amount, it does not directly lead to
knowledge of the copy number or concentration of the protein.
However, for simple samples which do not require any
fractionation and if complete digestion in solution is assured,
these limitations may not be serious.
Relying on only one or two peptides for quantitation of a
protein is not only a limitation for statistical assessment but
also, unless MRM methods are employed, risky in terms of
detectability. Even if one decides to synthesize more peptides
of a protein, one can encounter obstacles. Some sequences are
difficult to synthesize chemically, and several amino acids must
be avoided because they are susceptible to modifications
occurring in vitro. Furthermore, optimal AQUA peptides for one
ionization method and mass spectrometer may not be optimal
for another set-up.
QconCAT is an interesting approach combining features of
peptide and protein standards by designing a genetic construct
consisting of many peptide sequences from different proteins
fused together into one artificial protein. When assembling the
concatenated sequence, it is easily possible to optimize the
codons for the desired expression host. One QconCAT protein
can be used for the quantitation of several different proteins;
however, the desired amount to add might be very different
for the various target proteins. While this technique is poten-
tially an advance over peptide standards, it is still affected by
similar problems such as the peptide sequences to be selected,
the time point of spiking, the low number of peptides per
protein to be quantified, as well as the necessity of complete
digestion. However, compared to AQUA, this method may more
accurately recreate the peptide elution step during in-gel
digestion of proteins.26
Absolute SILAC is unaffected by these problems, and con-
ceptually its only limitations are the steps preceding the time
point of spiking (i.e., unknown cell lysis efficiency). The method
is of course still susceptible to general sources of error such as
Table 2. Copy Number of Grb2 per Cell for HeLa, HepG2, and C2C12 Cellsa
HeLa cells
analyzed
fraction
spiked amount
of heavy Grb2
peptides
quantified
ratio heavy:light
(avg ( SD) fmol light Grb2 % Grb2 in pellet
copy number
per cell
1a supernat. 1 pmol 12 2.47 ( 0.16 405 4.3 5.10 × 105
1b pellet 250 fmol 7 13.72 ( 2.31 18.2
2a supernat. 1 pmol 10 2.52 ( 0.20 397 3.3 4.95 × 105
2b pellet 250 fmol 6 18.37 ( 1.91 13.6
3a supernat. 1 pmol 12 2.34 ( 0.16 427 4.9 5.41 × 105
3b pellet 250 fmol 9 11.46 ( 2.04 21.8
4a supernat. 1 pmol 11 1.99 ( 0.24 503 3.5 6.28 × 105
4b pellet 250 fmol 8 13.71 ( 2.21 18.2
5a supernat. 1 pmol 13 2.12 ( 0.17 472 5.9 6.04 × 105
5b pellet 250 fmol 8 8.44 ( 1.06 29.6
average ((SEM): 4.4 ( 0.49 5.55 ( 0.26 × 105
HepG2 cells
analyzed
fraction
spiked amount
of heavy Grb2
peptides
quantified
ratio heavy:light
(avg ( SD) fmol light Grb2 % Grb2 in pellet
copy number
per cell
1a supernat. 1 pmol 14 1.36 ( 0.11 735 1.4 8.98 × 105
1b pellet 100 fmol 8 9.65 ( 1.90 10.4
2a supernat. 1 pmol 11 1.33 ( 0.07 752 1.1 9.16 × 105
2b pellet 100 fmol 9 11.46 ( 2.32 8.7
3a supernat. 1 pmol 14 1.42 ( 0.14 704 1.2 8.58 × 105
3b pellet 100 fmol 7 12.22 ( 1.04 8.2
4a supernat. 1 pmol 14 1.43 ( 0.11 699 1.2 8.52 × 105
4b pellet 100 fmol 9 11.66 ( 1.71 8.6
5a supernat. 1 pmol 11 1.39 ( 0.11 719 1.2 8.76 × 105
5b pellet 100 fmol 8 11.70 ( 1.58 8.5
average ((SEM): 1.2 ( 0.05 8.80 ( 0.12 × 105
C2C12 cells
analyzed
fraction
spiked amount
of heavy Grb2
peptides
quantified
ratio heavy:light
(avg ( SD) fmol light Grb2 % Grb2 in pellet
copy number
per cell
1a supernat. 1 pmol 11 2.44 ( 0.19 410 3.4 5.11 × 105
1b pellet 100 fmol 7 6.92 ( 0.82 14.5
2a supernat. 1 pmol 11 2.06 ( 0.22 485 3.1 6.03 × 105
2b pellet 100 fmol 8 6.51 ( 0.77 15.4
3a supernat. 1 pmol 11 2.36 ( 0.21 424 3.1 5.27 × 105
3b pellet 100 fmol 10 7.38 ( 1.28 13.6
4a supernat. 1 pmol 8 2.10 ( 0.23 476 3.4 5.93 × 105
4b pellet 100 fmol 10 6.06 ( 0.49 16.5
5a supernat. 1 pmol 10 2.06 ( 0.14 485 3.0 6.02 × 105
5b pellet 100 fmol 9 6.72 ( 0.79 14.9
average ((SEM): 3.2 ( 0.09 5.67 ( 0.20 × 105
a The quantitative data from five separate experiments are shown, each divided into supernatant and pellet.
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pipetting, etc., but those should not add up to more than 5–10%
when done with care. While this manuscript was in preparation,
an elegant study of the comparison of peptides, concatenated
peptides, and intact proteins as standards for absolute quan-
titation was published.44 The authors found that the QconCAT
approach was superior to AQUA but that both of them severely
underestimated the actual protein amount. In contrast, the in
vitro expressed intact protein standard provided a correct
quantitation. We therefore recommend the use of Absolute
SILAC unless specific experimental reasons suggest a different
approach. The major practical challenge in Absolute SILAC is
the need to recombinantly express and purify the proteins of
interest. Some proteins are very difficult to express and purify,
and if one cannot settle for the expression of a domain instead,
the best alternative would be to employ AQUA or QconCAT.
Obtaining purified SILAC-labeled proteins can of course be
labor-intensive. If properly stored and aliquoted, however, this
should be a one-time effort because only minute amounts are
needed per experiment. If desired, one can even get around
expressing SILAC-labeled proteins and instead use unlabeled
proteins by spiking it into a labeled cell line. This even works
for tissue samples, if a SILAC-labeled animal is available
(Krueger et al., submitted), and for researchers working with
SILAC cell lines, it is in any case a very convenient approach.
Furthermore, unlike AQUA and QconCAT and other peptide-
based approaches, Absolute SILAC is fully compatible with top-
down approaches where complete proteins instead of their
proteolytic peptides are measured by mass spectrometry.45 In
principle, modified versions of recombinant proteins can also
be produced, which should allow the accurate quantitation of
processed proteins, protein isoforms, or proteins with post-
translational modifications.
Conclusions and Perspectives
Accurate absolute quantitation of proteins in complex
environments as presented here by Absolute SILAC can deliver
excellent quantitative information. We have introduced a
targeted approach involving SIM scans, which makes some of
the advantages of MRM scans available on trapping instru-
ments and which extends the detection and quantitation limit
in complex mixtures by at least one order of magnitude.
Importantly, this approach allows retrieving previously unob-
servable endogenous peptides not only in Absolute SILAC but
also in any method employing labeled standard peptides, such
as AQUA. As an example, narrow range scans could be triggered
on labeled analogues of peptides from glyco-captured plasma
proteins.46
Data obtained by Absolute SILAC can supply biology in
general with a central piece of information on proteins of
interest and systems biology in particular with input for
modeling. Here we measured the copy number of a protein
per cell, but the stoichiometry within protein complexes and
the concentration of potential biomarkers in body fluids can
also be determined. We believe that Absolute SILAC may have
a possible role in biomarker quantitation in clinical diagnostics.
Biomarkers would have to be expressed recombinantly once
and distributed into many protein standards, similar to stan-
dards for ELISA tests used today. The absolute quantitation of
many different proteins at once in single LC-MS experiments
should be possible in a multiplexed format, after generating a
“master-mix” of known amounts of several diagnostically
relevant proteins in labeled form. This might eventually also
be a cheaper approach as compared to conducting multiple
immunoassays for the various proteins.
In academia, most research laboratories focus on a small
number of proteins for their investigations. They are often
experts in expressing and purifying them from recombinant
sources and will have a strong interest in their absolute
amounts in the biological system studied. Given the general
availability of in vitro expression systems as well as auxotrophic
strains from bacteria or yeast and the growing access to MS
facilities, the scientific community should be able to determine
absolute quantities of many proteins in different cell lines or
tissues. The data could be gathered by a central database such
as Swissprot and included in the protein information sheet
online.
Abbreviations: MS, mass spectrometry; LC, liquid chroma-
tography; MS/MS, tandem mass spectrometry; SIM, selected-
ion-monitoring; LTQ, linear quadrupole ion trap; Da, Dalton;
RP, reversed phase; SILAC, stable isotope labeling by amino
acids in cell culture; ICAT, isotope coded affinity tag; iTRAQ,
isobaric tag for relative and absolute quantification; CDIT,
culture derived isotope tag; AQUA, absolute quantitation;
QconCAT, quantitative concatamer; Arg, arginine; Lys, lysine;
Grb2, growth factor receptor-bound protein 2; MBP, maltose-
binding protein; BSA, bovine serum albumin; fmol, femtomole;
amol, attomole; UV, ultraviolet.
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4.1 PUBLICATION: MOTIF DECOMPOSITION OF THE 
PHOSPHOTYROSINE PROTEOME REVEALS A NEW N-TERMINAL 
BINDING MOTIF FOR SHIP2 
 
This article presents the results of the project on global analysis of pTyr-motifs and was 
published in 2008, in the January issue of Molecular and Cellular Proteomics on pages 
181-192. 
The project was carried out as a collaboration with Dr. Martin Miller and Prof. Dr. Søren 
Brunak from the center for biological sequence analysis at the Technical University of 
Denmark. 
The following pages contain the published version of the article. 
Motif Decomposition of the Phosphotyrosine
Proteome Reveals a New N-terminal Binding
Motif for SHIP2*□S
Martin Lee Miller‡, Stefan Hanke§, Anders Mørkeberg Hinsby‡, Carsten Friis‡,
Søren Brunak‡, Matthias Mann§, and Nikolaj Blom‡¶
Advances in mass spectrometry-based proteomics have
yielded a substantial mapping of the tyrosine phospho-
proteome and thus provided an important step toward a
systematic analysis of intracellular signaling networks in
higher eukaryotes. In this study we decomposed an un-
characterized proteomics data set of 481 unique phos-
photyrosine (Tyr(P)) peptides by sequence similarity to
known ligands of the Src homology 2 (SH2) and the phos-
photyrosine binding (PTB) domains. From 20 clusters we
extracted 16 known and four new interaction motifs. Us-
ing quantitative mass spectrometry we pulled down
Tyr(P)-specific binding partners for peptides correspond-
ing to the extracted motifs. We confirmed numerous pre-
viously known interaction motifs and found 15 new inter-
actions mediated by phosphosites not previously known
to bind SH2 or PTB. Remarkably, a novel hydrophobic
N-terminal motif ((L/V/I)(L/V/I)pY) was identified and val-
idated as a binding motif for the SH2 domain-containing
inositol phosphatase SHIP2. Our decomposition of the
in vivo Tyr(P) proteome furthermore suggests that two-
thirds of the Tyr(P) sites mediate interaction, whereas
the remaining third govern processes such as enzyme
activation and nucleic acid binding. Molecular & Cel-
lular Proteomics 7:181–192, 2008.
Phosphorylation-dependent protein-protein interaction is
one of the key organizing principles in intracellular signaling
events. The phosphotyrosine binding (PTB)1 domain and the
Src homology 2 (SH2) domain are modular domains that
typically bind phosphotyrosine (Tyr(P))-containing peptides (1,
2). “Linear motifs” (unstructured sequence recognition
patches with conserved residues at specific positions (3)) that
direct Tyr(P)-dependent interaction have traditionally been
studied using degenerate oriented peptide libraries. Such
studies revealed that PTB and SH2 domains have preference
for specific amino acids N- and C-terminal to the Tyr(P) resi-
due, respectively (4, 5).
Recent methodological developments in MS-based proteom-
ics have made it possible to identify hundreds to thousands of
protein phosphorylation sites in a single project (6–14). Exten-
sive mapping of the phosphoproteome is an important step
toward analyzing the regulatory components of the cell. Be-
cause the majority of newly identified phosphopeptides are
uncharacterized with respect to signaling context, there is now
a unique opportunity to mine the phosphoproteome for novel
phosphorylation motifs. Methods have been developed that
successfully mine for overrepresented motifs from large protein
data sets in general (15–17) and more recently also from phos-
phoproteomics data sets (18). However, these methods do not
partition the data set into smaller subsets with high sequence
similarity prior to motif extraction. Sequence patches flanking
the motif also govern phosphorylation-dependent recognition
(19); consequently there is a risk of extracting false positive
motifs from functionally unrelated peptides. Furthermore the
above mentioned methods are in silico approaches and do not
combine prediction with experimental validation.
To overcome such limitations in the area of Tyr(P) motif
discovery and classification, one may partition the data set
into smaller subsets e.g. by sequence similarity with known
kinase or binding substrates prior to motif extraction. Thus,
the risk of retrieving false positive motifs is minimized because
overrepresented motifs are extracted from peptides closely
related in sequence and function. Besides Tyr(P) recognition
motifs for kinases and interaction domains, there may also
potentially exist Tyr(P) motifs that mediate other processes
than binding such as e.g. enzyme activation and nucleic acid
binding. Thus, it is essential to validate the extracted motifs
both by experimental and bioinformatical means to obtain a
functional classification.
With this in mind we developed a motif extraction and
validation methodology and classified Tyr(P) motifs on a pro-
From the ‡Center for Biological Sequence Analysis, Technical Uni-
versity of Denmark, Kemitorvet, Building 208, DK-2800 Lyngby,
Denmark and §Department of Proteomics and Signal Transduction,
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teome level. Operating in sequence space, we stretched the
MS-mapped Tyr(P) peptides over a backbone of ligands al-
ready known to be involved in Tyr(P)-dependent interaction.
Using experimentally verified Tyr(P) ligands of the PTB and
SH2 domains as both a clustering backbone and as a control
for the partitioning, we split a literature-extracted data set of
mammalian Tyr(P) peptides into 20 different clusters. We ob-
tained a meaningful clustering because the controls parti-
tioned correctly into separate clusters.
From the 20 clusters we extracted both known and un-
known phosphorylation motifs, and peptides matching these
motifs were synthesized and assayed for phosphorylation-
specific interaction partners using a peptide pulldown assay
based on quantitative proteomics (20). In contrast to the
oriented peptide library approach that uses artificial degener-
ate peptides, we used naturally occurring peptides as baits to
pull down binding partners from the cell lysate. Moreover
because the interaction partners are in competition for bind-
ing, mimicking the in vivo binding situation, the risk of finding
kinetically unfavorable interaction motifs is minimized. Finally
this technique can potentially identify new types of domains
with modification-specific binding capability.
Using the pulldown assay we identified the expected bind-
ing partners for numerous known C-terminally directed SH2
domain motifs. We also found 15 new phosphorylation-de-
pendent interactions mediated by phosphosites not previ-
ously shown to direct interaction. Surprisingly we identified a
new N-terminal hydrophobic motif ((L/V/I)(L/V/I)pY where pY
is phosphotyrosine) for the SH2 domain-containing inositol
phosphatase SHIP2. The specificity of the motif was con-
firmed by mutational analysis. Surprisingly this motif is N-
terminally directed, which is in contrast to previous observa-
tions showing that binding of prototypical SH2 domains are
directed by C-terminal recognition (21). Until now the only
other known SH2 domain binding motif that is partly directed
by N-terminal recognition is the immunoreceptor tyrosine-
based inhibition motif (ITIM) (I/L/V)XpYXX(I/L/V) (22, 23).
On a proteome level we analyzed which Gene Ontology
(GO) categories were overrepresented in proteins matching
the extracted motifs. We found that motifs that mediate inter-
action in the pulldown assay are typically found in proteins
involved in signal transduction, whereas non-binding motifs
are found in enzymes and ion- and nucleic acid-binding pro-
teins. Thus, we estimate that one-third of the in vivo Tyr(P)
sites are not directly involved in interaction via domains such
as SH2 and PTB but rather are sites that could alter the
catalytic activity of enzymes or modulate the DNA binding
affinity of e.g. transcription factors.
EXPERIMENTAL PROCEDURES
Data Set Preparation—Large scale data sets of tyrosine phospho-
rylation sites mapped in MS/MS experiments with mammalian cell
lines were collected from the literature (8, 10, 12–14, 24, 25) yielding
a total of 847 tyrosine phosphorylation sites. To filter out phos-
phopeptides from closely related homologs and orthologs only
unique 13-mer peptide sequences with the Tyr(P) centrally positioned
were considered. This reduced the MS-based data set to 481 phos-
phopeptides distributed in 380 proteins. Furthermore 162 experimen-
tally verified Tyr(P) peptide ligands of one PTB domain and 10 differ-
ent SH2 domains were extracted from the Phospho.ELM database
(26). The 162 peptides were included in the data set as positive
controls, resulting in a data set of 643 Tyr(P) peptides (see supple-
mental Table 3). The criteria for selecting the positive controls were
the existence of a consensus binding motif and that a suitable amount
of examples could be obtained.
Generation of Weight Matrices—13-mers of the 162 phosphopep-
tide ligands of the 11 respective PTB and SH2 domains (see Table I)
were used to create 11 weight matrices using the weight matrix mode
of EasyGibbs 1.0 (27). Default settings were used except motif length
was set to 13 fixed around the central Tyr(P) residue. Subsequently all
phosphopeptides in the MS-based data set (481) and the positive
control data set (162) were scored by each of the 11 weight matrices,
and thus each phosphopeptide could be represented as a vector of
the 11 weight matrix scores.
Clustering Using Partitioning around Medoids (PAM)—A matrix
consisting of the 11 weight matrix scores and the 643 phosphopep-
tides was generated and subsequently clustered by the PAM method
(28) using the cluster package in R. The PAM algorithm is a robust
version of k-means, and it searches for a specified number of me-
doids (representatives), k, around which clusters are constructed. The
clusters are generated by minimizing the sum of the dissimilarities of
all observations and assigning them to their closest medoid. Using a
hypergeometrical test (see “Statistics”) the optimal number of clusters
(k  20) was inferred because this resulted in the best partitioning of
the positive controls. We use z-scores, i.e. multiples of standard
deviations from the mean, to account for the different numeric ranges
of the measured parameters.
The choice of an appropriate clustering algorithm is a complex one
because no given algorithm is universally superior (29, 30). Rather the
best choice will depend on the data set and in particular on what
constitutes a good distance measure for it. Another relevant concern
is the desired outcome and whether a hierarchical or partitional result
is preferable. Many sophisticated methods exist that are capable of
automatically determining the number of “natural clusters” in the data
like the popular density-based clustering algorithms that can describe
very complex non-circular relations in the data (31). It is, however, not
clear whether the ability to recognize non-circular structures in the
data is beneficial in this case. Proteins that share the same features
are likely to be related and will form a circular relation in feature space.
On the other hand, an elongated cluster in feature space will contain
proteins that share only some features but not others, and the bio-
logical implications thereof can be quite diverse. Other than being
computationally effective and easy to implement, the PAM algorithm
was selected because it satisfies the need for a robust clustering
algorithm and because its reliance on an Euclidean distance measure
ensures that the result can be easily interpreted. The primary weak-
ness of PAM is the need to arbitrarily select a number of clusters for
the data, which in this case is overcome by the mentioned application
of the hypergeometric test.
Dendrogram and Sequence Logo Plots—Weight matrices of the
peptides in the 20 clusters were made using positional weighting of
the three residues flanking the central Tyr(P) residue (27) and used to
calculate distance matrices as described previously (32). The dis-
tance matrices were used as input to the program neighbor from
version 3.5 of PHYLIP (Phylogeny Inference Package). To estimate
the significance of the neighbor-joining clustering we used the boot-
strap method and estimated the consensus tree by bootstrapping for
1000 repetitions as described earlier (32).
The frequencies of amino acids at particular positions in each
Motif Decomposition of the Tyr(P) Proteome
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cluster were calculated, and subsequently sequence logo plots were
used for graphic visualization (33). Each position in the aligned se-
quences corresponds to a column in the logo plot. The height of the
column represents the degree of conservation at that position,
whereas the height of the individual letters is proportional to the
relative frequency of this amino acid residue. The maximal height of
the column for the 20-amino acid alphabet is log220  4.32 bits.
Extraction of Motifs and Selection of Peptides to Synthesize—The
identified phosphomotifs in each of the 20 clusters were found using
the publicly available TEIRESIAS pattern discovery tool from IBM
Bioinformatics (17). Parameters were set so the extracted motifs were
within a window of 13 residues centered on the phosphoresidue. The
minimal number of literals in the motif was set to 4, and the amino
acids were grouped according to their chemical nature (Ala/Gly, Asp/
Glu, Phe/Tyr, Lys/Arg, Ile/Leu/Met/Val, Gln/Asn, Ser/Thr, Pro, Trp,
His, and Cys (17)). For each of the 20 clusters the most abundant
motif was selected, and subsequently one peptide matching the motif
was chosen from the respective cluster. Because multiple peptides in
each cluster matched the extracted motif, peptides from mouse and
peptides not previously known to be involved in phosphorylation-de-
pendent interaction were preferred. In the few cases (three) where
mouse sequences could not be obtained, peptides from humans with
high homology in mouse were chosen.
Gene Ontology Analysis—Gene Ontology categories were obtained
from Gene Ontology Annotation mouse database version 29.0. The
extracted motifs were matched to proteins in the International Protein
Index (IPI) mouse proteome version 3.20. Using a hypergeometrical
test (see “Statistics”) with the total proteome as background we found
the 10 most overrepresented GO terms in retrieved proteins. The hits
were inspected manually, and the consensus GO term was assessed
for each motif. For the purpose of the hypergeometrical test, each
annotated GO category was taken to include all of its ancestral terms
to avoid problems with diverging levels of annotation.
Statistics—To determine whether the positive controls were signif-
icantly overrepresented in specific clusters compared with the whole
data set, hypergeometric sampling without replacement (34) was
performed. The hypergeometric test is a statistical test used to de-
scribe the arbitrariness of a sampling without replacement from a
background of true or false examples. The probability (p) to observe
a given or more extreme situation by a pure coincidence is given by
the hypergeometric distribution,
PX  xN,M,K
Mx N  MK  x 
NK
(Eq. 1)
where N is the total number of peptides, M is the number of peptides
in the given set, K is the number of peptides in a particular cluster, and
x is the number of K that belongs to M. A Bonferroni correction was
performed to correct for multiple comparisons. In the case of GO
analysis, we performed the test once for each GO category present in
the data and evaluated the probability of sampling the set of retrieved
proteins from the background of the total proteome by mere chance,
considering a protein ‘true‘ or ‘false‘ depending on whether it had
been assigned the category in question. The end result of this test
was one p value for each GO category, describing the degree of
overrepresentation of that particular assignment in the retrieved set
against the background of the entire proteome.
Cell Culture—Mouse C2C12 muscle cells were grown in arginine-
and lysine-deficient Dulbecco’s modified Eagle’s medium with 10%
dialyzed fetal bovine serum for at least five passages and then
switched to 2% dialyzed fetal bovine serum to differentiate the cells
for 8 days. In accordance with the stable isotope labeling by amino
acids in cell culture (SILAC) procedure, one cell population was
supplemented with normal isotopic abundance L-arginine (Sigma)
and L-lysine, and the other was supplemented with 99% isotopic
abundance [13C6,
15N4]arginine and [
13C8]lysine (Aldrich) as described
previously (35). Thereby full labeling of all proteins was achieved.
Peptide Synthesis and Pulldowns—Desthiobiotinylated peptides
were synthesized on a solid-phase peptide synthesizer using amide
resin (Intavis, Koeln, Germany). All peptides were designed as
15-mers with the Tyr(P) residue placed centrally at position 7 or 8
expect for one peptide from cluster 1 (see Table I) that was 20
amino acids long. The peptides were synthesized with an N-termi-
nal biotin and an SG dipeptide linker. Peptides were synthesized as
pairs in phosphorylated and a non-phosphorylated “control” form.
The identity and purity of the synthesized peptides was confirmed
by mass spectrometric analysis. For pulldowns, 1.5 nmol of immo-
bilized peptide was added to an average of 1.5 mg of cell lysate.
Dynabeads MyOne Streptavidin were saturated with biotinylated
peptide prior to incubation with cell lysates. Cells were lysed as
described previously (36), and equal amounts of protein were incu-
bated overnight with the respective immobilized peptides at 4 °C.
After three rounds of washing with lysis buffer, beads of pulldown
pairs with the phosphorylated form and control were combined (20),
and bound proteins were eluted using 16 mM biotin. Eluted proteins
were precipitated and subsequently digested with trypsin for LC-
MS/MS analysis.
LC/MS/MS, Database Searching, and Quantitation—After reduc-
tion in 1 g of DTT and alkylation with 5 g of iodoacetamide the
eluted proteins were in-solution digested with 1 g of endoproteinase
Lys-C (Wako) for 3 h at room temperature. Subsequently samples
were diluted with 4 volumes of 50 mM NH4HCO3 and further digested
with 1 g of trypsin (Promega) overnight at room temperature. Pep-
tide mixtures were desalted on stop and go extraction tips (37) and
loaded onto reversed phase analytical columns for liquid chromatog-
raphy (38). Peptides were eluted from the analytical column by a
multistep linear gradient running from 2 to 40% acetonitrile in 100 min
and sprayed directly into the orifice of an LTQ-FT or an LTQ-Orbitrap
mass spectrometer (Thermo Electron, Bremen, Germany). Proteins
were identified by MS/MS by information-dependent acquisition of
fragmentation spectra of multiply charged peptides. The peak list was
generated using in-house software, raw2msm version 1.2, with de-
fault settings. The identified proteins were then searched against the
mouse IPI database using the Mascot (version 2.1.0) algorithm (39).
The MS/MS ion search parameters were set as follows: enzyme
specificity for trypsin, trypsin/Pro  AspPro; maximum number of
missed cleavages, 2; fixed modification, carbamidomethylcysteine;
variable modifications, oxidation (Met), N-acetyl (protein), deamida-
tion (NQ), [13C6,
15N4]arginine, [
13C8]lysine, and pyro (N-terminal QC);
mass tolerance for precursor ions, 5 ppm; fragment mass tolerance,
0.5 Da; database version, IPI_mouse mouse_v314 with 68,655 en-
tries. Common contaminants like human keratins were manually
added. No species-specific restrictions were used. MSQuant
(SourceForge) was used for quantitation and spectra validation. MS-
Quant uses peak area and extracted ion chromatogram for
quantitation.
Determination of Significant Binding Partners—Intensity ratios of
labeled to unlabeled forms of each validated tryptic peptide and the
associated average ratio for the whole protein were obtained by
MSQuant. We used ‘crossover‘ experiments in which the specific
interaction partners were required to have inverse ratios compared
with the ‘normal‘ experiment (20). A significant binder was defined as
a protein with a log ratio at least three standard deviations over the log
average ratio (3 log()  log()) of all the proteins identified in a
pulldown experiment. Furthermore the binder had to be confirmed in
at least two pulldown experiments (normal and crossover experi-
ment), and we only report specific binders for the phosphopeptide
Motif Decomposition of the Tyr(P) Proteome
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and not the non-phosphorylated peptides. Finally at least one peptide
had to have a score above 30, corresponding to p  0.05. In the 64
pulldowns performed we identified a few sequence-unspecific bind-
ers with high affinity to either the phosphorylated or non-phosphoryl-
ated peptides (staphylococcal nuclease domain-containing protein,
eukaryotic translation initiation factor, peptidylprolyl isomerase B,
RNA-binding protein SiahBP, and RIKEN cDNA 2410104I19). These
proteins were excluded because we consider them as false positive
binders, i.e. they bind in a sequence-unspecific manner and occa-
sionally bind most strongly to the non-phosphorylated peptide. In all
the pulldown experiments an average of 140  41 proteins was
quantified with an average ratio of 1.217  0.529.
RESULTS
A New Clustering Approach for Motif Extraction and Clas-
sification—To discover new interaction motifs in large aligned
peptide data sets, we developed a method that partitions the
sequences based on similarity with proteins previously known
to be involved in interaction. The method is generally appli-
cable for peptide interaction data sets. In this work we clus-
tered and classified motifs in the Tyr(P) proteome. A flow chart
of the method is presented in Fig. 1. In short, we used verified
Tyr(P) ligands of the PTB and SH2 domains as a backbone to
cluster a data set of uncharacterized phosphopeptides
mapped in MS-based proteomics experiments with mamma-
lian cell lines. From each clusters the most conserved motif
was extracted. To classify the function of each motifs in an
unbiased and systematic manner we conducted both exper-
imental and bioinformatical investigations. Peptides matching
the motifs were assayed for binding partners using a peptide-
protein interaction screen based on quantitative proteomics
(20, 36). On a proteome level we analyzed which GO catego-
ries were overrepresented in proteins matching the extracted
Tyr(P) motifs. Thus, we established a workflow that extracts,
verifies, and classifies motifs in phosphoproteome.
Clustering—In detail, we extracted 162 known 13-mer
phosphopeptide ligands of 10 different SH2 domains and a
general PTB domain from the Phospho.ELM database (26). In
this database, which is the key repository for high quality
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FIG. 1. Overview of the motif extraction and validation strategy.
A, verified Tyr(P) peptide ligands (162) of different PTB and SH2
domains are used to create 11 specific weight matrices that subse-
quently score both a large scale data set of 481 Tyr(P) peptides
identified in MS experiments and the 162 ligands themselves. All
peptides are 13-mers with the Tyr(P) (red) centrally positioned. Con-
sequently each phosphopeptide can be represented as a vector of
the 11 weight matrix scores. B, this is used as input for the k-means-
derived PAM algorithm (28), and the data set is split up into clusters
(20, see text for details) depending on sequence similarity of the
ligands used in the weight matrix generation. We use z-scores, i.e.
multiples of standard deviations from the mean, to account for the
different numeric ranges of the measured parameters. C, sequence
logo plots (33) of the peptides in the different clusters are used to
visually inspect the result of the partitioning (see Fig. 2). D, after
partitioning the most conserved motif from each cluster is extracted
(17). E, a GO analysis of the motifs on a proteome level is conducted
to determine in which functional class of proteins the motifs generally
are present compared with the whole proteome as background. F, a
peptide pulldown assay based on quantitative proteomics (20) is used
to evaluate the Tyr(P)-specific binding capability of the motifs. Pep-
tides matching the motifs are synthesized in phosphorylated and
non-phosphorylated pairs and used to pull down Tyr(P)-specific in-
teraction partners from the lysate of C2C12 muscle cells.
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annotated phosphorylation sites, these 11 domains had the
highest number of annotated ligands (see Table I for details).
Thus, the 162 substrates of the 11 domains represent the
broadest available in vivo data set of Tyr(P) ligands. These
ligands were aligned with the Tyr(P) centrally positioned and
used to generate a position-specific weight matrix for each of
the 11 domains. The 481 phosphopeptides in the MS-based
data set and the 162 ligands of the PTB and SH2 domains
(“positive controls”) were then scored by each of the 11
weight matrices. Consequently each phosphopeptide was
TABLE I
Clustering and motif extraction of the Tyr(P) proteome
The PAM algorithm was used to partition the data set by sequence similarity with the known ligands of the Tyr(P) binding domains (positive
controls). The first and second columns show the cluster number and the size of the clusters, respectively. The ability of the algorithm to
significantly partition (p  0.05) the positive controls into different clusters is shown in the third column. For example, eight out of a total of
10 ligands of the Crk SH2 domain are grouped in cluster 2, corresponding to a significant overrepresentation in a Bonferonni corrected
hypergeometric sampling test (p  3.67e08). The most conserved motif in each cluster was extracted and is stated in the fourth column. The
Tyr(P) residue is indicated in bold, and an 	X	 represents any amino acid. Also indicated is the number of occurrences of the motif in the
respective cluster and in the total data set. The identified motifs were matched to a library of known Tyr(P) binding motifs, and the expected
binding partner is indicated (fifth column). 15–20-mer peptides matching the motifs were synthesized in pairs, one with a Tyr(P) as indicated
in bold. Furthermore the parent protein of the peptide is given by Swiss-Prot entry name, and the position of the Tyr(P) is stated. The
Tyr(P)-dependent interaction partner(s) identified in a quantitative proteomics peptide-protein screen is shown in the last column (see also
Supplemental Table 1). PLC, phospholipase C.
Cluster Size
Positive
controls
Extracted motifs
Matched motifs,
expected partner
PubMed
ID
Peptides synthesized
Identified
partners
1 41 PTB
10 of 10
NPXpYX(S/T)
7 of 7
SHC PTB
(NPXpY)
7542744
7541030
KEVCDGWSLPNPEpYYTLRYA
ELMO2_MOUSE, 48
SHC
2 36 Crk SH2
8 of 10
(I/L/M/V)pYX(I/L/M/V)P
8 of 14
Crk/RasGAP SH2
(pYXXP)
9233798
11607838
KPSTDPLpYDTPDTRG
RIN1_MOUSE, 35
RasGAP
Nck1
3 29 Vav SH2
4 of 4
pYESPXX(D/E)
5 of 5
Vav SH2
(pYESP)
9151714 TETKTITpYESPQIDG
E41L2_MOUSE, 889
None
4 28 (D/E)XXX(I/L/V)(I/L/V)pY
4 of 6
New motif RETSKVIpYDFIEKTG
WASL_MOUSE, 253
SHIP2
5 20 (D/E)(D/E)XXXpYXN
4 of 6
Grb2 SH2
(pYXN)
11994738 VYDEDSPpYQNIKILH
SPSY_MOUSE, 147
Grb2
RasGAP
6 41 Grb2 SH2
14 of 31
pYXN(I/L/M/V)XXL
5 of 7
Grb2 SH2
(pYXN)
11994738 ELFDDPSpYVNIQNLD
SHC1_MOUSE, 423
Grb2
7 21 Grb2 SH2
6 of 31
(D/E)pYXN(I/L/M/V)
4 of 11
Grb2 SH2
(pYXN)
11994738 QPASVTDpYQNVSFSN
ITSN2_HUMAN, 858
Grb2
8 45 pY(I/L/M/V)XMXP
4 of 10
p85-PI3K SH2
(pYXXM)
7511210
11994738
PQRVDPNGpYMMMSPS
IRS1_MOUSE, 658
p85-PI3Ka
p85-PI3K
9 40 pY(D/E)X(I/L/M/V)X(I/L/M/V)
5 of 22
Fps/Fes SH2
(pY(E/D)X(I/V))
7511210 AGKQKLQpYEGIFIKD
SF3A1_MOUSE, 757
None
10 32 (D/E)XXpY(D/E)X(I/L/M/V)
7 of 27
Fps/Fes SH2
(pY(E/D)X(I/V))
7511210 DGGSDQNpYDIVTIGA
INP4A_HUMAN, 355
None
11 35 PI3K SH2
16 of 24
pY(I/L/M/V)PMXP
6 of 7
p85 PI3K SH2
(pYXXM)
7511210
11994738
NLHTDDGpYMPMSPGV
IRS1_MOUSE, 608
p85-PI3K
12 23 DpY(I/L/M/V)X(I/L/M/V)
7 of 18
SHP2 SH2
(pY(I/V/L)X(I/V/L))
7680959 DLINRMDpYVEINIDH
VIGLN_MOUSE, 437
SHP2
13 28 SHP2 SH2
7 of 12
(I/L/M/V)XpY(I/L/M/V)X(I/L/M/V)D
6 of 7
SHP2 SH2
(pY(I/V/L)X(I/V/L))
7680959 DIKEKLCpYVALDFEQ
ACTB_MOUSE, 218
SHP2
14 32 PLC SH2
5 of 16
(I/L/M/V)pYXX(I/L/M/V)(I/L/M/V)
5 of 11
General/SHP2 SH2
(pY(I/V/L)X(I/V/L))
7511210
7680959
GKSKQPLpYSSIVTVE
O88185_MOUSE, 948
SHP2
SHIP2
15 29 RasGAP SH2
7 of 8
(A/G)(I/L/M/V)pYXXP
6 of 10
Crk/RasGAP SH2
(pYXXP)
9233798
11607838
GVVDSGVpYAVPPPAE
BCAR1_HUMAN, 410
RasGAP
16 37 SHC SH2
9 of 13
PXEpYXXXXX(I/L/M/V)
3 of 3
New motif TTEAPGEYFFSDGVR
IMDH1_MOUSE, 400
None
17 25 Src SH2
7 of 14
pY(D/E)X(I/L/M/V)H
4 of 6
Fps/Fes SH2
(pY(E/D)X(I/V))
7511210 ELTAEFLpYDEVHPKQ
TWF2_MOUSE, 309
RasGAP
18 32 STAT SH2
15 of 19
pY(I/L/M/V)PQ
4 of 4
STAT SH2
(pYXXQ)
14966128 SGENFVPpYMPQFQTC
LEPR_MOUSE, 1138
None
19 33 H(S/T)GXKPpYXCXXCG
10 of 10
New motif RIHTGEKPpYECVQCGK
ZNF24_MOUSE, 335
None
20 36 (A/G)XpYXX(I/L/M/V)X(K/R)
8 of 15
New motif KKNRIAIpYELLFKEG
RS10_MOUSE, 12
None
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represented as a vector of the 11 weight matrix scores (Fig.
1A). Based on this profile of vectors we clustered the total of
643 peptides using the k-means-derived PAM algorithm (40).
The PAM algorithm searches for a predefined number of
medoids (representatives) around which clusters are con-
structed. We tried various cluster sizes, and by using a hy-
pergeometrical distribution test the number of clusters was
set to 20 because this gave the statistically best partition of
the positive controls into different clusters (Fig. 1, B and C).
We were able to obtain a convenient fit of the model be-
cause the positive controls were distributed such that all were
statistically overrepresented in separate clusters (p  0.05)
(see Table I). For example, 10 of a total of 10 ligands of the
PTB domains were grouped in cluster 1 (p  7.34e12). Only
the 31 ligands for the Grb2 SH2 domain were split up in two
significant groups (clusters 6 and 7). Furthermore eight of the
20 clusters did not contain a significant overrepresentation of
the known ligands used.
Motif Extraction—From each of the 20 clusters the most
conserved motif was extracted with the TEIRESIAS pattern
discovery tool from IBM Bioinformatics (Fig. 1D) (17) as de-
scribed under ‘Experimental Procedures.‘ The 20 identified
motifs are presented in Table I followed by the number of
matches to peptides in the particular cluster and in the total
data set. For example, a unique motif, NPXpYX(S/T), was
extracted from cluster 1 because all peptides (seven) that
matched this motif were in this cluster. To compare the 20
identified motifs with already characterized interaction motifs,
we matched each motif to a comprehensive library of Tyr(P)
interaction motifs in the Human Protein Reference Database
(HPRD) (41). Using the same example again, the motif ex-
tracted from cluster 1 could be matched to the NPXpY motif
described for the SHC and IRS-1 PTB domains (1), although
our extended motif contains a Ser or Thr residue at position
2 from the Tyr(P) residue. Considering that the ligands (the
positive controls) of the PTB domain were grouped in cluster
1, it is not surprising that we extracted the NPXpYX(S/T) motif
in this cluster; however, only three of the seven matching
peptides in cluster 1 were from these PTB ligands (data not
shown). Because this was a general trend it shows the ability
of the clustering method to gather previously uncharacterized
peptides with high sequence similarity to known ligands of the
different Tyr(P) binding domains. In total, 16 of the 20 identi-
fied motifs could be matched to the motif library, showing an
overall consistency between the positive controls and the
extracted and matched motifs. In four clusters new Tyr(P)
motifs were identified.
Gene Ontology Analysis—We used a GO analysis of the 20
extracted motifs on a proteome level to determine in which
type of proteins the extracted motifs generally are present
(Fig. 1E). We retrieved all proteins in the mouse proteome that
matched the motifs and used a hypergeometrical test with the
total proteome as background and thereby found the 10 most
overrepresented GO terms in retrieved proteins (see “Exper-
imental Procedures” for details). Using the same example
again, the NPXYX(S/T) motif from cluster 1 was overrepre-
sented in proteins involved in processes like ‘receptor activity‘
and ‘intrinsic to membrane‘ with the consensus parent GO
term assessed to be ‘transmembrane receptor activity‘ (see
supplemental Table 2). Thus, analyzing the motif on a pro-
teome level indicates that proteins containing the motif are
involved in early signaling transduction. This makes sense in
that this is a motif for the PTB domain, which is found in proteins
that function as molecular scaffolds and adaptors in signaling
pathways (1).
Tyr(P)-specific Interaction Partners—To experimentally ver-
ify the 20 extracted motifs we used a phosphorylation-specific
peptide-protein interaction screen (Fig. 1F) (20, 36). This as-
say is based on differential labeling of proteins using stable
isotope labeling by amino acids in cell culture (SILAC) making
it possible to distinguish specific binders from background
binders by their isotope ratios determined by quantitative
mass spectrometry (35, 42). The peptides are synthesized in a
phosphorylated form and a non-phosphorylated form and
used as baits to pull down competing binding partners from
cell lysate, thus mimicking the in vivo binding situation.
We synthesized peptide pairs matching the 20 extracted
motifs. If there were multiple matches we chose peptides with
Tyr(P) sites not previously known to mediate interaction. Us-
ing this experimental approach we could test our clustering
and motif extraction method and investigate the relevance of
known motifs in a near in vivo situation, i.e. endogenous
proteins competing for binding, and potentially discover bind-
ing partners for novel motifs. Again using cluster 1 as an
example, we synthesized a peptide pair from the engulfment
and cell motility protein 2 in which the Tyr-48 residue was
either phosphorylated or non-phosphorylated. This is an un-
characterized phosphosite identified in a large scale phos-
phoproteomics study (12), and it has not previously been
shown to direct Tyr(P)-dependent interaction. Using this pep-
tide pair as bait we retrieved one specific binder with a ratio
more than three standard deviations over the log mean of a
total of 162 background binders. This protein, SHC-trans-
forming protein 1 (SHC), which contains both a PTB and an
SH2 domain, had a total Mascot score of 1654 with 15 iden-
tified peptides of which nine were quantifiable (see supple-
mental Table 1). Theoretically it could be either the SH2 or the
PTB domain that binds the bait phosphopeptide; however,
because the peptide matches the consensus NPXpY motif
known to direct PTB domain binding, it is most likely that SHC
binds to the peptide through its PTB domain.
Assaying the Tyr(P) Sequence Space for Interaction Part-
ners—The identified phosphospecific binding partners of the
representative peptides from each cluster can be seen in
Table I. Besides the aforementioned SHC protein, these pro-
teins all contain SH2 domains, making it very likely that this
domain governed the phosphospecific interaction. The major-
ity (13 of 20) of the peptides retrieved one or more interaction
Motif Decomposition of the Tyr(P) Proteome
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proteins. Of these proteins seven were unique because some
proteins were identified several times. This is not surprising
because some of the clusters were close to each other in
sequence space resulting in extraction of similar motifs and
ultimately retrieving the same interaction partners.
To get an overview of the results of the pulldown experi-
ments, the GO analysis, and the sequence similarity between
the different clusters, we generated weight matrices of the
peptides in the individual clusters and constructed a dendro-
gram based on an alignment of these matrices (32). The tree
can be seen in Fig. 2 together with sequence logo plots where
the height of each position represents the degree of conser-
vation (33). The logo plots visually illustrate a successful par-
titioning because each cluster has a distinct pattern where
particular amino acids are highly abundant at specific posi-
tions flanking the central Tyr(P) residue. The tree is colored
according to the identified interaction partners retrieved by
peptides matching the motifs in the different clusters. For
example, clusters 8 and 11 are close in sequence space with
an overrepresentation of hydrophobic residues, especially
methionine, at position 3 from the central tyrosine residue.
Rather than being distinct clusters, these are more likely to be
subsets of the same motif. Thus, from these two clusters the
motifs pY(I/L/M/V)XMXP and pY(I/L/M/V)PMXP were ex-
tracted and matched to the consensus pYXXM in the library of
motifs. Accordingly the two peptide pairs synthesized from
these clusters both retrieve the PI3K-p85 protein. In the
same manner the majority of the expected interaction part-
ners were identified using peptides matching to the well char-
acterized C-terminally directed Tyr(P) motifs, such as pYXN,
pYXXP, and pY(I/V/L)X(I/V/L), that retrieved Grb2, RasGAP,
and SHP2, respectively. This illustrates the clear consistency
between the sequence similarity of the clusters, the con-
served residues in the motifs, and the interaction partners
identified.
There were four clusters (clusters 3, 9, 10, and 18) where we
did not identify the partners (Vav, Fps/Fes, and STAT) as
expected from the signature of motifs alone (see Table I). For
instance, we did not pull down the SH2 domain protein Fps/
Fes when using peptides matching a pY(E/D)X(I/V/L) motif
(clusters 9 and 10), which has previously been shown to direct
binding (4). This motif was defined using in vitro oriented
peptide library experiments, which have the inherent risk of
defining motifs that are not relevant in vivo. Whether this is the
case, the Fps/Fes protein was not present in the cell lysate, or
because of technical limitations remains unclear. In total, here
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FIG. 2. Dendrogram representing the
in vivo Tyr(P) sequence space, motifs,
and binding partners. Peptides in the 20
different clusters are used to generate
weight matrices that subsequently are
used as input in a phylogenetic alignment.
The tree is a consensus tree of 1000 boot-
strap trees (32). The tree represents the
distance between the clusters in se-
quence space, which is also visually illus-
trated by the sequence logo plots (33) of
the peptides in each cluster. The color of
the branches is based on the Tyr(P)-de-
pendent interaction partners that were
experimentally identified using a pep-
tide-protein interaction screen. Both
novel and previously known consensus
motifs (see Table I, fifth column) that
govern these specific interactions are in-
dicated in the same color. Branches and
extracted motifs are gray if no interaction
partners were retrieved via the motifs.
Furthermore overrepresented GO terms
from proteins in the whole mouse pro-
teome containing the motifs are stated
(see text for details). Note that the motifs
that do not retrieve a specific binding
partner (gray) are typically found in pro-
teins mediating processes such as ion
binding, ‘catalytic activity,‘ and nucleic
acid binding.
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we report 15 phosphorylation-dependent interactions medi-
ated by phosphosites not previously known to direct protein
interaction (see supplemental Table 1).
Non-binding Tyr(P) Motifs—We observed that motifs that
do not mediate interaction in the pulldown assay are typically
found in proteins involved in processes other than signal
transduction (see Fig. 2). It is particularly interesting that we
extracted a highly conserved H(S/T)GXKPpYXCXXXCG motif
from a number of closely related peptides from Cys2-His2 zinc
finger proteins (zf-C2H2) concentrated in cluster 19 that did
not pull down any phosphorylation-specific interaction part-
ner. The phosphosite of the first tyrosine residue in the zf-
C2H2 domain was also described recently in a study that
mined for novel motifs in the phosphoproteome (18), although
the identified motif in this work (EXXpY) was different from our
top scoring motif (H(S/T)GXKPYXCXXXCG), which does not
contain an acidic residue in position 3. However, our second
best motif in cluster 19 (HXGEXXpY) closely resembles that
reported by Schwartz and Gygi (18).
The H(S/T)GXKPYXCXXXCG motif is extremely specific for
proteins containing the zf-C2H2 domain: of 33,758 proteins
we retrieved 656 matches, all of which had the GO term
‘nucleic acid binding‘ (GO:0003676) (see supplemental Table
2), whereas 647 of the 656 matches had the term ‘zinc ion
binding‘ (GO:0008270) (p  1e100).
Recently a role for phosphorylation of zf-C2H2 domains in
inhibition of transcription has been suggested (43, 44), sup-
posedly as a consequence of the negatively charged
phosphomoiety that reduces DNA affinity (45). Indirectly our
results support this; because we did not retrieve any interac-
tion partner for the synthesized phosphopeptide matching the
zinc finger motif, it is unlikely that this motif directs protein-
protein interaction, but rather phosphorylation of this motif
modulates nucleic acid binding.
Similarly the novel motifs from clusters 16 and 20 could
mediate mechanisms other than protein-protein interactions,
for example, a kinase motif that mediates enzyme activation,
nucleic acid binding, protein folding, etc. Supporting this, we
found these motifs to be present in proteins overrepresented
in proteins with GO terms ‘ion binding‘ and ‘kinase activity,‘
respectively. Likewise the motifs from clusters where we did
not find the expected partners (clusters 3, 9, 10 and 18) are all
except motif 3 overrepresented in proteins involved in enzy-
matic processes and ion binding (see Fig. 2 or supplemental
Table 2).
This indicates that the motifs not mediating protein binding
could govern processes such as phosphorylation-dependent
enzyme activation and nucleic acid binding. Taken together
with the results from the pulldown experiment where 13 of 20
motifs mediated interaction, we estimate that one-third of the
Tyr(P) motifs in the proteome mediate processes other than
interaction through prototypic SH2 and PTB domains.
Identification of a New N-terminal Hydrophobic Tyr(P) Bind-
ing Motif for SHIP2—From cluster 4 we extracted a new
N-terminal hydrophobic motif, (D/E)XXX(I/L/V)(I/L/V)pY. We
synthesized a peptide pair from the neural Wiskott-Aldrich syn-
drome protein (N-WASP) matching the motif where Tyr-253 was
either phosphorylated or non-phosphorylated. This phospho-
Tyr-253 was identified in a large scale phosphoproteomics ex-
periment (12). It has previously been shown that phosphoryla-
tion of Tyr-253 modulates localization of N-WASP from
nucleus to cytoplasm, thereby possibly stimulating cell migra-
tion (46). Using the N-WASP peptide pair in our quantitative
proteomics experiment, we found the SH2 domain-bearing
inositol 5-phosphatase 2 (SHIP2) as a significant binding part-
ner with 12 peptides (ratio, 9.5  1.5) of 131 protein back-
ground partners (ratio, 1.2  0.9) (see supplemental Table 1).
To address the specificity of this N-terminal hydrophobic
phosphomotif we repeated the experiment with the only dif-
ference being that the two hydrophobic residues were mu-
tated to alanines (AApY) and paired this peptide with the wild
type N-WASP phosphopeptide (VIpY) (Fig. 3). The SHIP2
protein bound specifically to the wild type phosphopeptide
(ratio, 10.2  3) but not the mutated phosphopeptide, con-
firming the specificity of the hydrophobic motif. In a third
interaction experiment we obtained similar results by using a
phosphopeptide in which all three residues in the extracted
motif were mutated (see supplemental Table 1). This supports
the notion that recognition is based on two hydrophobic
amino acids adjacent to the Tyr(P), and we could confine the
motif to (I/L/V)(I/L/V)pY.
We next extracted three additional peptides from the same
cluster matching the (I/L/V)(I/L/V)pY motif. Two of three of
these phosphopeptide pairs also specifically pulled down
SHIP2 (see supplemental Table 1). Together these experiments
show that this indeed is a generic binding motif for SHIP2.
Similarly to previous studies using this phosphospecific
pulldown method (20, 36) in this work we only retrieved spe-
cific interaction partners containing either an SH2 or a PTB
domain. Because SHIP2 contains an SH2 domain it is highly
unlikely that interaction between SHIP2 and the phosphopep-
tides could be mediated by domains other than the SH2
domain.
Because the observed interaction seems to be one of the
first examples where N-terminal residues of the ligands guide
SH2 domain binding, we wanted to exclude the possibility
that the peptide was bound in a reverse fashion. We synthe-
sized the N-WASP peptide pair with the reverse sequence
(GTKEIFDpYIVKSTER) and found that SHIP2 was not re-
trieved using this scrambled peptide pair as bait (see supple-
mental Table 1). Thus, the assay has directional specificity,
and only the two hydrophobic residues N-terminal and not
C-terminal from the Tyr(P) direct SH2 domain-mediated
SHIP2 binding.
To investigate the significance of the motif on a proteome
level, we used the aforementioned GO analysis and found that
proteins containing the motif indeed are involved in signal
transduction. The (I/L/V)(I/L/V)Y is not particularly specific in
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itself because it matches 3618 times, which is about 10% of
all proteins in the mouse proteome. However, of the 3618
proteins, 2495 can be backtracked to the term ‘cell surface
receptor-linked signal transduction‘ (GO:0007166) (p 
1e100). In summary, the N-terminal hydrophobic motif we
characterized mediates SHIP2 interaction and is generally
overrepresented in proteins involved in signal transduction.
DISCUSSION
Currently there is a unique opportunity to mine and classify
Tyr(P) motifs in the proteome. 1) A significant portion of the
Tyr(P) sites have been mapped by MS-based proteomics
experiments. 2) Although not exhaustively, classical biochem-
ical studies have pinpointed interaction between SH2 and
PTB domain-containing proteins and specific Tyr(P) ligands.
3) Advances of high throughput validation methods, like the
peptide pulldown assay used in this study, make it possible to
validate dozens of interaction motifs. Together these devel-
opments constitute the basis for discovering and validating
Tyr(P) motifs on a global level.
Methodological Considerations—Compared with previ-
ously published methods that mine for motifs in large scale
phosphoproteomics data sets we partitioned by similarity with
functionally characterized peptides prior to motif extraction.
By this clustering approach we obtained high resolution and
can extract meaningful patterns from functionally and physi-
cally related groups of peptides. We used the binding ligands
of PTB and SH2 domains both as a clustering backbone and
as positive controls in the clustering and could consequently
obtain a satisfactory fit of the model. Ideally as more interac-
tion data become available one would use independent con-
trols; however, this was not possible due to data limitations.
For all the 20 extracted motifs we could either detect a match
to an existing Tyr(P) motif, retrieve a binding partner, or obtain
a meaningful GO term for all proteins containing the motif, and
thus, we estimate that we have an insignificantly low false
positive motif extraction rate in our method.
In the few cases where we did not retrieve the expected
binding partner from the Tyr(P) motif alone, i.e. Fps/Fes,
STAT, and Vav, it can be speculated that 1) the motifs, orig-
inally defined in vitro, could be low affinity motifs in vivo, 2) the
proteins were not expressed in the C2C12 muscle cell line
used in this study, or 3) it could be due to a technical limitation
in our assay.
protein is an unspecific binding protein because the ratio of the ion
intensities of the two differentially labeled peptides is 1:1. B, mass
spectrum of a doubly charged [13C6,
15N4]Arg-labeled tryptic peptide
from SHIP2. SHIP2 specifically binds to the phosphorylated peptide
from N-WASP as indicated by the larger peak intensity of the labeled
peptides. C, when mutating the VIpY motif to AApY and comparing
these two 15-mer phosphopeptides directly in a pulldown assay,
SHIP2 is still retrieved as a specific binding partner to the VIpY motif,
confirming the specificity of the hydrophobic motif immediately N-
terminal to the Tyr(P).
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FIG. 3. Identification of a new hydrophobic N-terminal motif for
SHIP2. A, mass spectrum of a doubly charged [13C6,
15N4]Arg-labeled
tryptic peptide from myosin light chain 1 pulled down with the
RETSKVIYDFIEKTG peptide from N-WASP. The myosin light chain 1
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Implications for a New Motif for SHIP2—One of our findings
was that the SH2 domain-containing inositol 5-phosphatase
SHIP2 binds to a novel N-terminal hydrophobic motif, (I/L/V)(I/
L/V)pY. The specificity of this motif was confirmed by muta-
tional analysis. A scrambled peptide pair with the reverse
sequence and thus with the motif C-terminal of the Tyr(P) did
not retrieve SHIP2, confirming that the recognition lies on the
N-terminal side of the Tyr(P). SHIP2 is also retrieved by two
other peptide pairs matching the motifs, indicating this is a
generic motif for SHIP2 binding.
In general, the C-terminal residues Tyr(P) 1 and 3 are
considered as the most important for the binding specificity of
prototypic SH2 domains (1, 2). Interestingly the SH2 binding
motif of SHIP2 that we describe is N-terminal, indicating that
the peptide binding groove of some SH2 domains also ac-
commodates residues N-terminal of the Tyr(P). In agreement
with this, the binding properties of the tandem SH2 domains
of the protein-tyrosine phosphatase SHP-2 are governed by
residues Tyr(P) 2 to 5 (47). SHP-1 and SHP-2 both bind
the (I/L/V)XpYXX(I/L/V) ITIM motif in the cytoplasmic part of Fc
receptors, and the Tyr(P) 2 hydrophobic residues have spe-
cifically been shown to mediate binding (23, 48, 49). In con-
trast to the prototypic SH2 domains that have an Arg in the
A2 binding pocket groove, the tandem SH2 domains of the
SHP-1 and SHP-2 phosphatases instead have Gly (50). Sup-
posedly this creates a gap that is filled by the side chain of the
Tyr(P) 2 residue of the bound peptide. Supporting this hy-
pothesis, it has been shown that a single point mutation in
A2 Gly3 Arg disrupts the Tyr(P) 2-mediated binding spec-
ificity of SHP-2 (48). Furthermore it is known that signaling
lymphocytic activation molecule-associated protein (SAP)
and Eat2 SH2 domains in part are directed by N-terminal
binding to ITIM motifs (51).
The binding motif of the SH2 domain of SHIP2 has not
previously been investigated using degenerate peptide bind-
ing experiments; however, the ITIM motif has also been re-
ported as a docking point for the SH2 domain of SHIP2 (52,
53). Combined with our observations, this indicates that the
binding specificity of SHIP2 may be conferred by hydrophobic
residues immediately upstream of the Tyr(P) with contribu-
tions from downstream hydrophobic patches. To our knowl-
edge, other than that of SHP, this is the only other reported
N-terminally directed Tyr(P) binding motif.
It could be speculated that the SHIP inositol phosphatases
could have a binding mechanism similar to that of SHP pro-
tein-tyrosine phosphatases. However, in contrast to SHP the
SH2 domains of the SHIP phosphatases resemble the proto-
typic SH2 domain because they have the highly conserved
A2 Arg (50), indicating that the N-terminally directed binding
mechanisms differ between SHIP and SHP phosphatases.
Because the crystal structure of the SHIP2 phosphatase with
a bound ligand has not been resolved, the specific binding
mechanisms have yet to be described.
SHIP2 is involved in membrane signaling by dephospho-
rylating the 5
-phosphate group of the key secondary messen-
ger phosphatidylinositol 3,4,5-trisphosphate (PIP3). Through
this action SHIP2 inhibits PI3K-mediated receptor tyrosine
kinase signaling because PIP3 is generated by PI3K (54). The
new motif we describe for the SH2 domain of SHIP2 fits into
this overall function because a GO term analysis of all proteins
containing the (I/L/V)(I/L/V)pY motif revealed that these pro-
teins are involved in cell surface receptor-linked signal trans-
duction. Presumably SHIP2 could bind to a number of yet
unidentified membrane signaling proteins through its SH2 do-
main and in this way be translocated to the membrane or act
cooperatively with these proteins. Negative regulators of PI3K
and PIP3 are attractive as antiobesity and diabetes drug targets
because PI3K is the main effector of insulin signaling. Recently
a role for SHIP2 as a candidate for such therapeutic intervention
has been proposed by studies of SHIP2 knock-out mice (55,
56). Thus, the new motif described in this report may not only be
involved in regulation of SHIP2-mediated signal transduction
but could also be relevant for medical use.
Conclusions—This work presents the first system-wide ap-
proach to mine the proteome for Tyr(P) interaction motifs
using both bioinformatics methods and experimental valida-
tion. Strikingly 16 of the 20 motifs extracted could be matched
to previously described interaction motifs. Our experimental
validation shows that the majority of the Tyr(P) interaction
motifs that previously have been defined in vitro are also able
to pull down interaction partners from complex lysate mix-
tures. The GO analysis revealed that motifs that mediate
interaction in the pulldown assay are found in proteins in-
volved in signal transduction, whereas remaining non-binding
motifs are found in enzymes and ion- and nucleic acid-binding
proteins. This raises the intriguing possibility that about one-
third of the in vivo Tyr(P) sites are not directly involved in
interaction via domains such as SH2 and PTB but rather are
sites that could alter the catalytic activity of enzymes or mod-
ulate the DNA binding affinity of e.g. transcription factors.
Perspectives—The developed clustering method is applicable
to other types of complex large scale data sets of post-transla-
tional modification where a substantial amount of peptide-pro-
tein interactions have been identified. As MS-based methods
map more modifications such as acetylation and methylation
sites, such interactomes could be mined for conserved motifs
and assayed for binding partners in a similar manner. Combin-
ing proteomics and bioinformatics enables one to do large scale
screens in an unbiased way and thus allows one to reconfirm
previous knowledge and discover new mechanisms at the same
time. As mass spectrometric streamlining and automation ad-
vances, entire post-translational modification proteomes can be
mapped, binding motifs can identified, and thus ultimately the
specificity of signaling networks can be unraveled.
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5.1 PUBLICATION: TOP-DOWN QUANTITATION AND 
CHARACTERIZATION OF SILAC-LABELED PROTEINS 
 
This article presents the investigation of top-down analysis of SILAC-labeled proteins and 
was published in 2007, in the November issue of Journal of the American Society for 
Mass Spectrometry on pages 2058-2064. 
The project was a joint effort together with Leonie Waanders in our group. 
The following pages contain the published version of the article. 
Top-Down Quantitation and Characterization
of SILAC-Labeled Proteins
Leonie F. Waanders, Stefan Hanke, and Matthias Mann
Proteomics and Signal Transduction, Max-Planck Institute for Biochemistry, Martinsried, Germany
Stable isotope labeling by amino acids in cell culture (SILAC) has become a popular labeling
strategy for peptide quantitation in proteomics experiments. If the SILAC technology could be
extended to intact proteins, it would enable direct quantitation of their relative expression
levels and of the degree of modification between different samples. Here we show through
modeling and experiments that SILAC is suitable for intact protein quantitation and top-down
characterization. When SILAC-labeling lysine and/or arginine, peaks of light and heavy
SILAC-doublets do not interfere with peaks of different charge states at least between 10 and
200 kDa. Unlike chemical methods, SILAC ensures complete incorporation—all amino acids
are labeled. The isotopic enrichment of commercially available SILAC amino acids of
nominally 95% to 98% shifts the mass difference between light and heavy state but does not
lead to appreciably broadened peaks. We expressed labeled and unlabeled Grb2, a 28 kDa
signaling protein, and showed that the two forms can be quantified with an average standard
deviation of 6%. We performed on-line top-down sequencing of both forms in a hybrid linear
ion trap orbitrap instrument. The quantized mass offset between fragments provided infor-
mation about the number of labeled residues in the fragments, thereby simplifying protein
identification and characterization. (J Am Soc Mass Spectrom 2007, 18, 2058–2064) © 2007
American Society for Mass Spectrometry
The use of mass spectrometry to analyze biologicalsamples has evolved tremendously over the lastdecade, and mass spectrometry-based proteom-
ics, in particular, has become an indispensable part of
modern life sciences [1]. In recent years, the need for
quantitative as opposed to qualitative proteomics ex-
periments has become apparent, and a large number of
different approaches have been developed, mainly
based on incorporation of a “light” and “heavy” stable
isotope tag [2]. In chemical approaches, such as in the
original ICAT and in the iTRAQ method, the label is
reacted with a functional group of an amino acid. In
metabolic approaches, the label is instead incorporated
by living cells through protein turnover. Our laboratory
has previously described a metabolic labeling method
called stable isotope labeling by amino acids in cell
culture (SILAC, [3]). In SILAC, an essential amino acid has
been substituted by its stable isotope counterpart in the
medium in which the cells grow, and this “heavy” amino
acid is hence incorporated into all expressed proteins.
SILAC allows very accurate peptide quantitation in an
automated, high throughput experimental setup.
In contrast to this “bottom-up” approach, “top-
down” proteomics seeks to characterize intact proteins.
Although not widely used in biological research yet,
top-down proteomics has unique potential because it
can characterize the complete primary structure of the
proteins, including modifications that may be missed in
the bottom-up approach. Until now, most top-down
studies have focused on mass measurement of the
protein, its identification in databases using MS or
MS/MS data, or on measuring protein modifications.
Hardware and software developments, such as im-
proved resolution and sensitivity, better fragmentation
techniques, and increasingly automated software have
recently made top-down identification and character-
ization much faster [4 –7]. These developments should
make quantitative rather than qualitative top-down
proteomics more feasible. So far, however, very few
studies have combined the top-down approach with
protein quantitation. Gordon et al. demonstrated that
relative molecular ion intensities can be used for intact
protein quantitation [8]. Kelleher and coworkers inves-
tigated the use of 15N labeling of yeast proteins for
intact protein quantitation and determined 50 protein
ratios [9]. In the same paper, the authors also chemically
labeled yeast proteins with acrylamide and iodoacet-
amide. They concluded that the use of stable isotopes is
preferred, since it prevents chromatographic shifts dur-
ing LC-MS separation and make quantitation easier and
more accurate. Furthermore, a general problem of
chemical labeling strategies is the fact that it is not 100%
complete in terms of incorporation. Due to steric hin-
drance in the intact proteins, not all amino acids react
evenly well with the isotope labeled reagent, and there-
fore the degree of labeling is difficult to control.
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Although quantitative approaches are rare in the
top-down proteomics field, stable isotopes have been
used for intact protein analysis for a number of years. In
2000, Smith and coworkers used deuterated leucine to
improve the identification of E. coli proteins as the mass
offset in the full scan indicated the number of leucines
present in the protein [10]. They also substituted other
essential amino acids such as Ile, Phe, Arg, His, and Lys
to determine their number in the protein [11]. “Heavy”
and “light” labeled proteins were well separated as
long as the labeled amino acid was present at least three
times per protein.
We have recently investigated the LTQ-Orbitrap, a
hybrid linear ion trap orbitrap mass spectrometer, for
top-down proteomics [12]. We found that the good
sensitivity and excellent mass accuracy and resolution
are sufficient for fast and reliable protein identification
and characterization. We now extend this work by inves-
tigating whether the SILAC technology is also applicable
to intact protein quantitation and characterization. We
show feasibility by modeling SILAC-labeling for proteins
up to 220 kDa, and by quantifying a 28 kDa signaling
protein that was expressed in medium with normal and
with heavy arginine and lysine residues.
Experimental
Modeling
The theoretical applicability of SILAC for protein quanti-
tation was tested by modeling the isotopic and charge
state clusters of proteins of different molecular weight.
Based on the amino acid frequencies as determined by
McCaldon and Argos [13], we calculated the mass of a
hypothetical sequence with 100 residues (11 kDa) and
extrapolated this to 55 and 220 kDa. For the modeling we
used the Isotopica web application, developed by the
groups of Fernandez-de-Cossio and Takao [14]. We first
simulated SILAC-labeling with 13C6
15N4-arginine and
13C6
15N2-lysine, inducing a mass increment of 10.008 and
8.014 Da, respectively, assuming that 100% of the substi-
tuted carbon and nitrogen atoms were “heavy.”
The influence of incomplete labeling and isotope
enrichment were tested by calculating the frequency of
different protein forms in an arginine-labeled 55 kDa
protein with approximately average amino acid distri-
bution. To test the effects of imperfect isotope enrichment
of the SILAC amino acids, we varied the relative abun-
dance of the substituted 13C and 15N in the labeled amino
acid from 100% to a lower value such as 98% or 95%.
To simulate incomplete amino acid incorporation,
we calculated the relative abundance of protein forms
when the chance of incorporation of light labels was
P  0.02 or P  0.05, assuming a binomial distribution.
For every protein form, the isotope distribution of the
34th charge state was predicted with Isotopica (resolu-
tion 60,000) and protein forms were weighted according
to their probabilistic frequencies.
In Vitro Expression and Purification of Grb2
The gene for growth factor receptor-bound protein 2
(Grb2) was purchased from RZPD German Resource
Center for Genome Research, Berlin, Germany (clone
RZPDo834A0934D). It was transferred into pDEST17 via
Gateway-cloning for T7-RNA polymerase dependent ex-
pression as an N-terminally His6-tagged protein.
All chemicals and enzymes were purchased from
Sigma (Taufkirchen, Germany) or Roche Applied Sci-
ence (Mannheim, Germany) at the highest purity.
Recombinant N-terminally His6-tagged Grb2 was
expressed using a cell-free system prepared as de-
scribed in reference [15] with slight modifications. E.
coli S30 lysate was prepared from BL21(DE3)RIL cells
(Novagen, Darmstadt, Germany). T7 RNA polymerase
was also expressed in BL21(DE3)RIL containing the
vector pAR1219 described in ref [16], but the enzyme
was not purified. Instead, we prepared another lysate
from this IPTG-induced culture and added 60 L for
this lysate to 400 L of the standard lysate to 1 mL of
reaction volume. The concentration of the reaction
components were adjusted to 57 mM HEPES-KOH
buffer (pH 8.2), 2 mM DTT, 1.2 mM ATP, 0.85 mM each
of CTP, GTP and UTP, 100 mM creatine phosphate, 130
g/mL creatine kinase, 2.0% PEG 8000, 0.64 mM 3=,5=-
cyclic AMP, 34 M L(-)-5-formyl-5,6,7,8-tetrahydrofolic
acid, 175 g/mL E. coli total tRNA, 90 mM potassium
glutamate, 80 mM ammonium acetate, 12 mM magne-
sium acetate, 2.0 mM each of the 20 amino acids, and 6.7
g/mL of plasmid DNA. The reaction mixture was
incubated for 2 h while shaking at 600 rpm at 30 °C.
For the heavy SILAC labeled Grb2, the normal
arginine and lysine were replaced with their heavy-
isotope counterparts 13C6
15N4-Arginine and
13C6
15N2-
Lysine, also at a concentration of 2 mM. The reaction
mixture contained the target protein mostly as precipi-
tate, which was solubilized with 6 M guanidinium chlo-
ride and subsequently purified employing Ni2-affinity
chromatography according to the manufacturer’s protocol
for purification of denatured protein using Ni-NTA sepha-
rose (Qiagen, Hilden, Germany) and spin columns (Mo-
BiTec, Goettingen, Germany). The purified protein was dia-
lyzed against distilled water to remove imidazole and
guanidinium, which again led to precipitation of the protein.
Sample Preparation and Mass Spectrometry
Heavy and light labeled forms of Grb2 were aliquoted
separately and stored at 80°C before use. Before mass
spectrometric analysis, the proteins were washed on RP-
C18 StageTips [17], eluted, and mixed in the desired ratio.
All experiments were done on a LTQ-Orbitrap
(Thermo Fisher, Bremen, Germany), coupled to a nanoLC
system (Agilent, Waldbronn, Germany). Online protein
separation was performed by use of 75 m  150 mm
IntegraFrit columns (New Objective, Berlin, Germany)
packed in-house with 5 m RP-C18 beads (Reprosil-Pur
Aq, 200 Å pore size, Dr. Maisch, Ammerbuch-Entringen,
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Germany). The column was connected to a short nano-
spray needle and spraying voltage was kept low (2 kV)
to prevent oxidation [18]. During loading and washing,
the flow was set to 500 nL/min; whereas during the actual
gradient the flow rate was 250 nL/min. Buffers composi-
tions were 0.5% acetic acid in mQ distilled water (Buffer
A) and 0.5% acetic acid in acetonitrile (Buffer B). The
proteins eluted in a 30 min gradient from 40% to 90% of
Buffer B. CID fragmentation was performed in the LTQ,
but MS/MS ions were detected in the orbitrap mass
analyzer.
Data Analysis
The MS scans were deconvoluted with Xtract soft-
ware (Thermo Fisher) and matched with the expected
sequence. The light form of Grb2 was used to deter-
mine the sequence of the linker between the His-tag
and the protein.
CID fragments observed in light or in both light and
heavy MS/MS spectra were searched in ProSight PTM
(developed by The Kelleher group, University of Illinois,
Urbana-Champaign, IL), but without success. We there-
fore suspected they were internal fragments and
searched them in Mascot (Matrix Science Ltd., Lon-
don, UK) after increasing light fragment masses by
one water molecule (18.0152 Da). A peptide mass
fingerprint search was performed against the human
IPI database (version 3.19) and a small database with
the predicted His-tagged Grb2 sequence with 10 ppm
maximum mass deviation and without enzyme specificity.
Results and Discussion
Simulation of SILAC Quantitation
for Intact Proteins
We first wanted to investigate whether SILAC would be
applicable for proteins of all sizes and whether any
overlap between charge states and labeled states could
occur. To this end, we used Isotopica, a software package
freely available on the Internet, and developed by
Fernandez-de-Cossio and Takao [14], to model the
effect of SILAC labeling. Isotopica can predict the
isotopic cluster of specific charge states and can also
calculate the mono-isotopic and average mass of all
charge states (up to 50) for both heavy and light labeled
proteins. As shown in Figure 1a– c, SILAC labeling with
heavy arginine and lysines results in mass offsets that
are clearly distinguishable in a spectrum. The thickness
of the lines is approximately equal to the full width of
the isotopic cluster. Even for a 220 kDa protein (Figure
1c) the two lines are separate, indicating that at least
theoretically the isotopic clusters of the light and heavy
protein forms do not overlap with consecutive charge
states.
Because the mass offset induced by SILAC is in the
range of a few hundred Da, when both arginine and
lysine are labeled, post-translational modifications with
a mass less than this would not overlap with either the
heavy or the light form of the protein. For example,
several phosphorylation sites on a 50 kDa protein
would not overlap with the heavy version, which is
500 Da higher in mass.
The simulation also allowed us to visualize the effect
of incomplete isotope enrichment. In principle, SILAC
amino acids should be labeled with 13C or 15N to 100%
at the substituted sites but in practice commercial
sources guarantee isotope enrichment between 95% and
98%. As described in the Experimental section, we
modeled this by varying isotope abundances in the
heavy form of an average 55 kDa arginine-labeled
protein. Interestingly, incomplete isotope enrichment
does not broaden the peaks but it does shift the mass of
the heavy form to a lower value (Figure 1d). It follows
from this that accurate mass measurement to determine
the molecular weight of the intact protein should be
performed on the light and not on the heavy form of the
SILAC protein pair.
Next, we modeled the effect of incomplete labeling,
that is, we modeled the case that not every light amino
acid was replaced by its heavy counterpart. This could
happen during SILAC cell adaptation, while light
amino acids are still present. As Figure 1e shows, even
incomplete labeling at the two percent level (no more
than one amino acid in our example), causes the signal
to split into at least three states and this reduces the
overall intensity and signal to noise (S/N) dramatically.
At the 5% level, severe splitting into at least four states
occurs, and the heavy peak is broadened at least 3-fold.
Therefore, complete labeling is a precondition for suc-
cessful quantitative top-down analysis. Fortunately, it is
not difficult in SILAC experiments to achieve complete
labeling; the only requirement is to grow the cells for a
sufficient number of cell doubling.
Note, however, that this broadening is very likely to
occur in chemical labeling strategies because it is very
difficult to achieve close to 100% labeling on the desired
amino acids while preventing any labeling of untar-
geted sites.
Expression and Mass Spectrometry
of SILAC-Labeled Grb2
To experimentally test the feasibility and accuracy of
quantitation by SILAC for an intact protein, we expressed
HIS-tagged Grb2, a signaling protein with a calculated
monoisotopic mass of 27,789.758 Da in vitro in normal
media and in media with heavy arginine and lysine. Light
and heavy protein forms were measured separately and
mixed in 1:1 or 2:1 ratio. The mixture was analyzed by
online HPLC MS on the LTQ-Orbitrap (see Figure 2).
The resolving power of the orbitrap was sufficient to
observe the isotopic clusters. By measuring the heavy
labeled protein only, we obtained a single population
and conclude that we achieved 100% label incorpora-
tion (data not shown).
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Influence of Isotope Enrichment in Heavy Label
Above, we modeled the influence of incomplete isotope
enrichment of the SILAC amino acid. The SILAC amino
acids used in our experiment were specified at 98% for
13C. For 15N they were specified as 95% for Lys and 98%
for Arg. Thus about 2% of the labeled carbon and
nitrogen atoms in their stable isotope labeled amino
acids should be light (12C and 14N). However, when we
used this value to predict the mass offset between the
heavy and light labeled Grb2 protein forms, we could
not explain an additional mass difference of 3 Da for the
heavy labeled Grb2 form in comparison with the calcu-
  100%
 labeled
1 residue 
unlabeled
2 residues 
unlabeled
1500 1520 1540 1560 1580 1600 1620 1640
m/z
7+
light heavy
1500 1520 1540 1560 1580 1600 1620 1640
m/z
light heavy
36+ 35+ 34+
1500 1520 1540 1560 1580 1600 1620 1640
m/z
146+ 142+ 140+ 138+ 136+ 134+light heavy
98% labeling
95% labeling
1624.4 1624.8
m/z
1625.21624.0
1624.4 1624.8
m/z
1625.21624.0
  100%
 labeled
1 residue 
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3 residues 
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light
1624.8
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1625.21616.0 1616.4
+/- 0.9 m/z
100% isotope
 enriched (ideal)
+/- 0.9 m/z
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(a) (d)
(b) (e)
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Figure 1. Simulation of heavy and light SILAC labeled proteins of various molecular weights with an
average amino acid distribution. (a)–(c) SILAC-labeling with 13C6
15N4-Arg and
13C6
15N2-Lys increases the
protein mass by approximately 1%, resulting in well separable isotope clusters, independent of protein
size. The isotopic clusters of light and heavy labeled proteins of 11, 55, and 200 kDa in the m/z range 1500
to 1650 are depicted in panels (a)–(c), respectively. The thickness of the lines indicates the full width of the
isotope cluster, which for all size proteins remains below 1 Thomson. (d)–(f) The effects of incomplete
isotope enrichment and incomplete mass labeling are modeled, based on the 34 peak of a theoretical
protein of 55 kDa with average amino acid composition, labeled with heavy arginine and measured with
60,000 resolving power. (d) A 98% isotope enrichment of 13C and 15N in the heavy amino acids results in
a shift of the total heavy isotopic cluster from 100% enrichment. The width and the intensity of the isotopic
cluster remain unchanged. (e) In contrast, if only 98% of the arginines and lysines are labeled with heavy
amino acids, the result is a significant spread of the signal. (f) With 95% labeling the signal is even more
spread and the total intensity is reduced to 33% of the original signal.
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lated one of 264.3 Da. Since the sequence of the protein
is known and confirmed by the light labeled protein,
this mass difference had to be caused by the heavy
amino acids.
When overlaying the experimentally obtained spec-
tra with the prediction made by Isotopica (Figure 2b),
we discovered that the matching became very accurate
when isotope enrichment was 99%. Thus, in this case,
the isotope enrichment of the SILAC amino acids was
almost complete and significantly higher than specified.
Furthermore, our measurements confirmed the simula-
tion in Figure 1d. The rare presence of 12C and 14N
instead of 13C and 15N in the heavy amino acids did not
cause problems for the analysis or quantitation, since
the signal intensity and the width of the isotopic distri-
bution remained the same. Note that the percentage of
light atoms in the heavy label needs to be determined
only once as it will be the same for all proteins that are
labeled with that specific batch of heavy amino acids.
Quantitation at the Protein Level Using SILAC
A contour plot of the SILAC labeled Grb2 forms
showed that they eluted as a 1 min peak with no
discernable retention time shift between them (Figure
2a). Complete isotopic separation and coelution should
allow for very accurate quantitation. The spreading of
the protein signal into multiple charge states reduces
the S/N but improves quantitation, since all charge
states should show the same ratio between heavy and
light labeled forms. To determine the quantitation pre-
cision, the ratio between Grb2-light and Grb2-heavy
was calculated for a single scan and for an averaged
scan, composed of 20 separate scans over the elution
profile. In both cases the eight most intense charge
states were used for the calculation. We then repeated
this measurement in five separate HPLC runs to dem-
onstrate the reproducibility of the measurement. In the
insert of Figure 2, the average ratio is displayed with
95% confidence interval error bars. When averaging 20
scans, the mean standard deviation was 6%, whereas
ratios determined from single scans had a standard
deviation of typically 18%.
The ratio calculation can be further improved by
using the complete elution profile of the proteins (see
Figure 2a). Furthermore, as Ong et al. [19] and Du et al.
[9] have noted, results become more accurate if they are
corrected for noise, especially in case of low S/N peaks.
Improved Assignment of Top-Down Fragments
by SILAC
Besides the accurate quantitation, SILAC can also be
used for identification and characterization purposes.
The information in fragmentation spectra is valuable in
assigning modifications and in improving the reliability
of protein identification. Modifications and truncations
are more easily detected and more likely correctly
assigned. Due to the speed and sensitivity of the orbi-
trap, such MS/MS spectra are readily obtainable on
small proteins [12].
To demonstrate this in a SILAC experiment, we per-
formed data-dependent CID fragmentation in the online
format, collecting MS and MS/MS scans in the orbitrap,
without microscanning to keep the duty cycle short.
The MS/MS scans were of relatively low intensity
(Figure 3), but the resolution and mass accuracy of the
fragments was sufficiently high that even low abundant
ions could be clearly distinguished from the noise.
When comparing the MS/MS scans of heavy and
light labeled Grb2, we observed very similar fragmen-
m/z1000 1200 1400 1600
single 
scan
1320 13401330
1320 13401330
m/z
average of
20 scans
light heavy(c)
(a)
39.8
40.8
Elution 
time
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1390 1395 1400 1405m/z
(e) (f)
m/z1000 1200 1400 1600
m/z1200 1400 1600 1800
(d)
0.2
0.6
1
1.4
1.8
1 2 3 4 5
Measurement number
Average of 20 scans
 Single scan
Ratio Light Grb2 / Heavy Grb2
(b)
Figure 2. Experimental spectra of mixed Grb2 forms, showing
the experimental feasibility of SILAC. (a) Contour plot of the
eluting SILAC labeled protein pair. The graph is color coded with
light green corresponding to low and dark green to high intensity.
(b) Single spectrum of mixed light and heavy Grb2 forms, show-
ing multiple charge states of both forms with isotopic clusters that
do not overlap. The ratio between heavy and light Grb2 is constant
over the different charge states and allows accurate quantitation
based on relative intensities. (c) Averaging of spectra leads to
significant noise reduction and improves quantitation accuracy.
(d) Intensity ratios between light and heavy labeled Grb2, based
on the eight most intense charge states of single or averaged
spectra (20 scans) for 5 different LC-MS-runs were determined
with their 95% confidence interval error bars. (e) An experimen-
tally obtained spectrum was overlaid with the Isotopica prediction
(red), calculated using 99% heavy isotope enrichment. (f) The
inserts show that the simulation is accurate down to the isotopic
resolution, indicating higher isotope enrichment of Arg and Lys
than specified by manufacturers.
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tation that appeared very useful for assigning the
fragments. The mass offset between the heavy and light
fragments should exactly represent the number of ly-
sines and arginines of every fragment. Table 1 lists the
fragments and their mass deviations from the calcu-
lated values. Most of the fragments were internal and
likely observed because the disulphide bridge was still
present in the protein.
The absolute mass deviation of the fragments was
very low, on average 3.2 ppm, and the number of
lysines and arginines determined by the mass incre-
ment of the heavy labeled fragments matched exactly
with the proposed identification. One potential false
positive hit could be eliminated both because of its mass
deviation of 14 ppm and also because of the fact that its
counterpart in the spectrum of the heavy form of Grb2
did not indicate the correct number of lysines. In total
the single scan CID fragmentation depicted in the figure
resulted in fragments covering 40% of the protein
sequence. Clearly the SILAC information at the frag-
ment level would have been very valuable to assign any
protein modification, had it been present.
Conclusions and Perspectives
Here we have investigated the applicability of the
SILAC technology to top-down proteomics. Through
theoretical modeling, we found that heavy and light
SILAC-doublets do not interfere with each other even
for very large proteins. The incomplete isotope enrich-
ment of commercial SILAC amino acids does not cause
peak broadening but does shift the mass to lower
values. This effect can be modeled very precisely.
Incomplete labeling, on the other hand, would lead to
distribution of the signal into several peaks, substan-
tially broadening them and decreasing the signal to
noise. Fortunately, incomplete labeling can easily be
avoided in SILAC-metabolic labeling experiments.
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Figure 3. Identification of Grb2 is supported by direct compari-
son of the heavy and light CID fragmentation spectra. Mass
differences between corresponding fragments observed in MS/
MS spectra of the (a) light and (b) heavy Grb2 protein indicate the
number of lysines and arginines per peptide and thereby simplify
and confirm the peptide and protein identification. Assigned
fragments have an average absolute mass accuracy of 3.1  2.3
ppm. The mass deviation of the ion indicated with an asterisk has
been derived from the 13C isotope. N-terminal fragments are
shown in blue and internal fragments in red. (c) In total the
fragments covered 40% of the total protein sequence.
Table 1. Fragments of Grb2 identified by Mascot
Light Heavy
Charge mass
No. of
heavy
residues
Mass
deviation
(ppm) Sequencem/z m/z
954.775 3 5.49 MSYYHHHHHHLESTSLYKKAGGME
978.788 3 3.90 MSYYHHHHHHLESTSLYKKAGGMEA
1039.831 1045.504 3 16.03 2 Lys (1.88)a MSYYHHHHHHLESTSLYKKAGGMEAIA
881.669 887.681 4 24.04 3 Lys 4.79 MSYYHHHHHHLESTSLYKKAGGMEAIAKYD
705.538 5 (0.50)a MSYYHHHHHHLESTSLYKKAGGMEAIAKYD
1175.223 3 4.81 MSYYHHHHHHLESTSLYKKAGGMEAIAKYD
1015.456 1015.455 2 0.01 0 2.00 SYYHHHHHHLESTSLY
1079.503 1083.511 2 8.02 1 Lys 1.10 SYYHHHHHHLESTSLYK
1577.204 2 1.67 LFDFDPQEDGELGFRRGDFIHVMDNSD
1520.661 1530.668 2 20.02 2 Arg 1.20 FDFDPQEDGELGFRRGDFIHVMDNSD
1447.125 2 0.57 DFDPQEDGELGFRRGDFIHVMDNSD
1100.515 1110.520 2 20.04 2 Arg 1.59 PQEDGELGFRRGDFIHVMD
1258.566 1268.573 2 20.03 2 Arg 1.07 QEDGELGFRRGDFIHVMDNSDP
1023.975 1033.983 2 20.03 2 Arg 1.18 GELGFRRGDFIHVMDNS
1747.536 1757.540 3 30.01 3 Arg (0.42)a FNSLNELVDYHRSTSVSRNQQIFLRDIE-QVPQQPTYVQALFDFD
a13C-peaks were used for mass accuracy determination.
2063J Am Soc Mass Spectrom 2007, 18, 2058–2064 TOP-DOWN OF SILAC-LABELED PROTEINS
103
We have shown that a 28 kDa signaling protein,
Grb2, can be readily quantified in the labeled versus the
unlabeled form. The quantitation in a one to one mix-
ture had a typical standard deviation of six percent and
is mainly limited by the lower signal to noise in protein
measurements compared with peptide measurements.
Grb2 was fragmented and analyzed in an LTQ-Orbitrap
instrument using single scan data from online experi-
ments. The high mass accuracy combined with the
quantized mass offsets significantly improves fragment
identification when comparing tandem mass spectra of
light and heavy SILAC labeled protein. The unambig-
uous information about the number of labeled residues
per fragment or protein is a clear advantage of the
SILAC technology over 15N labeling.
In our experiment we chose to use two amino acids,
arginine and lysine that were isotopically labeled, lead-
ing to a 1% mass offset between light and heavy form.
Often, it may be more convenient to label with a single
amino acid, for example, lysine. This would allow direct
“counting” of the number of lysines in the protein and
between fragments in the “heavy” and “light” tandem
spectrum. Double amino acids may be valuable when
analyzing proteins with potentially a high number of
modifications.
Extension of the SILAC technology to intact protein
analysis should allow direct quantitation of endoge-
nous and unprocessed proteins. However, the most
interesting application could be in the direct quantita-
tion of multiple and combinatorial modifications of
regulatory proteins as a function of cellular state. This
goal will require SILAC quantitation of fragments iso-
lating these modifications. It may also require noner-
godic fragmentation techniques such as ECD or ETD as
well as several stages of fragmentation.
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6 FURTHER PUBLISHED AND UNPUBLISHED WORK 
Apart from the printed publications mentioned above, some projects were presented at 
international conferences in the form of the following oral presentations and posters: 
 S. Hanke, H. Besir, D. Oesterhelt, M. Mann. Absolute SILAC for accurate 
quantitation of proteins in complex mixtures down to the attomole level. Oral 
presentation at HUPO-conference in Amsterdam 08-2008 
 S. Hanke, H. Besir, D. Oesterhelt, M. Mann. Absolute quantitation of proteins in 
proteomics: measuring the copy number per cell. Poster at Interact-PhD-
symposium in Munich, 12-2007 
 S. Hanke, H. Besir, D. Oesterhelt, M. Mann. Absolute SILAC: Absolute quantitation 
of proteins in complex mixtures using recombinant stable isotope labeled proteins. 
Poster at ASMS-conference in Indianapolis, 06-2007 
 S. Hanke, WX. Schulze, H. Gausepohl, M. Mann. Microscale peptide synthesis for 
protein interaction experiments. Poster at HUPO-conference in Munich, 09-2005 
 
6.1 VESICULAR TRANSPORT IN THE GOLGI-APPARATUS 
As part of a collaborative project with the research group of Prof. Dr. Felix Wieland at the 
biochemistry center of the University of Heidelberg, mass spectrometric protein 
identification was conducted to determine interaction partners of ADP-ribosylation factor-1 
(Arf1). Arf1 is a small GTPase that can attach to membranes and is relevant for vesicular 
transport in the secretory pathway of cells. Using site-directed photo-activated 
crosslinking, interaction partners for different regions within Arf1 could be determined. 
The project culminated in a publication in the journal Traffic in May 2007 on pages 582-
593. 
 
6.2 TRAFFICKING OF CAVEOLAE 
As part of a collaborative project with the research group of Prof. Dr. Miguel del Pozo at 
the national center for cardiovascular research in Madrid, quantitative proteomics was 
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applied to identify interaction partners of Caveolin-1. Peptide pulldown experiments 
revealed pTyr-based specific binding events that in part depend on cell culture conditions 
(adherent versus suspension). Biological follow-up experiments are still being performed 
in Madrid, and publication of the results is scheduled for the year 2009. 
 
6.3 CAPSID PROTEINS OF HERPES SIMPLEX VIRUS 
As part of a collaborative project with the research group of Prof. Dr. Baumeister at the 
Max-Planck-Institute for biochemistry, absolute quantitation of Herpes simplex virus 
proteins was carried out. Stable isotope labeled peptide standards were used to 
determine the copy number per viral particle for several capsid proteins and to determine 
the stoichiometric relationship between them. These data form part of a structural project 
on viral architecture and are planned to be published in the year 2009. 
 
6.4 PHOSPHORYLATION DYNAMICS OF IRS-1 AND IRS-2 
The project on the pTyr-interactome in the insulin signaling pathway yielded many 
interactions that can be mediated by tyrosine phosphorylated sites in IRS proteins. This 
raised the question which of these sites are in fact phosphorylated in vivo, and which 
stimuli trigger them. Thus, an experimental approach was designed that enables the 
identification of phosphorylation sites in response to hormone stimulation. 
A multiplexed quantitative phosphoproteomics strategy was chosen in order to also 
address the time dimension and deliver dynamic profiles of phosphorylation sites 
depending on the timepoint after stimulation. This strategy is described by the scheme in 
figure 19, and the analyzed timepoints were 0, 5, 10, 20, 30, 40 and 60 minutes after 
stimulation. 
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Figure 19: Simplified scheme of the experimental strategy for the investigation of time-resolved 
phosphorylation changes in IRS proteins after hormone stimulation. 
Triple encoding SILAC allows for the quantitative comparison of 3 different stimulation times in one 
experiment. Immuno-precipitations against IRS-1 and IRS-2 are carried out separately, and 
samples are combined before SDS-PAGE. 
 
This setup allows to simultaneously identify phosphorylation sites and IRS-interacting 
proteins with a readout for their quantitative increase (or decrease) in response to 
hormone stimulation. Different variants of individual steps in the procedure were tested 
and optimized. Antibodies against IRS-1 and IRS-2 were chemically crosslinked to 
magnetic beads, and efficient removal of IRS proteins from myotube cell lysates was 
achieved. Due to relatively clean IRS-bands in SDS-PAGE, further enrichment of 
phosphopeptides via titanium dioxide chromatography after proteolytic digestion did not 
increase the yield and was therefore omitted. More than 20 phosphorylation sites per IRS 
protein were identified with high confidence, however, only three of them were pTyr-sites 
despite targeted MS-acquisition via inclusion lists. Quantitative abundances of 
phosphorylation sites hardly changed in response to insulin stimulation. The most 
pronounced increase was found for the pTyr-sites, but all changes remained below a 
factor of 2. Accordingly, not more than two of the previously identified interaction partners 
of IRS proteins were found. 
Our conclusion from these results is that the stimulation with insulin did not work properly. 
For future efforts this needs to be improved substantially. Additionally, more focused data 
acquisition methods in MS analysis, together with improved performance of inclusion list 
dependent events, will likely enhance the output of this experimental approach. Due to 
time constraints the experiment could not be repeated within the scale of this thesis.
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7.1 SUMMARY AND CONCLUSIONS 
The work presented in this thesis applied quantitative proteomics to different fields of 
biology. On the one hand, specific protein interactions based on pTyr were characterized, 
leading to a large array of novel possible interactions in the insulin signaling pathway and 
to the definition of binding motifs. On the other hand, MS-analysis of SILAC-labeled 
proteins was assessed. This resulted in the development of a novel technique in MS-
based absolute quantitation of proteins, Absolute SILAC, which allows for unprecedented 
quantitative accuracy. 
The insulin signal is known to be translated into a cascade of tyrosine phosphorylation at 
the intracellular side of target cells, which forms the molecular basis for regulated 
interactions between proteins. The molecular interaction platforms IRS-1 and IRS-2 as 
well as the receptors InsR, IGF1R and IRR were successfully screened for their pTyr-
based interaction profiles in a site-specific format. The results provide novel insights into 
the connectivity and the concerted organization of signal transmission at this central stage 
of the pathway. A large body of evidence points at more extended interaction capabilities 
of IRS-1 and IRS-2 than currently known. Several proteins involved in signaling and 
metabolism interact differentially with them and thus provide an explanation for their 
different physiological roles. A large body of common interactors, on the other hand, 
contributes to their frequently observed redundant roles. The hitherto undiscovered direct 
binding of fatty acid degrading enzymes to IRS-proteins provides an additional and direct 
link to metabolic control. The data furthermore suggest the presence of novel pTyr-binding 
modules besides the established SH2 and PTB domains. Differential recruitment of 
interactors by members of the insulin receptor family yielded a molecular basis for their 
unequal physiological roles. Particularly intriguing was the discovery of exclusive binding 
events for the insulin receptor related receptor. In addition, doubly- and triply 
phosphorylated motifs provided insight into the combinatorial effects of phosphorylation 
events in close proximity to each other. 
The technology applied to the insulin project was also exploited in a system-wide 
approach to mine the proteome for pTyr-interaction motifs using both bioinformatic 
methods and experimental validation. A novel algorithm clustered experimentally 
observed pTyr-sites into 20 different groups of motifs. Two thirds of them were found to 
mediate protein interactions. Interestingly, those clusters stem from proteins that are 
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annotated as being involved in signal transduction. The other third of clusters was derived 
from proteins that are annotated as enzymes or proteins involved in nucleic acid or ion 
binding. This suggests that approximately one third of in vivo pTyr-sites does not trigger 
interactions between proteins, but instead may serve structural functions by modulating 
the catalytic activity of enzymes or influencing the affinity for DNA or RNA of proteins 
involved in gene expression. In addition to these global insights, a new type of binding 
motif was discovered for the inositol phosphatase SHIP-2. Remarkably, residues N-
terminal of the pTyr govern the binding event, which has been observed for very few SH2 
domains so far. 
Conventional methods for absolute quantitation of proteins by MS-based proteomics 
suffer from questionable accuracy due to the different nature of the quantitation standard 
as compared to the endogenous protein to be quantified. This work has endowed the field 
of protein quantitation with a novel technique called Absolute SILAC, which delivers 
unprecedented accuracy in absolute quantitation. The generation of SILAC-labeled 
recombinant proteins for use as quantitation standards was demonstrated in vivo and in 
vitro. Handling of the standard was optimized to guarantee high quality of results. The 
approach was characterized in depth, proving excellent accuracy and linearity. Beyond 
the biochemical and analytical features, a novel mass spectrometric data acquisition 
method was designed that improves the detection limit by more than an order of 
magnitude, enhances the success of identification and optimizes the quality of quantitation 
especially for low abundant proteins. Accurate quantitation of a protein down to 150 
attomole could be demonstrated in the complex background of a whole cell lysate without 
any upfront fractionation. Application of Absolute SILAC to the quantitation of the signaling 
adaptor protein Grb2 in several different cell lines resulted in a copy number of close to 
500,000 molecules per cell. Comparison against data from whole proteome analysis 
suggested that approximately 1000 proteins in a cell can be estimated to have a copy 
number higher than this. 
Finally, the analysis of intact proteins as SILAC-pairs by top-down proteomics yielded 
valuable findings for applications that might use top-down measurements on SILAC-
labeled material in the future. It was demonstrated that isotope clusters of light and heavy 
versions of a protein never overlap. Despite the high number of isotopic peaks in case of 
large proteins, isotope clusters are always confined within the width of one Thomson. 
Incomplete isotope enrichment in the amino acid(s) used for SILAC-labeling was shown to 
shift the isotope cluster of the labeled protein slightly to a lower mass without affecting the 
performance of the method. In contrast, incomplete labeling efficiency through 
incorporation of unlabeled components has a strong negative effect by spreading the total 
signal across several isotope clusters. This confirms the importance of using metabolic 
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labeling because chemical labeling can hardly reach complete labeling efficiency. 
Moreover the behavior in MS/MS was investigated, which demonstrated the potential of 
top-down analysis of SILAC-labeled proteins for improved certainty in identification and for 
the quantitative assessment of combinatorial posttranslational modifications. 
7.2 PERSPECTIVES 
With the accomplishment of a comprehensive pTyr-dependent interaction profile of IRS-1, 
IRS-2, InsR, IGF1R and IRR, this study extends the known pTyr-interactome of these 
proteins and provides solid hypotheses for a plethora of biological follow-up projects. In 
the future, it will be exciting to find out which of the pTyr-sites that were found to attract 
interaction partners indeed become phosphorylated in vivo. This is a multidimensional 
space, given the large number of different tissues, stimuli and physiological conditions that 
can decide on the occurrence of phosphorylation events. Thorough investigation of the 
precise role of novel interactions is likely to yield valuable information on the way the 
insulin signal is spread in a cell. Particularly interesting insights can be expected from the 
exploration of the pathways linking insulin to the regulation of transcription and lipid 
catabolism. The fact that several proteins showed pTyr-dependent interactions that are 
not mediated by SH2 or PTB domains provides promising ground for the discovery of 
novel pTyr-binding modules. 
The clustering method developed within the proteome-wide pTyr-motif project is not 
restricted to pTyr-sites. It can be applied to other types of posttranslational modifications 
and supply those areas with an assessment of conserved motifs that can then be assayed 
for interactions using a similar experimental setup like the one reported here. 
Absolute SILAC as a novel method for absolute quantitation of individual proteins in 
complex mixtures shows great promise for applications in research and clinical 
diagnostics. Accurate copy numbers of proteins per cell can provide systems biology with 
input for modeling and enable a more realistic view of connectivities in signaling networks 
and quantitative flux in metabolic pathways. Ultimately, contemporary immunoassays 
employed in patient diagnosis might be complemented or replaced by high-throughput 
multiplexed MS-based quantitation in the future. The high data quality of Absolute SILAC 
provides an important prerequisite for this kind of application. In addition, features of the 
newly developed data acquisition method are of generic nature and can be applied for 
other targeted approaches that aim at signal enhancement and improvements in 
identification and quantitation. 
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Analysis of proteins derived from SILAC-labeled cultures in intact form (top-down) holds 
great promise for the quantitative assessment of combinatorial modifications that change 
dynamically as a function of the cellular state. 
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Abl  Abelson murine leukemia viral oncogene homolog 
AGC  automatic gain control 
Akt  =PKB (protein kinase B) 
ATP  adenosine 5´-triphosphate 
AQUA  absolute quantification 
Cbl  Casitas B-lineage lymphoma proto-oncogene 
CDIT  culture-derived isotope tag 
CID  collisionally induced dissociation 
CoA  coenzyme A 
Crk  chicken tumor virus no. 10 regulator of kinase 
Da  Dalton 
Dab  disabled homolog 
DOK  downstream of kinase 
eIF4E  eukaryotic translation initiation factor 4E 
ERK  extracellular signal-regulated kinase 
ESI  electrospray ionization 
Fes  feline sarcoma virus oncogene homolog 
FFAs  free fatty acids 
FHA  forkhead associated domain 
FOXO1 forkhead box protein O1 
FOXA2 forkhead box protein A2 
FT-ICR Fourier transform ion cyclotron resonance 
Fyn  tyrosine-protein kinase Fyn 
Gab1  Grb2-associated binding protein 1 
GAP  GTPase activating protein 
GLUT-4 glucose transporter 4 
GPR40 G protein-coupled receptor 40 
Grb2  growth factor receptor-bound protein 2 
GSV  GLUT-4 storage vesicle 
HPLC  high performance liquid chromatography 
ICAT  isotope-coded affinity tag 
ICPL  isotope-coded protein label 
iTRAQ  isobaric tag for relative and absolute quantification 
IGF1R  insulin-like growth factor 1 receptor 
InsR  insulin receptor 
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IRR  insulin receptor related receptor 
IRS  insulin receptor substrate 
JAK  janus kinase 
JNK  c-Jun NH2-terminal kinase 
LC-MS  liquid chromatography mass spectrometry 
MALDI  matrix assisted laser desorption/ionization 
MAPK  mitogen activated protein kinase 
MEK  MAP/ERK kinase 
MODY  maturity-onset diabetes of the young 
MS  mass spectrometry 
MS/MS tandem mass spectrometry 
mTOR  mammalian target of rapamycin 
Nck  Nck adaptor protein 
O-GlcNAc O-linked N-acetylglucosamine 
PCS  peptide concatenated standard 
PDB  protein database 
PDK1  phosphoinositide dependent kinase 
PH  pleckstrin homology domain 
PHAS-I phosphorylated heat- and acid-stable protein regulated by insulin 1 
( = eIF4E-binding protein 1) 
PI3K  phosphatidylinositol-3-kinase 
PKC  protein kinase C 
PLC  phospholipase C 
PTB  phosphotyrosine binding domain 
PTM  posttranslational modification 
pTyr  phosphotyrosine 
QconCAT quantitative concatemer 
Raf  Raf protein 
Ras  GTPase Ras 
ROS  reactive oxygen species 
RTK  receptor tyrosine kinase 
S6K  S6 kinase 
SAP  signaling lymphocyte activation molecule-associated protein 
SGK  serum/glucocorticoid-regulated kinase 1 
Shc  SH2 domain containing transforming protein C1 
SILAC  stable isotope labeling by amino acids in cell culture 
Src  Rous sarcoma virus oncogene 
SH2  Src homology 2 domain 
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SH3  Src homology 3 domain 
SHP2  SH2 domain containing protein tyrosine phosphatase 2 
SNAP23 synaptosomal-associated protein 23 
SOCS  suppressor of cytokine signaling 
Sos  son of sevenless 
STAT  signal transducer and activator of transcription 
TNF   tumor necrosis factor alpha 
UDP  uridine 5´-diphosphate 
VAMP2 vesicle-associated membrane protein 2 
VLDL  very low density lipoprotein 
WW  WW domain (2 conserved tryptophanes spaced 20-22 amino acids apart) 
XIC  extracted ion chromatogram 
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